ElementType,Class,Style,Value
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISARESOLUTION OF THE BOARD OF DIRECTORS - RDC NO. 751, OF SEPTEMBER 15, 2022(Published in DOU No. 180, of September 21, 2022)Provides for risk classification,notification and registrationschemes,andlabelingrequirements and instructions foruse of medical devices.TheBoard of Directors of the National Health Surveillance Agency, in theuse of the attributions conferred on it by art. 15, III and IV, together with art. 7, III andIV of Law No. 9,782, of January 26, 1999, and art. 187, VI, § 1st of the Internal Rulesapproved by the Resolution of the Collegiate Board of Directors - RDC No. 585, ofDecember 10, 2021, decides to adopt the following Resolution, as decided at a meetingheld on September 14, 2022, and I, Director-President, determine its publication.CHAPTER IOF THE INITIAL PROVISIONSSection IPurposeArticle 1 This Resolution defines the rules for the risk classification ofmedical devices, the requirements for labeling and instructions for use, and theprocedures for notification, registration, alteration, revalidation and cancellation ofnotification or registration of medical devices.Section IIScopeArticle 2 This Resolution applies to the medical devices defined therein,and notification or registration of such devices is mandatory, according to riskclassification.§ 1 The risk classification, procedures and specifications described in thisdocument, for the purposes of notification and registration, apply to medical devicesand their accessories.§° 2º This Resolution does not apply to used or refurbished medicaldevices, which are subject to the specific rules established in the Resolution of theCollegiate Board of Directors - RDC No. 579, of November 25, 2021, published in DOUNo. 225, of December 1, 2021.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISARESOLUTION OF THE BOARD OF DIRECTORS - RDC NO. 751, OF SEPTEMBER 15, 2022(Published in DOU No. 180, of September 21, 2022)Provides for risk classification,notification and registrationschemes,andlabelingrequirements and instructions foruse of medical devices.TheBoard of Directors of the National Health Surveillance Agency, in theuse of the attributions conferred on it by art. 15, III and IV, together with art. 7, III andIV of Law No. 9,782, of January 26, 1999, and art. 187, VI, § 1st of the Internal Rulesapproved by the Resolution of the Collegiate Board of Directors - RDC No. 585, ofDecember 10, 2021, decides to adopt the following Resolution, as decided at a meetingheld on September 14, 2022, and I, Director-President, determine its publication.CHAPTER IOF THE INITIAL PROVISIONSSection IPurposeArticle 1 This Resolution defines the rules for the risk classification ofmedical devices, the requirements for labeling and instructions for use, and theprocedures for notification, registration, alteration, revalidation and cancellation ofnotification or registration of medical devices.Section IIScopeArticle 2 This Resolution applies to the medical devices defined therein,and notification or registration of such devices is mandatory, according to riskclassification.§ 1 The risk classification, procedures and specifications described in thisdocument, for the purposes of notification and registration, apply to medical devicesand their accessories.§° 2º This Resolution does not apply to used or refurbished medicaldevices, which are subject to the specific rules established in the Resolution of theCollegiate Board of Directors - RDC No. 579, of November 25, 2021, published in DOUNo. 225, of December 1, 2021.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:87px; top:137px;,"RESOLUTION OF THE BOARD OF DIRECTORS - RDC NO. 751, OF SEPTEMBER 15, 2022"
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","RESOLUTION OF THE BOARD OF DIRECTORS - RDC NO. 751, OF SEPTEMBER 15, 2022"
div,['txt'],position:absolute; left:169px; top:158px;,"(Published in DOU No. 180, of September 21, 2022)"
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,255,1);","(Published in DOU No. 180, of September 21, 2022)"
div,['txt'],position:absolute; left:340px; top:181px;,"Provides for risk classification,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Provides for risk classification,"
div,['txt'],position:absolute; left:340px; top:196px;,notification and registration
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",notification and registration
div,['txt'],position:absolute; left:340px; top:211px;,"schemes,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","schemes,"
div,['txt'],position:absolute; left:419px; top:211px;,and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and
div,['txt'],position:absolute; left:472px; top:211px;,labeling
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",labeling
div,['txt'],position:absolute; left:340px; top:226px;,requirements and instructions for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",requirements and instructions for
div,['txt'],position:absolute; left:340px; top:241px;,use of medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",use of medical devices.
div,['txt'],position:absolute; left:144px; top:277px;,"TheBoard of Directors of the National Health Surveillance Agency, in the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",The
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Board of Directors of the National Health Surveillance Agency
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",", in the"
div,['txt'],position:absolute; left:84px; top:292px;,"use of the attributions conferred on it by art. 15, III and IV, together with art. 7, III and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","use of the attributions conferred on it by art. 15, III and IV, together with art. 7, III and"
div,['txt'],position:absolute; left:84px; top:307px;,"IV of Law No. 9,782, of January 26, 1999, and art. 187, VI, § 1st of the Internal Rules"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","IV of Law No. 9,782, of January 26, 1999, and art. 187, VI, § 1st of the Internal Rules"
div,['txt'],position:absolute; left:84px; top:321px;,"approved by the Resolution of the Collegiate Board of Directors - RDC No. 585, of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","approved by the Resolution of the Collegiate Board of Directors - RDC No. 585, of"
div,['txt'],position:absolute; left:84px; top:336px;,"December 10, 2021, decides to adopt the following Resolution, as decided at a meeting"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","December 10, 2021, decides to adopt the following Resolution, as decided at a meeting"
div,['txt'],position:absolute; left:84px; top:351px;,"held on September 14, 2022, and I, Director-President, determine its publication."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","held on September 14, 2022, and I, Director-President, determine its publication."
div,['txt'],position:absolute; left:271px; top:373px;,CHAPTER I
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",CHAPTER I
div,['txt'],position:absolute; left:227px; top:395px;,OF THE INITIAL PROVISIONS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",OF THE INITIAL PROVISIONS
div,['txt'],position:absolute; left:276px; top:417px;,Section I
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section I
div,['txt'],position:absolute; left:277px; top:440px;,Purpose
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Purpose
div,['txt'],position:absolute; left:144px; top:462px;,Article 1 This Resolution defines the rules for the risk classification of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Article 1 This Resolution defines the rules for the risk classification of
div,['txt'],position:absolute; left:84px; top:476px;,"medical devices, the requirements for labeling and instructions for use, and the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","medical devices, the requirements for labeling and instructions for use, and the"
div,['txt'],position:absolute; left:84px; top:491px;,"procedures for notification, registration, alteration, revalidation and cancellation of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","procedures for notification, registration, alteration, revalidation and cancellation of"
div,['txt'],position:absolute; left:84px; top:505px;,notification or registration of medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",notification or registration of medical devices.
div,['txt'],position:absolute; left:278px; top:528px;,Section II
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section II
div,['txt'],position:absolute; left:265px; top:550px;,Scope
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Scope
div,['txt'],position:absolute; left:144px; top:571px;,"Article 2 This Resolution applies to the medical devices defined therein,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Article 2 This Resolution applies to the medical devices defined therein,"
div,['txt'],position:absolute; left:84px; top:586px;,"and notification or registration of such devices is mandatory, according to risk"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","and notification or registration of such devices is mandatory, according to risk"
div,['txt'],position:absolute; left:84px; top:601px;,classification.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classification.
div,['txt'],position:absolute; left:144px; top:623px;,"§ 1 The risk classification, procedures and specifications described in this"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 1 The risk classification, procedures and specifications described in this"
div,['txt'],position:absolute; left:84px; top:638px;,"document, for the purposes of notification and registration, apply to medical devices"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","document, for the purposes of notification and registration, apply to medical devices"
div,['txt'],position:absolute; left:84px; top:653px;,and their accessories.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and their accessories.
div,['txt'],position:absolute; left:144px; top:675px;,§° 2º This Resolution does not apply to used or refurbished medical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§° 2º This Resolution does not apply to used or refurbished medical
div,['txt'],position:absolute; left:84px; top:690px;,"devices, which are subject to the specific rules established in the Resolution of the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","devices, which are subject to the specific rules established in the Resolution of the"
div,['txt'],position:absolute; left:84px; top:704px;,"Collegiate Board of Directors - RDC No. 579, of November 25, 2021, published in DOU"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Collegiate Board of Directors - RDC No. 579, of November 25, 2021, published in DOU"
div,['txt'],position:absolute; left:84px; top:719px;,"No. 225, of December 1, 2021."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","No. 225, of December 1, 2021."
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 3º This Resolution does not apply to custom medical devices, which aresubject to the specific rules established in the Collegiate Board Resolution - RDC No.305, of September 24, 2019, published in DOU No. 186, of September 25, 2019,Section 1, p. 69.§ 4 This Resolution does not apply to medical devices for in vitro diagnosis,including instruments for in vitro diagnosis, which are subject to the specific rules setout in the Resolution of the Collegiate Board - RDC No. 36, of August 26, 2015,published in DOU No. 164, Of August 27, 2015, Section 1, p. 43.§ 5 This Resolution does not apply to medicines, cells, tissues, organs orblood of human origin or derivatives, cosmetics, sanitizers or foodstuffs treated byother regulations.§ 6 The active devices (equipment) indicated for aesthetic correction andbeautification are considered medical devices.§ 7 Active devices (equipment) specifically intended for the cleaning,disinfection or sterilization of medical devices are considered medical devices.§ 8 Medical devices intended for clinical investigations are exempt fromnotification or registration, complying with the legal provisions of the health authoritycompetent to carry out this activity, and marketing and use for other purposes isprohibited.§ 9 Presentations consisting of two or more notified or registered medicaldevices and in their individual packaging of intact presentation shall be exempt fromnotification or registration. They shall contain on the label the information of thecorresponding medical devices, including the notification or registration numbers.§ 10. Accessories produced by a manufacturer exclusively to integrate themedical devices of their manufacture already notified or registered and whose technicalfiles contain information about these accessories are exempted from notification orregistration.§ 11. The new accessories may be included in the notifications or in theoriginal records, detailing the fundamentals of operation, action and content.Art. 3 Anvisa will also grant notification or registration to families, systemsand sets (or kits) of medical devices.Single paragraph. The grouping of products, for the purpose of notificationor registration, shall take place in accordance with the rules laid down in a specificregulation.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 3º This Resolution does not apply to custom medical devices, which aresubject to the specific rules established in the Collegiate Board Resolution - RDC No.305, of September 24, 2019, published in DOU No. 186, of September 25, 2019,Section 1, p. 69.§ 4 This Resolution does not apply to medical devices for in vitro diagnosis,including instruments for in vitro diagnosis, which are subject to the specific rules setout in the Resolution of the Collegiate Board - RDC No. 36, of August 26, 2015,published in DOU No. 164, Of August 27, 2015, Section 1, p. 43.§ 5 This Resolution does not apply to medicines, cells, tissues, organs orblood of human origin or derivatives, cosmetics, sanitizers or foodstuffs treated byother regulations.§ 6 The active devices (equipment) indicated for aesthetic correction andbeautification are considered medical devices.§ 7 Active devices (equipment) specifically intended for the cleaning,disinfection or sterilization of medical devices are considered medical devices.§ 8 Medical devices intended for clinical investigations are exempt fromnotification or registration, complying with the legal provisions of the health authoritycompetent to carry out this activity, and marketing and use for other purposes isprohibited.§ 9 Presentations consisting of two or more notified or registered medicaldevices and in their individual packaging of intact presentation shall be exempt fromnotification or registration. They shall contain on the label the information of thecorresponding medical devices, including the notification or registration numbers.§ 10. Accessories produced by a manufacturer exclusively to integrate themedical devices of their manufacture already notified or registered and whose technicalfiles contain information about these accessories are exempted from notification orregistration.§ 11. The new accessories may be included in the notifications or in theoriginal records, detailing the fundamentals of operation, action and content.Art. 3 Anvisa will also grant notification or registration to families, systemsand sets (or kits) of medical devices.Single paragraph. The grouping of products, for the purpose of notificationor registration, shall take place in accordance with the rules laid down in a specificregulation.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,"§ 3º This Resolution does not apply to custom medical devices, which are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 3º This Resolution does not apply to custom medical devices, which are"
div,['txt'],position:absolute; left:84px; top:146px;,subject to the specific rules established in the Collegiate Board Resolution - RDC No.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",subject to the specific rules established in the Collegiate Board Resolution - RDC No.
div,['txt'],position:absolute; left:84px; top:161px;,"305, of September 24, 2019, published in DOU No. 186, of September 25, 2019,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","305, of September 24, 2019, published in DOU No. 186, of September 25, 2019,"
div,['txt'],position:absolute; left:84px; top:175px;,"Section 1, p. 69."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Section 1, p. 69."
div,['txt'],position:absolute; left:144px; top:197px;,"§ 4 This Resolution does not apply to medical devices for in vitro diagnosis,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 4 This Resolution does not apply to medical devices for in vitro diagnosis,"
div,['txt'],position:absolute; left:84px; top:212px;,"including instruments for in vitro diagnosis, which are subject to the specific rules set"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","including instruments for in vitro diagnosis, which are subject to the specific rules set"
div,['txt'],position:absolute; left:84px; top:226px;,"out in the Resolution of the Collegiate Board - RDC No. 36, of August 26, 2015,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","out in the Resolution of the Collegiate Board - RDC No. 36, of August 26, 2015,"
div,['txt'],position:absolute; left:84px; top:241px;,"published in DOU No. 164, Of August 27, 2015, Section 1, p. 43."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","published in DOU No. 164, Of August 27, 2015, Section 1, p. 43."
div,['txt'],position:absolute; left:144px; top:263px;,"§ 5 This Resolution does not apply to medicines, cells, tissues, organs or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 5 This Resolution does not apply to medicines, cells, tissues, organs or"
div,['txt'],position:absolute; left:84px; top:278px;,"blood of human origin or derivatives, cosmetics, sanitizers or foodstuffs treated by"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","blood of human origin or derivatives, cosmetics, sanitizers or foodstuffs treated by"
div,['txt'],position:absolute; left:84px; top:293px;,other regulations.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",other regulations.
div,['txt'],position:absolute; left:144px; top:315px;,§ 6 The active devices (equipment) indicated for aesthetic correction and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 6 The active devices (equipment) indicated for aesthetic correction and
div,['txt'],position:absolute; left:84px; top:330px;,beautification are considered medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",beautification are considered medical devices.
div,['txt'],position:absolute; left:144px; top:352px;,"§ 7 Active devices (equipment) specifically intended for the cleaning,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 7 Active devices (equipment) specifically intended for the cleaning,"
div,['txt'],position:absolute; left:84px; top:366px;,disinfection or sterilization of medical devices are considered medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",disinfection or sterilization of medical devices are considered medical devices.
div,['txt'],position:absolute; left:144px; top:388px;,§ 8 Medical devices intended for clinical investigations are exempt from
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 8 Medical devices intended for clinical investigations are exempt from
div,['txt'],position:absolute; left:84px; top:403px;,"notification or registration, complying with the legal provisions of the health authority"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","notification or registration, complying with the legal provisions of the health authority"
div,['txt'],position:absolute; left:84px; top:418px;,"competent to carry out this activity, and marketing and use for other purposes is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","competent to carry out this activity, and marketing and use for other purposes is"
div,['txt'],position:absolute; left:84px; top:432px;,prohibited.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",prohibited.
div,['txt'],position:absolute; left:144px; top:454px;,§ 9 Presentations consisting of two or more notified or registered medical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 9 Presentations consisting of two or more notified or registered medical
div,['txt'],position:absolute; left:84px; top:469px;,devices and in their individual packaging of intact presentation shall be exempt from
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",devices and in their individual packaging of intact presentation shall be exempt from
div,['txt'],position:absolute; left:84px; top:484px;,notification or registration. They shall contain on the label the information of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",notification or registration. They shall contain on the label the information of the
div,['txt'],position:absolute; left:84px; top:498px;,"corresponding medical devices, including the notification or registration numbers."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","corresponding medical devices, including the notification or registration numbers."
div,['txt'],position:absolute; left:144px; top:520px;,§ 10. Accessories produced by a manufacturer exclusively to integrate the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 10. Accessories produced by a manufacturer exclusively to integrate the
div,['txt'],position:absolute; left:84px; top:535px;,medical devices of their manufacture already notified or registered and whose technical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",medical devices of their manufacture already notified or registered and whose technical
div,['txt'],position:absolute; left:84px; top:550px;,files contain information about these accessories are exempted from notification or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",files contain information about these accessories are exempted from notification or
div,['txt'],position:absolute; left:84px; top:564px;,registration.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",registration.
div,['txt'],position:absolute; left:144px; top:586px;,§ 11. The new accessories may be included in the notifications or in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 11. The new accessories may be included in the notifications or in the
div,['txt'],position:absolute; left:84px; top:601px;,"original records, detailing the fundamentals of operation, action and content."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","original records, detailing the fundamentals of operation, action and content."
div,['txt'],position:absolute; left:144px; top:623px;,"Art. 3 Anvisa will also grant notification or registration to families, systems"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 3 Anvisa will also grant notification or registration to families, systems"
div,['txt'],position:absolute; left:84px; top:638px;,and sets (or kits) of medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and sets (or kits) of medical devices.
div,['txt'],position:absolute; left:144px; top:660px;,"Single paragraph. The grouping of products, for the purpose of notification"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Single paragraph. The grouping of products, for the purpose of notification"
div,['txt'],position:absolute; left:84px; top:674px;,"or registration, shall take place in accordance with the rules laid down in a specific"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","or registration, shall take place in accordance with the rules laid down in a specific"
div,['txt'],position:absolute; left:84px; top:690px;,regulation.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",regulation.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASectionIIIDefinitionsArticle 4 For the purposes of this Resolution the following shall applydefinitions, which can have different meaning in another context.I - accessory (of a medical device): a product intended by its manufacturerto be used in conjunction with one or more specific medical devices, to permit or assistspecifically and directly that the medical device(s) are used for the intended purpose;II - agglomerate: for the purpose of defining nanomaterial, a set of weaklybound particles in which the resulting external surface area is equal to the sum of thesurface areas of the individual components;III - aggregate: for the purpose of the definition of nanomaterial, a particlecomprising heavily bonded or fused particles, in which the resulting external surfacearea may be significantly less than the sum of the calculated surface areas of theindividual components;IV - Change: Modification of information submitted to Anvisa in thenotification process or registration of the medical device and in its respectivesecondary petitions;V - Change of approval required: Amendment of greater sanitaryrelevance, which deals with change to be introduced in the registration process, beingauthorized in national territory only after technical documentary analysis andfavorable manifestation of Anvisa;VI - Change of immediate implementation: Change of medium healthrelevance, which deals with a change to be introduced in the notification orregistration process, and its implementation is authorized in national territory afterfiling a petition with Anvisa;VII - Non-reportable change: Any other change of less sanitary relevance,resulting from a change that is not classified as required approval or immediateimplementation, and that does not depend on protocol in Anvisa for implementation;VIII - Holder (notification or registration): Legal entity, public or private,manufacturer or importer, responsible for the medical device in national territory,which holds the concession of marketing of medical device, issued by Anvisa;IX - Surgically invasive device: Invasive device that penetrates the bodythrough its surface, including through the mucous membranes of the body holes, in thecontext of a surgical intervention; and device that penetrates the body by a route otherthan a body hole;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASectionIIIDefinitionsArticle 4 For the purposes of this Resolution the following shall applydefinitions, which can have different meaning in another context.I - accessory (of a medical device): a product intended by its manufacturerto be used in conjunction with one or more specific medical devices, to permit or assistspecifically and directly that the medical device(s) are used for the intended purpose;II - agglomerate: for the purpose of defining nanomaterial, a set of weaklybound particles in which the resulting external surface area is equal to the sum of thesurface areas of the individual components;III - aggregate: for the purpose of the definition of nanomaterial, a particlecomprising heavily bonded or fused particles, in which the resulting external surfacearea may be significantly less than the sum of the calculated surface areas of theindividual components;IV - Change: Modification of information submitted to Anvisa in thenotification process or registration of the medical device and in its respectivesecondary petitions;V - Change of approval required: Amendment of greater sanitaryrelevance, which deals with change to be introduced in the registration process, beingauthorized in national territory only after technical documentary analysis andfavorable manifestation of Anvisa;VI - Change of immediate implementation: Change of medium healthrelevance, which deals with a change to be introduced in the notification orregistration process, and its implementation is authorized in national territory afterfiling a petition with Anvisa;VII - Non-reportable change: Any other change of less sanitary relevance,resulting from a change that is not classified as required approval or immediateimplementation, and that does not depend on protocol in Anvisa for implementation;VIII - Holder (notification or registration): Legal entity, public or private,manufacturer or importer, responsible for the medical device in national territory,which holds the concession of marketing of medical device, issued by Anvisa;IX - Surgically invasive device: Invasive device that penetrates the bodythrough its surface, including through the mucous membranes of the body holes, in thecontext of a surgical intervention; and device that penetrates the body by a route otherthan a body hole;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:277px; top:131px;,Section
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section
div,['txt'],position:absolute; left:271px; top:154px;,III
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III
div,['txt'],position:absolute; left:271px; top:176px;,Definitions
span,['f1'],"font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);",Definitions
div,['txt'],position:absolute; left:145px; top:196px;,Article 4 For the purposes of this Resolution the following shall apply
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Article 4 For the purposes of this Resolution the following shall apply
div,['txt'],position:absolute; left:84px; top:211px;,"definitions, which can have different meaning in another context."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","definitions, which can have different meaning in another context."
div,['txt'],position:absolute; left:144px; top:233px;,I - accessory (of a medical device): a product intended by its manufacturer
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - accessory (of a medical device): a product intended by its manufacturer
div,['txt'],position:absolute; left:84px; top:248px;,"to be used in conjunction with one or more specific medical devices, to permit or assist"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","to be used in conjunction with one or more specific medical devices, to permit or assist"
div,['txt'],position:absolute; left:84px; top:262px;,specifically and directly that the medical device(s) are used for the intended purpose;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",specifically and directly that the medical device(s) are used for the intended purpose;
div,['txt'],position:absolute; left:144px; top:284px;,"II - agglomerate: for the purpose of defining nanomaterial, a set of weakly"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","II - agglomerate: for the purpose of defining nanomaterial, a set of weakly"
div,['txt'],position:absolute; left:84px; top:299px;,bound particles in which the resulting external surface area is equal to the sum of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",bound particles in which the resulting external surface area is equal to the sum of the
div,['txt'],position:absolute; left:84px; top:313px;,surface areas of the individual components;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",surface areas of the individual components;
div,['txt'],position:absolute; left:144px; top:336px;,"III - aggregate: for the purpose of the definition of nanomaterial, a particle"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","III - aggregate: for the purpose of the definition of nanomaterial, a particle"
div,['txt'],position:absolute; left:84px; top:351px;,"comprising heavily bonded or fused particles, in which the resulting external surface"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","comprising heavily bonded or fused particles, in which the resulting external surface"
div,['txt'],position:absolute; left:84px; top:366px;,area may be significantly less than the sum of the calculated surface areas of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",area may be significantly less than the sum of the calculated surface areas of the
div,['txt'],position:absolute; left:84px; top:380px;,individual components;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",individual components;
div,['txt'],position:absolute; left:144px; top:402px;,IV - Change: Modification of information submitted to Anvisa in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - Change: Modification of information submitted to Anvisa in the
div,['txt'],position:absolute; left:84px; top:417px;,notification process or registration of the medical device and in its respective
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",notification process or registration of the medical device and in its respective
div,['txt'],position:absolute; left:84px; top:431px;,secondary petitions;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",secondary petitions;
div,['txt'],position:absolute; left:144px; top:453px;,V - Change of approval required: Amendment of greater sanitary
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",V - Change of approval required: Amendment of greater sanitary
div,['txt'],position:absolute; left:84px; top:468px;,"relevance, which deals with change to be introduced in the registration process, being"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","relevance, which deals with change to be introduced in the registration process, being"
div,['txt'],position:absolute; left:84px; top:482px;,authorized in national territory only after technical documentary analysis and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",authorized in national territory only after technical documentary analysis and
div,['txt'],position:absolute; left:84px; top:497px;,favorable manifestation of Anvisa;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",favorable manifestation of Anvisa;
div,['txt'],position:absolute; left:144px; top:519px;,VI - Change of immediate implementation: Change of medium health
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",VI - Change of immediate implementation: Change of medium health
div,['txt'],position:absolute; left:84px; top:534px;,"relevance, which deals with a change to be introduced in the notification or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","relevance, which deals with a change to be introduced in the notification or"
div,['txt'],position:absolute; left:84px; top:548px;,"registration process, and its implementation is authorized in national territory after"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","registration process, and its implementation is authorized in national territory after"
div,['txt'],position:absolute; left:84px; top:563px;,filing a petition with Anvisa;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",filing a petition with Anvisa;
div,['txt'],position:absolute; left:144px; top:586px;,"VII - Non-reportable change: Any other change of less sanitary relevance,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","VII - Non-reportable change: Any other change of less sanitary relevance,"
div,['txt'],position:absolute; left:84px; top:600px;,resulting from a change that is not classified as required approval or immediate
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",resulting from a change that is not classified as required approval or immediate
div,['txt'],position:absolute; left:84px; top:615px;,"implementation, and that does not depend on protocol in Anvisa for implementation;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","implementation, and that does not depend on protocol in Anvisa for implementation;"
div,['txt'],position:absolute; left:144px; top:637px;,"VIII - Holder (notification or registration): Legal entity, public or private,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","VIII - Holder (notification or registration): Legal entity, public or private,"
div,['txt'],position:absolute; left:84px; top:652px;,"manufacturer or importer, responsible for the medical device in national territory,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","manufacturer or importer, responsible for the medical device in national territory,"
div,['txt'],position:absolute; left:84px; top:666px;,"which holds the concession of marketing of medical device, issued by Anvisa;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","which holds the concession of marketing of medical device, issued by Anvisa;"
div,['txt'],position:absolute; left:144px; top:688px;,IX - Surgically invasive device: Invasive device that penetrates the body
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IX - Surgically invasive device: Invasive device that penetrates the body
div,['txt'],position:absolute; left:84px; top:703px;,"through its surface, including through the mucous membranes of the body holes, in the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","through its surface, including through the mucous membranes of the body holes, in the"
div,['txt'],position:absolute; left:84px; top:718px;,context of a surgical intervention; and device that penetrates the body by a route other
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",context of a surgical intervention; and device that penetrates the body by a route other
div,['txt'],position:absolute; left:84px; top:732px;,than a body hole;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",than a body hole;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAX - medical device (medical product); any instrument, apparatus,equipment, implant, Medical device for in vitro diagnosis, software, material or otherarticles, intended by the manufacturer to be used, alone or jointly, in human beings,for any of the following specific medical purposes, and whose main intended action isnot achieved by pharmacological, immunological or metabolic means in the humanbody, but that can be assisted in their intended action by such means:disease;a) diagnosis, prevention, monitoring, treatment (or relief) of oneb) diagnosis, monitoring, treatment or repair of an injury ordisability;c) research, substitution, alteration of anatomy or process orphysiological or pathological state;d) support or maintenance of life;e) control or support to conception; orf) provision of information through in vitro examination of samples fromthe human body, including donations from organs and tissues.XI - active medical device: any device whose operation depends on asource of energy not generated by the human body for that purpose, or by gravity, andwhich acts by changing the density or by converting that energy, except for thoseintended to transmit energy, substances or other elements between an active deviceand the patient without producing any significant change;XII - active medical device for diagnosis and monitoring: any active deviceused alone or in combination with other devices to provide information for thedetection, diagnosis, monitoring, observation or treatment of physiological states,health states, diseases or congenital malformations;XIII - single-use medical device: a device intended for use in a personduring a single procedure, according to the manufacturer's specification;XIV - implantable medical device: any device, including those which arepartially or totally absorbed, intended to be fully inserted into the human body; or toreplace an epithelial surface or the ocular surface, by clinical intervention, andintended to remain in this place after the intervention, or that intended to be partiallyintroduced into the human body through clinical intervention and to remain in thisplace after the intervention for a period of at least 30 days;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAX - medical device (medical product); any instrument, apparatus,equipment, implant, Medical device for in vitro diagnosis, software, material or otherarticles, intended by the manufacturer to be used, alone or jointly, in human beings,for any of the following specific medical purposes, and whose main intended action isnot achieved by pharmacological, immunological or metabolic means in the humanbody, but that can be assisted in their intended action by such means:disease;a) diagnosis, prevention, monitoring, treatment (or relief) of oneb) diagnosis, monitoring, treatment or repair of an injury ordisability;c) research, substitution, alteration of anatomy or process orphysiological or pathological state;d) support or maintenance of life;e) control or support to conception; orf) provision of information through in vitro examination of samples fromthe human body, including donations from organs and tissues.XI - active medical device: any device whose operation depends on asource of energy not generated by the human body for that purpose, or by gravity, andwhich acts by changing the density or by converting that energy, except for thoseintended to transmit energy, substances or other elements between an active deviceand the patient without producing any significant change;XII - active medical device for diagnosis and monitoring: any active deviceused alone or in combination with other devices to provide information for thedetection, diagnosis, monitoring, observation or treatment of physiological states,health states, diseases or congenital malformations;XIII - single-use medical device: a device intended for use in a personduring a single procedure, according to the manufacturer's specification;XIV - implantable medical device: any device, including those which arepartially or totally absorbed, intended to be fully inserted into the human body; or toreplace an epithelial surface or the ocular surface, by clinical intervention, andintended to remain in this place after the intervention, or that intended to be partiallyintroduced into the human body through clinical intervention and to remain in thisplace after the intervention for a period of at least 30 days;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,"X - medical device (medical product); any instrument, apparatus,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","X - medical device (medical product); any instrument, apparatus,"
div,['txt'],position:absolute; left:84px; top:146px;,"equipment, implant, Medical device for in vitro diagnosis, software, material or other"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","equipment, implant, Medical device for in vitro diagnosis, software, material or other"
div,['txt'],position:absolute; left:84px; top:160px;,"articles, intended by the manufacturer to be used, alone or jointly, in human beings,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","articles, intended by the manufacturer to be used, alone or jointly, in human beings,"
div,['txt'],position:absolute; left:84px; top:175px;,"for any of the following specific medical purposes, and whose main intended action is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","for any of the following specific medical purposes, and whose main intended action is"
div,['txt'],position:absolute; left:84px; top:190px;,"not achieved by pharmacological, immunological or metabolic means in the human"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","not achieved by pharmacological, immunological or metabolic means in the human"
div,['txt'],position:absolute; left:84px; top:204px;,"body, but that can be assisted in their intended action by such means:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","body, but that can be assisted in their intended action by such means:"
div,['txt'],position:absolute; left:84px; top:226px;,"disease;a) diagnosis, prevention, monitoring, treatment (or relief) of one"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",disease;
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);","a) diagnosis, prevention, monitoring, treatment (or relief) of one"
div,['txt'],position:absolute; left:145px; top:263px;,"b) diagnosis, monitoring, treatment or repair of an injury or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","b) diagnosis, monitoring, treatment or repair of an injury or"
div,['txt'],position:absolute; left:84px; top:278px;,disability;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",disability;
div,['txt'],position:absolute; left:145px; top:300px;,"c) research, substitution, alteration of anatomy or process or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","c) research, substitution, alteration of anatomy or process or"
div,['txt'],position:absolute; left:84px; top:315px;,physiological or pathological state;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",physiological or pathological state;
div,['txt'],position:absolute; left:145px; top:337px;,d) support or maintenance of life;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",d) support or maintenance of life;
div,['txt'],position:absolute; left:144px; top:360px;,e) control or support to conception; or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",e) control or support to conception; or
div,['txt'],position:absolute; left:144px; top:382px;,f) provision of information through in vitro examination of samples from
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",f) provision of information through in vitro examination of samples from
div,['txt'],position:absolute; left:84px; top:396px;,"the human body, including donations from organs and tissues."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the human body, including donations from organs and tissues."
div,['txt'],position:absolute; left:144px; top:418px;,XI - active medical device: any device whose operation depends on a
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XI - active medical device: any device whose operation depends on a
div,['txt'],position:absolute; left:84px; top:433px;,"source of energy not generated by the human body for that purpose, or by gravity, and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","source of energy not generated by the human body for that purpose, or by gravity, and"
div,['txt'],position:absolute; left:84px; top:448px;,"which acts by changing the density or by converting that energy, except for those"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","which acts by changing the density or by converting that energy, except for those"
div,['txt'],position:absolute; left:84px; top:462px;,"intended to transmit energy, substances or other elements between an active device"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","intended to transmit energy, substances or other elements between an active device"
div,['txt'],position:absolute; left:84px; top:477px;,and the patient without producing any significant change;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and the patient without producing any significant change;
div,['txt'],position:absolute; left:144px; top:499px;,XII - active medical device for diagnosis and monitoring: any active device
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XII - active medical device for diagnosis and monitoring: any active device
div,['txt'],position:absolute; left:84px; top:514px;,used alone or in combination with other devices to provide information for the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",used alone or in combination with other devices to provide information for the
div,['txt'],position:absolute; left:84px; top:529px;,"detection, diagnosis, monitoring, observation or treatment of physiological states,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","detection, diagnosis, monitoring, observation or treatment of physiological states,"
div,['txt'],position:absolute; left:84px; top:543px;,"health states, diseases or congenital malformations;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","health states, diseases or congenital malformations;"
div,['txt'],position:absolute; left:144px; top:565px;,XIII - single-use medical device: a device intended for use in a person
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XIII - single-use medical device: a device intended for use in a person
div,['txt'],position:absolute; left:84px; top:580px;,"during a single procedure, according to the manufacturer's specification;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","during a single procedure, according to the manufacturer's specification;"
div,['txt'],position:absolute; left:144px; top:602px;,"XIV - implantable medical device: any device, including those which are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XIV - implantable medical device: any device, including those which are"
div,['txt'],position:absolute; left:84px; top:616px;,"partially or totally absorbed, intended to be fully inserted into the human body; or to"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","partially or totally absorbed, intended to be fully inserted into the human body; or to"
div,['txt'],position:absolute; left:84px; top:631px;,"replace an epithelial surface or the ocular surface, by clinical intervention, and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","replace an epithelial surface or the ocular surface, by clinical intervention, and"
div,['txt'],position:absolute; left:84px; top:646px;,"intended to remain in this place after the intervention, or that intended to be partially"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","intended to remain in this place after the intervention, or that intended to be partially"
div,['txt'],position:absolute; left:84px; top:661px;,introduced into the human body through clinical intervention and to remain in this
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",introduced into the human body through clinical intervention and to remain in this
div,['txt'],position:absolute; left:84px; top:675px;,place after the intervention for a period of at least 30 days;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",place after the intervention for a period of at least 30 days;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXV - invasive medical device: any device that penetrates partially or totallyinto the body, either through one of its holes or through its surface;XVI - medical device for in vitro diagnosis: reagents, calibrators, standards,controls, sample collectors, software, instruments or other articles, used individually orin combination, intended for use determined by the manufacturer for in vitro analysisof human body-derived samples, exclusively or primarily, to provide information fordiagnostic purposes, diagnosis aid, monitoring, compatibility, screening,predisposition, prognosis, prediction or determination of the physiological state;XVII - active therapeutic medical device: any active device used alone orin combination with other devices to maintain, modify, replace or restore biologicalfunctions or structures in the context of treatment or mitigation of a disease, injury ordisability;XVIII - technical dossier: document describing the elements that make upthe product, indicating the characteristics, purpose, mode of use, content, special care,potential risks, the production process and additional information;XIX - legal manufacturer: legal entity, public or private, responsible forthe design, manufacture, packaging and labeling of a product, with the intention ofmaking it available for use under its name, these operations being carried out by thecompany itself or by third parties on its behalf.XX - family: grouping of medical devices, for the purpose of notification orregistration, provided for in a specific regulation, where each product has similartechnical characteristics of:a) Indication, purpose of use;b) Operation and action;c) Technology;d) Content or composition, where applicable; ande) Precautions, restrictions, warnings and special care.XXI - intended purpose (purpose of use): the use for which a device isintended, according to the information stated by the manufacturer in the clinicalevaluation;XXII - importer: legal entity, public or private, responsible for the importactivity for the entry of medical devices from abroad into the national territory;XXIII - instructions for use: document containing information provided bythe manufacturer to clarify the user about the intended purpose of a device, its correctuse and any precautions to be taken;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXV - invasive medical device: any device that penetrates partially or totallyinto the body, either through one of its holes or through its surface;XVI - medical device for in vitro diagnosis: reagents, calibrators, standards,controls, sample collectors, software, instruments or other articles, used individually orin combination, intended for use determined by the manufacturer for in vitro analysisof human body-derived samples, exclusively or primarily, to provide information fordiagnostic purposes, diagnosis aid, monitoring, compatibility, screening,predisposition, prognosis, prediction or determination of the physiological state;XVII - active therapeutic medical device: any active device used alone orin combination with other devices to maintain, modify, replace or restore biologicalfunctions or structures in the context of treatment or mitigation of a disease, injury ordisability;XVIII - technical dossier: document describing the elements that make upthe product, indicating the characteristics, purpose, mode of use, content, special care,potential risks, the production process and additional information;XIX - legal manufacturer: legal entity, public or private, responsible forthe design, manufacture, packaging and labeling of a product, with the intention ofmaking it available for use under its name, these operations being carried out by thecompany itself or by third parties on its behalf.XX - family: grouping of medical devices, for the purpose of notification orregistration, provided for in a specific regulation, where each product has similartechnical characteristics of:a) Indication, purpose of use;b) Operation and action;c) Technology;d) Content or composition, where applicable; ande) Precautions, restrictions, warnings and special care.XXI - intended purpose (purpose of use): the use for which a device isintended, according to the information stated by the manufacturer in the clinicalevaluation;XXII - importer: legal entity, public or private, responsible for the importactivity for the entry of medical devices from abroad into the national territory;XXIII - instructions for use: document containing information provided bythe manufacturer to clarify the user about the intended purpose of a device, its correctuse and any precautions to be taken;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,XV - invasive medical device: any device that penetrates partially or totally
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XV - invasive medical device: any device that penetrates partially or totally
div,['txt'],position:absolute; left:84px; top:146px;,"into the body, either through one of its holes or through its surface;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","into the body, either through one of its holes or through its surface;"
div,['txt'],position:absolute; left:144px; top:168px;,"XVI - medical device for in vitro diagnosis: reagents, calibrators, standards,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XVI - medical device for in vitro diagnosis: reagents, calibrators, standards,"
div,['txt'],position:absolute; left:84px; top:183px;,"controls, sample collectors, software, instruments or other articles, used individually or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","controls, sample collectors, software, instruments or other articles, used individually or"
div,['txt'],position:absolute; left:84px; top:197px;,"in combination, intended for use determined by the manufacturer for in vitro analysis"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","in combination, intended for use determined by the manufacturer for in vitro analysis"
div,['txt'],position:absolute; left:84px; top:212px;,"of human body-derived samples, exclusively or primarily, to provide information for"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of human body-derived samples, exclusively or primarily, to provide information for"
div,['txt'],position:absolute; left:84px; top:226px;,"diagnostic purposes, diagnosis aid, monitoring, compatibility, screening,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","diagnostic purposes, diagnosis aid, monitoring, compatibility, screening,"
div,['txt'],position:absolute; left:84px; top:241px;,"predisposition, prognosis, prediction or determination of the physiological state;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","predisposition, prognosis, prediction or determination of the physiological state;"
div,['txt'],position:absolute; left:144px; top:263px;,XVII - active therapeutic medical device: any active device used alone or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XVII - active therapeutic medical device: any active device used alone or
div,['txt'],position:absolute; left:84px; top:278px;,"in combination with other devices to maintain, modify, replace or restore biological"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","in combination with other devices to maintain, modify, replace or restore biological"
div,['txt'],position:absolute; left:84px; top:293px;,"functions or structures in the context of treatment or mitigation of a disease, injury or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","functions or structures in the context of treatment or mitigation of a disease, injury or"
div,['txt'],position:absolute; left:84px; top:308px;,disability;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",disability;
div,['txt'],position:absolute; left:144px; top:330px;,XVIII - technical dossier: document describing the elements that make up
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XVIII - technical dossier: document describing the elements that make up
div,['txt'],position:absolute; left:84px; top:344px;,"the product, indicating the characteristics, purpose, mode of use, content, special care,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the product, indicating the characteristics, purpose, mode of use, content, special care,"
div,['txt'],position:absolute; left:84px; top:359px;,"potential risks, the production process and additional information;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","potential risks, the production process and additional information;"
div,['txt'],position:absolute; left:144px; top:381px;,"XIX - legal manufacturer: legal entity, public or private, responsible for"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XIX - legal manufacturer: legal entity, public or private, responsible for"
div,['txt'],position:absolute; left:84px; top:396px;,"the design, manufacture, packaging and labeling of a product, with the intention of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the design, manufacture, packaging and labeling of a product, with the intention of"
div,['txt'],position:absolute; left:84px; top:410px;,"making it available for use under its name, these operations being carried out by the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","making it available for use under its name, these operations being carried out by the"
div,['txt'],position:absolute; left:84px; top:425px;,company itself or by third parties on its behalf.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",company itself or by third parties on its behalf.
div,['txt'],position:absolute; left:144px; top:447px;,"XX - family: grouping of medical devices, for the purpose of notification or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XX - family: grouping of medical devices, for the purpose of notification or"
div,['txt'],position:absolute; left:84px; top:462px;,"registration, provided for in a specific regulation, where each product has similar"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","registration, provided for in a specific regulation, where each product has similar"
div,['txt'],position:absolute; left:84px; top:477px;,technical characteristics of:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",technical characteristics of:
div,['txt'],position:absolute; left:144px; top:498px;,"a) Indication, purpose of use;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) Indication, purpose of use;"
div,['txt'],position:absolute; left:145px; top:521px;,b) Operation and action;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) Operation and action;
div,['txt'],position:absolute; left:145px; top:543px;,c) Technology;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",c) Technology;
div,['txt'],position:absolute; left:145px; top:565px;,"d) Content or composition, where applicable; and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","d) Content or composition, where applicable; and"
div,['txt'],position:absolute; left:144px; top:588px;,"e) Precautions, restrictions, warnings and special care."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","e) Precautions, restrictions, warnings and special care."
div,['txt'],position:absolute; left:144px; top:610px;,XXI - intended purpose (purpose of use): the use for which a device is
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXI - intended purpose (purpose of use): the use for which a device is
div,['txt'],position:absolute; left:84px; top:624px;,"intended, according to the information stated by the manufacturer in the clinical"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","intended, according to the information stated by the manufacturer in the clinical"
div,['txt'],position:absolute; left:84px; top:639px;,evaluation;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",evaluation;
div,['txt'],position:absolute; left:144px; top:661px;,"XXII - importer: legal entity, public or private, responsible for the import"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXII - importer: legal entity, public or private, responsible for the import"
div,['txt'],position:absolute; left:84px; top:676px;,activity for the entry of medical devices from abroad into the national territory;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",activity for the entry of medical devices from abroad into the national territory;
div,['txt'],position:absolute; left:144px; top:697px;,XXIII - instructions for use: document containing information provided by
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXIII - instructions for use: document containing information provided by
div,['txt'],position:absolute; left:84px; top:712px;,"the manufacturer to clarify the user about the intended purpose of a device, its correct"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the manufacturer to clarify the user about the intended purpose of a device, its correct"
div,['txt'],position:absolute; left:84px; top:727px;,use and any precautions to be taken;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",use and any precautions to be taken;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXXIV - reusable surgical instrument: an instrument intended to cut, drill,ripple, sawing, scrape, remove, staple, remove, trim or perform similar procedures inthe context of clinical and surgical interventions, and may or may not connect to anactive device, and intended by the manufacturer to be reused after appropriateprocedures have been carried out, such as cleaning, disinfection and sterilization;XXV - clinical investigation: any systematic investigation or study in one ormore human beings carried out to assess the safety, clinical performance and/orefficacy of a medical device. For the purposes of this regulation, this term issynonymous with ""clinical trial"" or ""clinical research"";XXVI - kit (set, set or tray): set of medical devices that, regardless of whetherthey are registered or notified individually, are grouped into a sales unit for a specificpurpose of use or procedure:a) for the purpose of regularization, the whole shall be of the samemanufacturer or group; andb) the components of a medical device kit alone do not maintain aninterdependence relationship to achieve the functionality and performance it isintended for.XXVII - lot or departure: the quantity of a medical device prepared in amanufacturing or sterilization cycle, the essential characteristic of which ishomogeneity;XXVIII - nanomaterial: natural, incidental or manufactured materialcontaining particles in a non-bound state or in the form of aggregate or agglomerate,in which 50% or more of the number of particles presents size distribution within therange of 1 to 100 nm, in one or more of its external dimensions, may include:a) fulerenos, graphene flakes and single-wall carbon nanotubes with oneor more external dimensions below 1 nm are also considered nanomaterials.b) manufactured materials with dimensions that extrapolate the upperlimit of the nanoscale (established between 1 and 100 nm), up to the 1000 nm mark,and that exhibit different size-dependent properties or phenomena from thosepresented by the same material in macroscale, may be framed in the definition ofnanomaterial;XXIX - technical standard: document established by consensus andapproved by a recognized body, which provides for common and repetitive use rules,guidelines or characteristics for activities or their results, aiming to obtain an optimaldegree of ordering in a given context;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXXIV - reusable surgical instrument: an instrument intended to cut, drill,ripple, sawing, scrape, remove, staple, remove, trim or perform similar procedures inthe context of clinical and surgical interventions, and may or may not connect to anactive device, and intended by the manufacturer to be reused after appropriateprocedures have been carried out, such as cleaning, disinfection and sterilization;XXV - clinical investigation: any systematic investigation or study in one ormore human beings carried out to assess the safety, clinical performance and/orefficacy of a medical device. For the purposes of this regulation, this term issynonymous with ""clinical trial"" or ""clinical research"";XXVI - kit (set, set or tray): set of medical devices that, regardless of whetherthey are registered or notified individually, are grouped into a sales unit for a specificpurpose of use or procedure:a) for the purpose of regularization, the whole shall be of the samemanufacturer or group; andb) the components of a medical device kit alone do not maintain aninterdependence relationship to achieve the functionality and performance it isintended for.XXVII - lot or departure: the quantity of a medical device prepared in amanufacturing or sterilization cycle, the essential characteristic of which ishomogeneity;XXVIII - nanomaterial: natural, incidental or manufactured materialcontaining particles in a non-bound state or in the form of aggregate or agglomerate,in which 50% or more of the number of particles presents size distribution within therange of 1 to 100 nm, in one or more of its external dimensions, may include:a) fulerenos, graphene flakes and single-wall carbon nanotubes with oneor more external dimensions below 1 nm are also considered nanomaterials.b) manufactured materials with dimensions that extrapolate the upperlimit of the nanoscale (established between 1 and 100 nm), up to the 1000 nm mark,and that exhibit different size-dependent properties or phenomena from thosepresented by the same material in macroscale, may be framed in the definition ofnanomaterial;XXIX - technical standard: document established by consensus andapproved by a recognized body, which provides for common and repetitive use rules,guidelines or characteristics for activities or their results, aiming to obtain an optimaldegree of ordering in a given context;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,"XXIV - reusable surgical instrument: an instrument intended to cut, drill,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXIV - reusable surgical instrument: an instrument intended to cut, drill,"
div,['txt'],position:absolute; left:84px; top:146px;,"ripple, sawing, scrape, remove, staple, remove, trim or perform similar procedures in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","ripple, sawing, scrape, remove, staple, remove, trim or perform similar procedures in"
div,['txt'],position:absolute; left:84px; top:160px;,"the context of clinical and surgical interventions, and may or may not connect to an"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the context of clinical and surgical interventions, and may or may not connect to an"
div,['txt'],position:absolute; left:84px; top:175px;,"active device, and intended by the manufacturer to be reused after appropriate"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","active device, and intended by the manufacturer to be reused after appropriate"
div,['txt'],position:absolute; left:84px; top:190px;,"procedures have been carried out, such as cleaning, disinfection and sterilization;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","procedures have been carried out, such as cleaning, disinfection and sterilization;"
div,['txt'],position:absolute; left:144px; top:212px;,XXV - clinical investigation: any systematic investigation or study in one or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXV - clinical investigation: any systematic investigation or study in one or
div,['txt'],position:absolute; left:84px; top:227px;,"more human beings carried out to assess the safety, clinical performance and/or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","more human beings carried out to assess the safety, clinical performance and/or"
div,['txt'],position:absolute; left:84px; top:241px;,"efficacy of a medical device. For the purposes of this regulation, this term is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","efficacy of a medical device. For the purposes of this regulation, this term is"
div,['txt'],position:absolute; left:84px; top:256px;,"synonymous with ""clinical trial"" or ""clinical research"";"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","synonymous with ""clinical trial"" or ""clinical research"";"
div,['txt'],position:absolute; left:144px; top:278px;,"XXVI - kit (set, set or tray): set of medical devices that, regardless of whether"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXVI - kit (set, set or tray): set of medical devices that, regardless of whether"
div,['txt'],position:absolute; left:84px; top:293px;,"they are registered or notified individually, are grouped into a sales unit for a specific"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","they are registered or notified individually, are grouped into a sales unit for a specific"
div,['txt'],position:absolute; left:84px; top:308px;,purpose of use or procedure:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",purpose of use or procedure:
div,['txt'],position:absolute; left:144px; top:329px;,"a) for the purpose of regularization, the whole shall be of the same"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) for the purpose of regularization, the whole shall be of the same"
div,['txt'],position:absolute; left:84px; top:344px;,manufacturer or group; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",manufacturer or group; and
div,['txt'],position:absolute; left:144px; top:366px;,b) the components of a medical device kit alone do not maintain an
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) the components of a medical device kit alone do not maintain an
div,['txt'],position:absolute; left:84px; top:381px;,interdependence relationship to achieve the functionality and performance it is
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",interdependence relationship to achieve the functionality and performance it is
div,['txt'],position:absolute; left:84px; top:396px;,intended for.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",intended for.
div,['txt'],position:absolute; left:144px; top:417px;,XXVII - lot or departure: the quantity of a medical device prepared in a
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXVII - lot or departure: the quantity of a medical device prepared in a
div,['txt'],position:absolute; left:84px; top:432px;,"manufacturing or sterilization cycle, the essential characteristic of which is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","manufacturing or sterilization cycle, the essential characteristic of which is"
div,['txt'],position:absolute; left:84px; top:447px;,homogeneity;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",homogeneity;
div,['txt'],position:absolute; left:144px; top:469px;,"XXVIII - nanomaterial: natural, incidental or manufactured material"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXVIII - nanomaterial: natural, incidental or manufactured material"
div,['txt'],position:absolute; left:84px; top:484px;,"containing particles in a non-bound state or in the form of aggregate or agglomerate,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","containing particles in a non-bound state or in the form of aggregate or agglomerate,"
div,['txt'],position:absolute; left:84px; top:498px;,in which 50% or more of the number of particles presents size distribution within the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",in which 50% or more of the number of particles presents size distribution within the
div,['txt'],position:absolute; left:84px; top:513px;,"range of 1 to 100 nm, in one or more of its external dimensions, may include:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","range of 1 to 100 nm, in one or more of its external dimensions, may include:"
div,['txt'],position:absolute; left:144px; top:535px;,"a) fulerenos, graphene flakes and single-wall carbon nanotubes with one"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) fulerenos, graphene flakes and single-wall carbon nanotubes with one"
div,['txt'],position:absolute; left:84px; top:550px;,or more external dimensions below 1 nm are also considered nanomaterials.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",or more external dimensions below 1 nm are also considered nanomaterials.
div,['txt'],position:absolute; left:144px; top:572px;,b) manufactured materials with dimensions that extrapolate the upper
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) manufactured materials with dimensions that extrapolate the upper
div,['txt'],position:absolute; left:84px; top:586px;,"limit of the nanoscale (established between 1 and 100 nm), up to the 1000 nm mark,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","limit of the nanoscale (established between 1 and 100 nm), up to the 1000 nm mark,"
div,['txt'],position:absolute; left:84px; top:601px;,and that exhibit different size-dependent properties or phenomena from those
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and that exhibit different size-dependent properties or phenomena from those
div,['txt'],position:absolute; left:84px; top:616px;,"presented by the same material in macroscale, may be framed in the definition of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","presented by the same material in macroscale, may be framed in the definition of"
div,['txt'],position:absolute; left:84px; top:630px;,nanomaterial;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",nanomaterial;
div,['txt'],position:absolute; left:144px; top:652px;,XXIX - technical standard: document established by consensus and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXIX - technical standard: document established by consensus and
div,['txt'],position:absolute; left:84px; top:667px;,"approved by a recognized body, which provides for common and repetitive use rules,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","approved by a recognized body, which provides for common and repetitive use rules,"
div,['txt'],position:absolute; left:84px; top:682px;,"guidelines or characteristics for activities or their results, aiming to obtain an optimal"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","guidelines or characteristics for activities or their results, aiming to obtain an optimal"
div,['txt'],position:absolute; left:84px; top:696px;,degree of ordering in a given context;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",degree of ordering in a given context;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXXX - Notification: Act of communicating to Anvisa the intention tocommercialize medical device, intended to prove the right to manufacture and importmedical device exempted from registration in the form of §1 of article 25 of Law No.6,360 of September 23, 1976, And classified in risk classes I or II, with the name,manufacturer, purpose and other elements that characterize it;XXXI - body hole: any natural opening of the body, as well as the eyecavity, or any permanent artificial opening such as a stoma;XXXII - particle: for the purpose of nanomaterial definition, a tiny portionof matter with defined physical boundaries;XXXIII - injured skin or mucous membrane: a skin surface or a mucousmembrane that has a pathological change or caused by disease or injury;XXXIV - Procedural reassessment: Procedure carried out by Anvisa’stechnical area in notifications and records of medical devices for audit purposes in theprocesses;XXXV - Registration: Private act of Anvisa intended to prove the right tomanufacture and import product submitted to the regime of Law No. 6,360 ofSeptember 23, 1976, and classified in risk classes III or IV, with the name, of themanufacturer, the purpose and other elements that characterize it;XXXVI - Documentary repository of medical devices: A digital tool for storingand making available documents related to notified and registered medical devices,available on the electronic portal of Anvisa;XXXVII - legal guardian: a natural person designated by statute, socialcontract or minutes, responsible for representing, actively and passively, in judicial andextrajudicial acts, the requesting legal entity (manufacturer or importer);XXXVIII - technical manager: a higher level professional, legally qualified,trained in the technologies that make up the product, responsible for the technicalinformation presented by the applicant (manufacturer or importer) and for the quality,safety and performance of the product marketed;XXXIX - label: written, printed or graphic information on the product itself,on the packaging of each unit or on the packaging of several devices;XL - System: A set of compatible medical devices, which relate to orinteract with each other, exclusively for the purpose of fulfilling a purpose intended bythe manufacturer;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }
@font-face { font-family: ff3; src: url(""3.ttf""); }
.f5 { font-family:ff3,sans-serif; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXXX - Notification: Act of communicating to Anvisa the intention tocommercialize medical device, intended to prove the right to manufacture and importmedical device exempted from registration in the form of §1 of article 25 of Law No.6,360 of September 23, 1976, And classified in risk classes I or II, with the name,manufacturer, purpose and other elements that characterize it;XXXI - body hole: any natural opening of the body, as well as the eyecavity, or any permanent artificial opening such as a stoma;XXXII - particle: for the purpose of nanomaterial definition, a tiny portionof matter with defined physical boundaries;XXXIII - injured skin or mucous membrane: a skin surface or a mucousmembrane that has a pathological change or caused by disease or injury;XXXIV - Procedural reassessment: Procedure carried out by Anvisa’stechnical area in notifications and records of medical devices for audit purposes in theprocesses;XXXV - Registration: Private act of Anvisa intended to prove the right tomanufacture and import product submitted to the regime of Law No. 6,360 ofSeptember 23, 1976, and classified in risk classes III or IV, with the name, of themanufacturer, the purpose and other elements that characterize it;XXXVI - Documentary repository of medical devices: A digital tool for storingand making available documents related to notified and registered medical devices,available on the electronic portal of Anvisa;XXXVII - legal guardian: a natural person designated by statute, socialcontract or minutes, responsible for representing, actively and passively, in judicial andextrajudicial acts, the requesting legal entity (manufacturer or importer);XXXVIII - technical manager: a higher level professional, legally qualified,trained in the technologies that make up the product, responsible for the technicalinformation presented by the applicant (manufacturer or importer) and for the quality,safety and performance of the product marketed;XXXIX - label: written, printed or graphic information on the product itself,on the packaging of each unit or on the packaging of several devices;XL - System: A set of compatible medical devices, which relate to orinteract with each other, exclusively for the purpose of fulfilling a purpose intended bythe manufacturer;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,XXX - Notification: Act of communicating to Anvisa the intention to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXX - Notification: Act of communicating to Anvisa the intention to
div,['txt'],position:absolute; left:84px; top:146px;,"commercialize medical device, intended to prove the right to manufacture and import"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","commercialize medical device, intended to prove the right to manufacture and import"
div,['txt'],position:absolute; left:84px; top:160px;,medical device exempted from registration in the form of §1 of article 25 of Law No.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",medical device exempted from registration in the form of §1 of article 25 of Law No.
div,['txt'],position:absolute; left:84px; top:175px;,"6,360 of September 23, 1976, And classified in risk classes I or II, with the name,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","6,360 of September 23, 1976, And classified in risk classes I or II, with the name,"
div,['txt'],position:absolute; left:84px; top:190px;,"manufacturer, purpose and other elements that characterize it;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","manufacturer, purpose and other elements that characterize it;"
div,['txt'],position:absolute; left:144px; top:212px;,"XXXI - body hole: any natural opening of the body, as well as the eye"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXXI - body hole: any natural opening of the body, as well as the eye"
div,['txt'],position:absolute; left:84px; top:226px;,"cavity, or any permanent artificial opening such as a stoma;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","cavity, or any permanent artificial opening such as a stoma;"
div,['txt'],position:absolute; left:144px; top:248px;,"XXXII - particle: for the purpose of nanomaterial definition, a tiny portion"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXXII - particle: for the purpose of nanomaterial definition, a tiny portion"
div,['txt'],position:absolute; left:84px; top:263px;,of matter with defined physical boundaries;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of matter with defined physical boundaries;
div,['txt'],position:absolute; left:144px; top:285px;,XXXIII - injured skin or mucous membrane: a skin surface or a mucous
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXXIII - injured skin or mucous membrane: a skin surface or a mucous
div,['txt'],position:absolute; left:84px; top:300px;,membrane that has a pathological change or caused by disease or injury;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",membrane that has a pathological change or caused by disease or injury;
div,['txt'],position:absolute; left:144px; top:322px;,XXXIV - Procedural reassessment: Procedure carried out by Anvisa’s
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXXIV - Proce
span,['f5'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",dural reassessment: Procedure carried out by Anvisa’s
div,['txt'],position:absolute; left:84px; top:336px;,technical area in notifications and records of medical devices for audit purposes in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",technical area in notifications and records of medical devices for audit purposes in the
div,['txt'],position:absolute; left:84px; top:351px;,processes;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",processes;
div,['txt'],position:absolute; left:144px; top:373px;,XXXV - Registration: Private act of Anvisa intended to prove the right to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXXV - Registration: Private act of Anvisa intended to prove the right to
div,['txt'],position:absolute; left:84px; top:388px;,"manufacture and import product submitted to the regime of Law No. 6,360 of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","manufacture and import product submitted to the regime of Law No. 6,360 of"
div,['txt'],position:absolute; left:84px; top:402px;,"September 23, 1976, and classified in risk classes III or IV, with the name, of the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","September 23, 1976, and classified in risk classes III or IV, with the name, of the"
div,['txt'],position:absolute; left:84px; top:417px;,"manufacturer, the purpose and other elements that characterize it;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","manufacturer, the purpose and other elements that characterize it;"
div,['txt'],position:absolute; left:144px; top:439px;,XXXVI - Documentary repository of medical devices: A digital tool for storing
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XXXVI - Documentary repository of medical devices: A digital tool for storing
div,['txt'],position:absolute; left:84px; top:454px;,"and making available documents related to notified and registered medical devices,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","and making available documents related to notified and registered medical devices,"
div,['txt'],position:absolute; left:84px; top:468px;,available on the electronic portal of Anvisa;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",available on the electronic portal of Anvisa;
div,['txt'],position:absolute; left:144px; top:490px;,"XXXVII - legal guardian: a natural person designated by statute, social"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXXVII - legal guardian: a natural person designated by statute, social"
div,['txt'],position:absolute; left:84px; top:505px;,"contract or minutes, responsible for representing, actively and passively, in judicial and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","contract or minutes, responsible for representing, actively and passively, in judicial and"
div,['txt'],position:absolute; left:84px; top:520px;,"extrajudicial acts, the requesting legal entity (manufacturer or importer);"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","extrajudicial acts, the requesting legal entity (manufacturer or importer);"
div,['txt'],position:absolute; left:144px; top:542px;,"XXXVIII - technical manager: a higher level professional, legally qualified,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXXVIII - technical manager: a higher level professional, legally qualified,"
div,['txt'],position:absolute; left:84px; top:557px;,"trained in the technologies that make up the product, responsible for the technical"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","trained in the technologies that make up the product, responsible for the technical"
div,['txt'],position:absolute; left:84px; top:572px;,"information presented by the applicant (manufacturer or importer) and for the quality,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","information presented by the applicant (manufacturer or importer) and for the quality,"
div,['txt'],position:absolute; left:84px; top:587px;,safety and performance of the product marketed;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",safety and performance of the product marketed;
div,['txt'],position:absolute; left:144px; top:608px;,"XXXIX - label: written, printed or graphic information on the product itself,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XXXIX - label: written, printed or graphic information on the product itself,"
div,['txt'],position:absolute; left:84px; top:623px;,on the packaging of each unit or on the packaging of several devices;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",on the packaging of each unit or on the packaging of several devices;
div,['txt'],position:absolute; left:144px; top:645px;,"XL - System: A set of compatible medical devices, which relate to or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XL - System: A set of compatible medical devices, which relate to or"
div,['txt'],position:absolute; left:84px; top:660px;,"interact with each other, exclusively for the purpose of fulfilling a purpose intended by"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","interact with each other, exclusively for the purpose of fulfilling a purpose intended by"
div,['txt'],position:absolute; left:84px; top:675px;,the manufacturer;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the manufacturer;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXLI - Central Circulatory System: A system that includes the followingblood vessels: Pulmonary arteries, ascending aorta, aortic arch, descending aorta toaortic bifurcation, coronary arteries, common carotid artery, external carotid artery,internal carotid artery, cerebral arteries, brachycephalic trunk, coronary veins,pulmonary veins, superior vena cava and inferior vena cava;XLII - Central nervous system: System that includes the brain, meningesand spinal cord;XLIII - Software as a Medical Device (Software as a Medical Device - SaMD):A product or application intended for one or more purposes indicated in the definitionof a medical device and which performs its functions without being part of thehardware of a medical device, having the following characteristics:a) SaMD can be run on a general purpose computing platform (non-medical purpose);b) the ""computing platform"" includes hardware and software features(operating system, processing hardware, storage, database, visualization devices, inputdevices, programming language, etc.);c) ""without being part of"" means that the program does not need thehardware of a medical device to achieve its purpose of use;d) A software is not considered SaMD if its purpose is to control thehardware of a medical device;e) A SAMD can be used in combination (e.g. as a module) with otherproducts, including other medical devices;f) A SaMD may interact with other medical devices, including hardwarefrom other medical devices and other SaMD, as well as general purpose software; andSaMD;g) mobile apps (apps) that meet the definition are consideredXLIV - Applicant: Legal entity, public or private, that forwardspetitions for the notification or registration of medical devices with the health authority;XLV - manufacturing unit: Place where one or more stages of manufacturetakes place, may be the legal manufacturer itself, contracted manufacturer or originalmanufacturer of product;XLVI - Short-term use: Use normally performed continuously over a periodof 60 (sixty) minutes to 30 (thirty) days;XLVII - Long-term use: Use normally performed continuously over a periodof more than thirty (30) days;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXLI - Central Circulatory System: A system that includes the followingblood vessels: Pulmonary arteries, ascending aorta, aortic arch, descending aorta toaortic bifurcation, coronary arteries, common carotid artery, external carotid artery,internal carotid artery, cerebral arteries, brachycephalic trunk, coronary veins,pulmonary veins, superior vena cava and inferior vena cava;XLII - Central nervous system: System that includes the brain, meningesand spinal cord;XLIII - Software as a Medical Device (Software as a Medical Device - SaMD):A product or application intended for one or more purposes indicated in the definitionof a medical device and which performs its functions without being part of thehardware of a medical device, having the following characteristics:a) SaMD can be run on a general purpose computing platform (non-medical purpose);b) the ""computing platform"" includes hardware and software features(operating system, processing hardware, storage, database, visualization devices, inputdevices, programming language, etc.);c) ""without being part of"" means that the program does not need thehardware of a medical device to achieve its purpose of use;d) A software is not considered SaMD if its purpose is to control thehardware of a medical device;e) A SAMD can be used in combination (e.g. as a module) with otherproducts, including other medical devices;f) A SaMD may interact with other medical devices, including hardwarefrom other medical devices and other SaMD, as well as general purpose software; andSaMD;g) mobile apps (apps) that meet the definition are consideredXLIV - Applicant: Legal entity, public or private, that forwardspetitions for the notification or registration of medical devices with the health authority;XLV - manufacturing unit: Place where one or more stages of manufacturetakes place, may be the legal manufacturer itself, contracted manufacturer or originalmanufacturer of product;XLVI - Short-term use: Use normally performed continuously over a periodof 60 (sixty) minutes to 30 (thirty) days;XLVII - Long-term use: Use normally performed continuously over a periodof more than thirty (30) days;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,XLI - Central Circulatory System: A system that includes the following
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XLI - Central Circulatory System: A system that includes the following
div,['txt'],position:absolute; left:84px; top:146px;,"blood vessels: Pulmonary arteries, ascending aorta, aortic arch, descending aorta to"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","blood vessels: Pulmonary arteries, ascending aorta, aortic arch, descending aorta to"
div,['txt'],position:absolute; left:84px; top:160px;,"aortic bifurcation, coronary arteries, common carotid artery, external carotid artery,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","aortic bifurcation, coronary arteries, common carotid artery, external carotid artery,"
div,['txt'],position:absolute; left:84px; top:175px;,"internal carotid artery, cerebral arteries, brachycephalic trunk, coronary veins,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","internal carotid artery, cerebral arteries, brachycephalic trunk, coronary veins,"
div,['txt'],position:absolute; left:84px; top:190px;,"pulmonary veins, superior vena cava and inferior vena cava;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","pulmonary veins, superior vena cava and inferior vena cava;"
div,['txt'],position:absolute; left:144px; top:212px;,"XLII - Central nervous system: System that includes the brain, meninges"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XLII - Central nervous system: System that includes the brain, meninges"
div,['txt'],position:absolute; left:84px; top:226px;,and spinal cord;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and spinal cord;
div,['txt'],position:absolute; left:144px; top:248px;,XLIII - Software as a Medical Device (Software as a Medical Device - SaMD):
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XLIII - Software as a Medical Device (Software as a Medical Device - SaMD):
div,['txt'],position:absolute; left:84px; top:263px;,A product or application intended for one or more purposes indicated in the definition
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",A product or application intended for one or more purposes indicated in the definition
div,['txt'],position:absolute; left:84px; top:278px;,of a medical device and which performs its functions without being part of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of a medical device and which performs its functions without being part of the
div,['txt'],position:absolute; left:84px; top:293px;,"hardware of a medical device, having the following characteristics:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","hardware of a medical device, having the following characteristics:"
div,['txt'],position:absolute; left:144px; top:315px;,a) SaMD can be run on a general purpose computing platform (non-
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",a) SaMD can be run on a general purpose computing platform (non-
div,['txt'],position:absolute; left:84px; top:330px;,medical purpose);
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",medical purpose);
div,['txt'],position:absolute; left:144px; top:352px;,"b) the ""computing platform"" includes hardware and software features"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","b) the ""computing platform"" includes hardware and software features"
div,['txt'],position:absolute; left:84px; top:366px;,"(operating system, processing hardware, storage, database, visualization devices, input"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","(operating system, processing hardware, storage, database, visualization devices, input"
div,['txt'],position:absolute; left:84px; top:381px;,"devices, programming language, etc.);"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","devices, programming language, etc.);"
div,['txt'],position:absolute; left:144px; top:403px;,"c) ""without being part of"" means that the program does not need the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","c) ""without being part of"" means that the program does not need the"
div,['txt'],position:absolute; left:84px; top:418px;,hardware of a medical device to achieve its purpose of use;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",hardware of a medical device to achieve its purpose of use;
div,['txt'],position:absolute; left:144px; top:439px;,d) A software is not considered SaMD if its purpose is to control the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",d) A software is not considered SaMD if its purpose is to control the
div,['txt'],position:absolute; left:84px; top:455px;,hardware of a medical device;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",hardware of a medical device;
div,['txt'],position:absolute; left:144px; top:476px;,e) A SAMD can be used in combination (e.g. as a module) with other
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",e) A SAMD can be used in combination (e.g. as a module) with other
div,['txt'],position:absolute; left:84px; top:491px;,"products, including other medical devices;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","products, including other medical devices;"
div,['txt'],position:absolute; left:144px; top:513px;,"f) A SaMD may interact with other medical devices, including hardware"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","f) A SaMD may interact with other medical devices, including hardware"
div,['txt'],position:absolute; left:84px; top:528px;,"from other medical devices and other SaMD, as well as general purpose software; and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","from other medical devices and other SaMD, as well as general purpose software; and"
div,['txt'],position:absolute; left:84px; top:550px;,SaMD;g) mobile apps (apps) that meet the definition are considered
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",SaMD;
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",g) mobile apps (apps) that meet the definition are considered
div,['txt'],position:absolute; left:145px; top:586px;,"XLIV - Applicant: Legal entity, public or private, that forwards"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XLIV - Applicant: Legal entity, public or private, that forwards"
div,['txt'],position:absolute; left:84px; top:601px;,petitions for the notification or registration of medical devices with the health authority;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",petitions for the notification or registration of medical devices with the health authority;
div,['txt'],position:absolute; left:144px; top:623px;,XLV - manufacturing unit: Place where one or more stages of manufacture
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XLV - manufacturing unit: Place where one or more stages of manufacture
div,['txt'],position:absolute; left:84px; top:638px;,"takes place, may be the legal manufacturer itself, contracted manufacturer or original"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","takes place, may be the legal manufacturer itself, contracted manufacturer or original"
div,['txt'],position:absolute; left:84px; top:652px;,manufacturer of product;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",manufacturer of product;
div,['txt'],position:absolute; left:144px; top:674px;,XLVI - Short-term use: Use normally performed continuously over a period
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XLVI - Short-term use: Use normally performed continuously over a period
div,['txt'],position:absolute; left:84px; top:689px;,of 60 (sixty) minutes to 30 (thirty) days;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of 60 (sixty) minutes to 30 (thirty) days;
div,['txt'],position:absolute; left:144px; top:711px;,XLVII - Long-term use: Use normally performed continuously over a period
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XLVII - Long-term use: Use normally performed continuously over a period
div,['txt'],position:absolute; left:84px; top:726px;,of more than thirty (30) days;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of more than thirty (30) days;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXLVIII - Transitional use: Use normally performed continuously for less thansixty (60) minutes; andXLIX - User: Health professional or layperson, may be the patient himself,who uses a medical device, according to the instructions for use.CHAPTER II.RISK CLASSIFICATION OF MEDICAL DEVICESSection I Frameworkand Control RegimeArticle 5 Medical devices, the object of this Resolution, are framed accordingto the intrinsic risk they pose to the health of the user, patient, operator orThird parties involved in classes I, II, III or IV: I- Class I: Low risk;II - Class II: Medium risk;III - Class III: High risk; EIV - Class IV: Maximum risk.§ 1 For framing the medical device in one of these classes, theclassification rules set out in this Resolution shall be applied.§ 2 In case of doubt as to the classification resulting from the application ofthe rules established in this Resolution, Anvisa will be awarded the framework of themedical device.Article 6 Medical devices falling within risk classes I and II are subject tonotification.Article 7 Medical devices classified in risk classes III and IV are subject toregistration.Section IIApplication RulesArticle 8 The application of the classification rules shall be governed by theintended purpose of medical devices, with the exception of in vitro diagnostic devices,which are governed by specific classification rules.§ 1 If the device in question is intended to be used in combination withanother device, the classification rules shall apply separately to each device.§ 2 The accessories of a device must be classified by themselves, separatelyfrom the device with which they are used.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXLVIII - Transitional use: Use normally performed continuously for less thansixty (60) minutes; andXLIX - User: Health professional or layperson, may be the patient himself,who uses a medical device, according to the instructions for use.CHAPTER II.RISK CLASSIFICATION OF MEDICAL DEVICESSection I Frameworkand Control RegimeArticle 5 Medical devices, the object of this Resolution, are framed accordingto the intrinsic risk they pose to the health of the user, patient, operator orThird parties involved in classes I, II, III or IV: I- Class I: Low risk;II - Class II: Medium risk;III - Class III: High risk; EIV - Class IV: Maximum risk.§ 1 For framing the medical device in one of these classes, theclassification rules set out in this Resolution shall be applied.§ 2 In case of doubt as to the classification resulting from the application ofthe rules established in this Resolution, Anvisa will be awarded the framework of themedical device.Article 6 Medical devices falling within risk classes I and II are subject tonotification.Article 7 Medical devices classified in risk classes III and IV are subject toregistration.Section IIApplication RulesArticle 8 The application of the classification rules shall be governed by theintended purpose of medical devices, with the exception of in vitro diagnostic devices,which are governed by specific classification rules.§ 1 If the device in question is intended to be used in combination withanother device, the classification rules shall apply separately to each device.§ 2 The accessories of a device must be classified by themselves, separatelyfrom the device with which they are used.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,XLVIII - Transitional use: Use normally performed continuously for less than
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XLVIII - Transitional use: Use normally performed continuously for less than
div,['txt'],position:absolute; left:84px; top:146px;,sixty (60) minutes; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",sixty (60) minutes; and
div,['txt'],position:absolute; left:144px; top:168px;,"XLIX - User: Health professional or layperson, may be the patient himself,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XLIX - User: Health professional or layperson, may be the patient himself,"
div,['txt'],position:absolute; left:84px; top:183px;,"who uses a medical device, according to the instructions for use."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","who uses a medical device, according to the instructions for use."
div,['txt'],position:absolute; left:268px; top:205px;,CHAPTER II.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",CHAPTER II.
div,['txt'],position:absolute; left:163px; top:227px;,RISK CLASSIFICATION OF MEDICAL DEVICES
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",RISK CLASSIFICATION OF MEDICAL DEVICES
div,['txt'],position:absolute; left:280px; top:249px;,Section I Framework
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section I Framework
div,['txt'],position:absolute; left:199px; top:272px;,and Control Regime
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and Control Regime
div,['txt'],position:absolute; left:144px; top:293px;,"Article 5 Medical devices, the object of this Resolution, are framed according"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Article 5 Medical devices, the object of this Resolution, are framed according"
div,['txt'],position:absolute; left:84px; top:308px;,"to the intrinsic risk they pose to the health of the user, patient, operator or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","to the intrinsic risk they pose to the health of the user, patient, operator or"
div,['txt'],position:absolute; left:84px; top:322px;,"Third parties involved in classes I, II, III or IV: I"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Third parties involved in classes I, II, III or IV: I"
div,['txt'],position:absolute; left:145px; top:345px;,- Class I: Low risk;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",- Class I: Low risk;
div,['txt'],position:absolute; left:145px; top:367px;,II - Class II: Medium risk;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - Class II: Medium risk;
div,['txt'],position:absolute; left:145px; top:389px;,III - Class III: High risk; E
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - Class III: High risk; E
div,['txt'],position:absolute; left:145px; top:412px;,IV - Class IV: Maximum risk.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - Class IV: Maximum risk.
div,['txt'],position:absolute; left:144px; top:433px;,"§ 1 For framing the medical device in one of these classes, the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 1 For framing the medical device in one of these classes, the"
div,['txt'],position:absolute; left:84px; top:448px;,classification rules set out in this Resolution shall be applied.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classification rules set out in this Resolution shall be applied.
div,['txt'],position:absolute; left:144px; top:470px;,§ 2 In case of doubt as to the classification resulting from the application of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2 In case of doubt as to the classification resulting from the application of
div,['txt'],position:absolute; left:84px; top:485px;,"the rules established in this Resolution, Anvisa will be awarded the framework of the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the rules established in this Resolution, Anvisa will be awarded the framework of the"
div,['txt'],position:absolute; left:84px; top:499px;,medical device.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",medical device.
div,['txt'],position:absolute; left:144px; top:521px;,Article 6 Medical devices falling within risk classes I and II are subject to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Article 6 Medical devices falling within risk classes I and II are subject to
div,['txt'],position:absolute; left:84px; top:536px;,notification.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",notification.
div,['txt'],position:absolute; left:144px; top:558px;,Article 7 Medical devices classified in risk classes III and IV are subject to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Article 7 Medical devices classified in risk classes III and IV are subject to
div,['txt'],position:absolute; left:84px; top:573px;,registration.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",registration.
div,['txt'],position:absolute; left:278px; top:595px;,Section II
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section II
div,['txt'],position:absolute; left:247px; top:617px;,Application Rules
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Application Rules
div,['txt'],position:absolute; left:144px; top:640px;,Article 8 The application of the classification rules shall be governed by the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Article 8 The application of the classification rules shall be governed by the
div,['txt'],position:absolute; left:84px; top:654px;,"intended purpose of medical devices, with the exception of in vitro diagnostic devices,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","intended purpose of medical devices, with the exception of in vitro diagnostic devices,"
div,['txt'],position:absolute; left:84px; top:669px;,which are governed by specific classification rules.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which are governed by specific classification rules.
div,['txt'],position:absolute; left:144px; top:691px;,§ 1 If the device in question is intended to be used in combination with
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 If the device in question is intended to be used in combination with
div,['txt'],position:absolute; left:84px; top:706px;,"another device, the classification rules shall apply separately to each device."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","another device, the classification rules shall apply separately to each device."
div,['txt'],position:absolute; left:144px; top:728px;,"§ 2 The accessories of a device must be classified by themselves, separately"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 2 The accessories of a device must be classified by themselves, separately"
div,['txt'],position:absolute; left:84px; top:742px;,from the device with which they are used.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",from the device with which they are used.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 3 The software that commands a device or influences its use is classifiedin the same class as that device.§ 4 If the software (SaMD) is independent of any other device, it must beindependently classified.§ 5 If the device is not intended to be used exclusively or mainly in acertain part of the body, it shall be considered and classified on the basis of the mostcritical use.§ 6 If several rules apply to the same device or, within the same rule,several sub-rules, based on their intended purpose, apply the stricter rule and sub-ruleleading to higher classification.§ 7 In the calculation of the duration of use ""continuously"" one shouldconsider:a) the entire duration of use of the same device without taking intoaccount temporary interruptions of use during a procedure or temporary removal forcleaning or disinfection of the device, and whether the interruption of use, or removal,it is temporary because of the duration of use prior to and after the period in whichuse is interrupted or the device is removed; andb) the accumulated use of a device intended by the manufacturer to bereplaced immediately by another of the same type.§ 8 It is considered that a device allows a direct diagnosis when it providesitself the diagnosis of the disease or condition in question, or when it provides decisiveinformation for the diagnosis.Section IIIClassification RulesArticle 9 Medical devices are classified according to risk, as perThe rules set out in Annex I to this Resolution.CHAPTER III.REQUEST FOR NOTIFICATION OR REGISTRATION AND ITS MAINTENANCESection IProcedures for Notification or Registration of Medical DevicesArt. 10. The applicant must submit to Anvisa the documents fornotification, registration, alteration, revalidation or cancellation of notification orregistration of the medical device, related in this Resolution.§ 1 Anvisa will evaluate the documentation submitted for registration,alteration or revalidation of the registration and will manifest itself through officialmeans.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 3 The software that commands a device or influences its use is classifiedin the same class as that device.§ 4 If the software (SaMD) is independent of any other device, it must beindependently classified.§ 5 If the device is not intended to be used exclusively or mainly in acertain part of the body, it shall be considered and classified on the basis of the mostcritical use.§ 6 If several rules apply to the same device or, within the same rule,several sub-rules, based on their intended purpose, apply the stricter rule and sub-ruleleading to higher classification.§ 7 In the calculation of the duration of use ""continuously"" one shouldconsider:a) the entire duration of use of the same device without taking intoaccount temporary interruptions of use during a procedure or temporary removal forcleaning or disinfection of the device, and whether the interruption of use, or removal,it is temporary because of the duration of use prior to and after the period in whichuse is interrupted or the device is removed; andb) the accumulated use of a device intended by the manufacturer to bereplaced immediately by another of the same type.§ 8 It is considered that a device allows a direct diagnosis when it providesitself the diagnosis of the disease or condition in question, or when it provides decisiveinformation for the diagnosis.Section IIIClassification RulesArticle 9 Medical devices are classified according to risk, as perThe rules set out in Annex I to this Resolution.CHAPTER III.REQUEST FOR NOTIFICATION OR REGISTRATION AND ITS MAINTENANCESection IProcedures for Notification or Registration of Medical DevicesArt. 10. The applicant must submit to Anvisa the documents fornotification, registration, alteration, revalidation or cancellation of notification orregistration of the medical device, related in this Resolution.§ 1 Anvisa will evaluate the documentation submitted for registration,alteration or revalidation of the registration and will manifest itself through officialmeans.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,§ 3 The software that commands a device or influences its use is classified
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3 The software that commands a device or influences its use is classified
div,['txt'],position:absolute; left:84px; top:146px;,in the same class as that device.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",in the same class as that device.
div,['txt'],position:absolute; left:144px; top:168px;,"§ 4 If the software (SaMD) is independent of any other device, it must be"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 4 If the software (SaMD) is independent of any other device, it must be"
div,['txt'],position:absolute; left:84px; top:183px;,independently classified.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",independently classified.
div,['txt'],position:absolute; left:144px; top:205px;,§ 5 If the device is not intended to be used exclusively or mainly in a
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 5 If the device is not intended to be used exclusively or mainly in a
div,['txt'],position:absolute; left:84px; top:219px;,"certain part of the body, it shall be considered and classified on the basis of the most"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","certain part of the body, it shall be considered and classified on the basis of the most"
div,['txt'],position:absolute; left:84px; top:234px;,critical use.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",critical use.
div,['txt'],position:absolute; left:144px; top:256px;,"§ 6 If several rules apply to the same device or, within the same rule,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 6 If several rules apply to the same device or, within the same rule,"
div,['txt'],position:absolute; left:84px; top:271px;,"several sub-rules, based on their intended purpose, apply the stricter rule and sub-rule"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","several sub-rules, based on their intended purpose, apply the stricter rule and sub-rule"
div,['txt'],position:absolute; left:84px; top:286px;,leading to higher classification.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",leading to higher classification.
div,['txt'],position:absolute; left:145px; top:307px;,"§ 7 In the calculation of the duration of use ""continuously"" one should"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 7 In the calculation of the duration of use ""continuously"" one should"
div,['txt'],position:absolute; left:145px; top:322px;,consider:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",consider:
div,['txt'],position:absolute; left:144px; top:345px;,a) the entire duration of use of the same device without taking into
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",a) the entire duration of use of the same device without taking into
div,['txt'],position:absolute; left:84px; top:359px;,account temporary interruptions of use during a procedure or temporary removal for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",account temporary interruptions of use during a procedure or temporary removal for
div,['txt'],position:absolute; left:84px; top:374px;,"cleaning or disinfection of the device, and whether the interruption of use, or removal,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","cleaning or disinfection of the device, and whether the interruption of use, or removal,"
div,['txt'],position:absolute; left:84px; top:389px;,it is temporary because of the duration of use prior to and after the period in which
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",it is temporary because of the duration of use prior to and after the period in which
div,['txt'],position:absolute; left:84px; top:403px;,use is interrupted or the device is removed; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",use is interrupted or the device is removed; and
div,['txt'],position:absolute; left:144px; top:425px;,b) the accumulated use of a device intended by the manufacturer to be
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) the accumulated use of a device intended by the manufacturer to be
div,['txt'],position:absolute; left:84px; top:440px;,replaced immediately by another of the same type.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",replaced immediately by another of the same type.
div,['txt'],position:absolute; left:144px; top:462px;,§ 8 It is considered that a device allows a direct diagnosis when it provides
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 8 It is considered that a device allows a direct diagnosis when it provides
div,['txt'],position:absolute; left:84px; top:477px;,"itself the diagnosis of the disease or condition in question, or when it provides decisive"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","itself the diagnosis of the disease or condition in question, or when it provides decisive"
div,['txt'],position:absolute; left:84px; top:492px;,information for the diagnosis.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",information for the diagnosis.
div,['txt'],position:absolute; left:277px; top:513px;,Section III
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section III
div,['txt'],position:absolute; left:239px; top:536px;,Classification Rules
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Classification Rules
div,['txt'],position:absolute; left:145px; top:558px;,"Article 9 Medical devices are classified according to risk, as per"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Article 9 Medical devices are classified according to risk, as per"
div,['txt'],position:absolute; left:84px; top:573px;,The rules set out in Annex I to this Resolution.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",The rules set out in Annex I to this Resolution.
div,['txt'],position:absolute; left:266px; top:595px;,CHAPTER III.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",CHAPTER III.
div,['txt'],position:absolute; left:116px; top:617px;,REQUEST FOR NOTIFICATION OR REGISTRATION AND ITS MAINTENANCE
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",REQUEST FOR NOTIFICATION OR REGISTRATION AND ITS MAINTENANCE
div,['txt'],position:absolute; left:276px; top:640px;,Section I
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section I
div,['txt'],position:absolute; left:125px; top:661px;,Procedures for Notification or Registration of Medical Devices
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Procedures for Notification or Registration of Medical Devices
div,['txt'],position:absolute; left:144px; top:683px;,Art. 10. The applicant must submit to Anvisa the documents for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 10. The applicant must submit to Anvisa the documents for
div,['txt'],position:absolute; left:84px; top:698px;,"notification, registration, alteration, revalidation or cancellation of notification or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","notification, registration, alteration, revalidation or cancellation of notification or"
div,['txt'],position:absolute; left:84px; top:713px;,"registration of the medical device, related in this Resolution."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","registration of the medical device, related in this Resolution."
div,['txt'],position:absolute; left:144px; top:735px;,"§ 1 Anvisa will evaluate the documentation submitted for registration,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 1 Anvisa will evaluate the documentation submitted for registration,"
div,['txt'],position:absolute; left:84px; top:750px;,alteration or revalidation of the registration and will manifest itself through official
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",alteration or revalidation of the registration and will manifest itself through official
div,['txt'],position:absolute; left:84px; top:765px;,means.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",means.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 2º The evaluation of the documentation will be carried out within thedeadlines and legal conditions provided for in the Brazilian health legislation.§ 3 For technical reasons, in order to prove the safety and performance ofthe product, due to potential risk to public health, Anvisa may determine thepresentation of additional documents and information.§ 4 The petition without documents, forms and declarations, provided forin the list of documents of procedural instruction, completed in incomplete form orwith missing or illegible information, or obsolete, without certificate of conformitywhere applicable, shall not be subject to technical requirement. or without clinicalevidence for products with innovative technology or indication, giving rise to non-consent or summary rejection of the petition.§ 5 There shall be no technical analysis of the requests for notification andamendment of notification so that the products are considered regularized, withoutprejudice to the carrying out, at any time, of documentary or fiscal evaluations on thenotification procedures and their amendments, and, if necessary, request foradditional information or clarifications.§ 6 The processing of medical device notification will occur routinelywithin thirty (30) days of the protocol by the requester.§ 7 Maintaining notification and registration is bound by compliance withthe requirements of Good Manufacturing Practices, essential safety and performancerequirements and specific regulations where they exist.§ 8 The approval of the registration is conditional on the publication of theCertificate of Good Manufacturing Practices issued by Anvisa.§ 9 Petition forms, instructions for use or user/operator manuals andlabeling models should be presented in the Portuguese language.§ 10. The other documents, not mentioned in the previous paragraph,which make up petitions for medical devices may be presented in Portuguese, Spanishor English, according to rules defined in specific regulations.Art. 11. The registration of medical devices shall be valid for ten (10)years, counted from the day of its publication in the Official Gazette, and may berevalidated successively for the same period, under the terms set out in section V ofthis Resolution.Art. 12. Medical devices subject to conformity certification under theBrazilian Conformity Assessment System (SBAC) can only be imported and marketed ifmanufactured during the validity of the Certificate of Conformity.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 2º The evaluation of the documentation will be carried out within thedeadlines and legal conditions provided for in the Brazilian health legislation.§ 3 For technical reasons, in order to prove the safety and performance ofthe product, due to potential risk to public health, Anvisa may determine thepresentation of additional documents and information.§ 4 The petition without documents, forms and declarations, provided forin the list of documents of procedural instruction, completed in incomplete form orwith missing or illegible information, or obsolete, without certificate of conformitywhere applicable, shall not be subject to technical requirement. or without clinicalevidence for products with innovative technology or indication, giving rise to non-consent or summary rejection of the petition.§ 5 There shall be no technical analysis of the requests for notification andamendment of notification so that the products are considered regularized, withoutprejudice to the carrying out, at any time, of documentary or fiscal evaluations on thenotification procedures and their amendments, and, if necessary, request foradditional information or clarifications.§ 6 The processing of medical device notification will occur routinelywithin thirty (30) days of the protocol by the requester.§ 7 Maintaining notification and registration is bound by compliance withthe requirements of Good Manufacturing Practices, essential safety and performancerequirements and specific regulations where they exist.§ 8 The approval of the registration is conditional on the publication of theCertificate of Good Manufacturing Practices issued by Anvisa.§ 9 Petition forms, instructions for use or user/operator manuals andlabeling models should be presented in the Portuguese language.§ 10. The other documents, not mentioned in the previous paragraph,which make up petitions for medical devices may be presented in Portuguese, Spanishor English, according to rules defined in specific regulations.Art. 11. The registration of medical devices shall be valid for ten (10)years, counted from the day of its publication in the Official Gazette, and may berevalidated successively for the same period, under the terms set out in section V ofthis Resolution.Art. 12. Medical devices subject to conformity certification under theBrazilian Conformity Assessment System (SBAC) can only be imported and marketed ifmanufactured during the validity of the Certificate of Conformity.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,§ 2º The evaluation of the documentation will be carried out within the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2º The evaluation of the documentation will be carried out within the
div,['txt'],position:absolute; left:84px; top:146px;,deadlines and legal conditions provided for in the Brazilian health legislation.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",deadlines and legal conditions provided for in the Brazilian health legislation.
div,['txt'],position:absolute; left:144px; top:168px;,"§ 3 For technical reasons, in order to prove the safety and performance of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 3 For technical reasons, in order to prove the safety and performance of"
div,['txt'],position:absolute; left:84px; top:183px;,"the product, due to potential risk to public health, Anvisa may determine the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the product, due to potential risk to public health, Anvisa may determine the"
div,['txt'],position:absolute; left:84px; top:197px;,presentation of additional documents and information.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",presentation of additional documents and information.
div,['txt'],position:absolute; left:144px; top:219px;,"§ 4 The petition without documents, forms and declarations, provided for"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 4 The petition without documents, forms and declarations, provided for"
div,['txt'],position:absolute; left:84px; top:234px;,"in the list of documents of procedural instruction, completed in incomplete form or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","in the list of documents of procedural instruction, completed in incomplete form or"
div,['txt'],position:absolute; left:84px; top:248px;,"with missing or illegible information, or obsolete, without certificate of conformity"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","with missing or illegible information, or obsolete, without certificate of conformity"
div,['txt'],position:absolute; left:84px; top:263px;,"where applicable, shall not be subject to technical requirement. or without clinical"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","where applicable, shall not be subject to technical requirement. or without clinical"
div,['txt'],position:absolute; left:84px; top:278px;,"evidence for products with innovative technology or indication, giving rise to non-"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","evidence for products with innovative technology or indication, giving rise to non-"
div,['txt'],position:absolute; left:84px; top:292px;,consent or summary rejection of the petition.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",consent or summary rejection of the petition.
div,['txt'],position:absolute; left:144px; top:315px;,§ 5 There shall be no technical analysis of the requests for notification and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 5 There shall be no technical analysis of the requests for notification and
div,['txt'],position:absolute; left:84px; top:330px;,"amendment of notification so that the products are considered regularized, without"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","amendment of notification so that the products are considered regularized, without"
div,['txt'],position:absolute; left:84px; top:344px;,"prejudice to the carrying out, at any time, of documentary or fiscal evaluations on the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","prejudice to the carrying out, at any time, of documentary or fiscal evaluations on the"
div,['txt'],position:absolute; left:84px; top:359px;,"notification procedures and their amendments, and, if necessary, request for"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","notification procedures and their amendments, and, if necessary, request for"
div,['txt'],position:absolute; left:84px; top:374px;,additional information or clarifications.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",additional information or clarifications.
div,['txt'],position:absolute; left:144px; top:395px;,§ 6 The processing of medical device notification will occur routinely
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 6 The processing of medical device notification will occur routinely
div,['txt'],position:absolute; left:84px; top:410px;,within thirty (30) days of the protocol by the requester.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",within thirty (30) days of the protocol by the requester.
div,['txt'],position:absolute; left:144px; top:432px;,§ 7 Maintaining notification and registration is bound by compliance with
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 7 Maintaining notification and registration is bound by compliance with
div,['txt'],position:absolute; left:84px; top:447px;,"the requirements of Good Manufacturing Practices, essential safety and performance"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the requirements of Good Manufacturing Practices, essential safety and performance"
div,['txt'],position:absolute; left:84px; top:462px;,requirements and specific regulations where they exist.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",requirements and specific regulations where they exist.
div,['txt'],position:absolute; left:144px; top:484px;,§ 8 The approval of the registration is conditional on the publication of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 8 The approval of the registration is conditional on the publication of the
div,['txt'],position:absolute; left:84px; top:499px;,Certificate of Good Manufacturing Practices issued by Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Certificate of Good Manufacturing Practices issued by Anvisa.
div,['txt'],position:absolute; left:144px; top:521px;,"§ 9 Petition forms, instructions for use or user/operator manuals and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 9 Petition forms, instructions for use or user/operator manuals and"
div,['txt'],position:absolute; left:84px; top:535px;,labeling models should be presented in the Portuguese language.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",labeling models should be presented in the Portuguese language.
div,['txt'],position:absolute; left:144px; top:558px;,"§ 10. The other documents, not mentioned in the previous paragraph,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 10. The other documents, not mentioned in the previous paragraph,"
div,['txt'],position:absolute; left:84px; top:572px;,"which make up petitions for medical devices may be presented in Portuguese, Spanish"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","which make up petitions for medical devices may be presented in Portuguese, Spanish"
div,['txt'],position:absolute; left:84px; top:587px;,"or English, according to rules defined in specific regulations."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","or English, according to rules defined in specific regulations."
div,['txt'],position:absolute; left:144px; top:609px;,Art. 11. The registration of medical devices shall be valid for ten (10)
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 11. The registration of medical devices shall be valid for ten (10)
div,['txt'],position:absolute; left:84px; top:624px;,"years, counted from the day of its publication in the Official Gazette, and may be"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","years, counted from the day of its publication in the Official Gazette, and may be"
div,['txt'],position:absolute; left:84px; top:638px;,"revalidated successively for the same period, under the terms set out in section V of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","revalidated successively for the same period, under the terms set out in section V of"
div,['txt'],position:absolute; left:84px; top:653px;,this Resolution.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",this Resolution.
div,['txt'],position:absolute; left:144px; top:675px;,Art. 12. Medical devices subject to conformity certification under the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 12. Medical devices subject to conformity certification under the
div,['txt'],position:absolute; left:84px; top:690px;,Brazilian Conformity Assessment System (SBAC) can only be imported and marketed if
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Brazilian Conformity Assessment System (SBAC) can only be imported and marketed if
div,['txt'],position:absolute; left:84px; top:704px;,manufactured during the validity of the Certificate of Conformity.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",manufactured during the validity of the Certificate of Conformity.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASection II.Notification of medical devicesArt. 13. The applicant to request the notification of medical device mustproceed with the payment of the corresponding fee and submit to Anvisa the followingdocuments:I - Form for notification of medical device, duly completed, available onthe electronic portal of Anvisa;II - For imported medical devices: A statement issued by the legalmanufacturer, consulted or apostilated, written in Portuguese, English or Spanish oraccompanied by a sworn translation, for a maximum of two years when there isno express validity indicated in the document, authorizing the requesting company torepresent and market its product(s) in Brazil;III - Copy of the certificate of conformity issued under the Brazilian Systemof Conformity Assessment (SBAC), applicable only to medical devices with compulsorycertification, related by Anvisa in specific regulations; andIV - proof of compliance with the legal provisions determined in technicalregulations, in the form of legislation regulating specific medical devices.Single paragraph. The statement that it deals with item II shall contain thesocial reason and full address of the legal manufacturer and the requesting company,the express authorization for the requesting company to represent and market itsproducts in Brazil, and, The statement about the knowledge and compliance with therequirements of Good Manufacturing Practices of Health Products established in theResolution of the Collegiate Board - RDC No. 665, of March 30, 2022, or regulation thatwill replace - la.Section III.Registration of medical devicesArt. 14. The applicant to apply for medical device registration must proceedwith the payment of the corresponding fee and submit to Anvisa thefollowing documents:I - Form for registration of medical device, duly completed, available on theelectronic portal of Anvisa;II - Technical Dossier, as provided for in Chapter VII of this Resolution;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASection II.Notification of medical devicesArt. 13. The applicant to request the notification of medical device mustproceed with the payment of the corresponding fee and submit to Anvisa the followingdocuments:I - Form for notification of medical device, duly completed, available onthe electronic portal of Anvisa;II - For imported medical devices: A statement issued by the legalmanufacturer, consulted or apostilated, written in Portuguese, English or Spanish oraccompanied by a sworn translation, for a maximum of two years when there isno express validity indicated in the document, authorizing the requesting company torepresent and market its product(s) in Brazil;III - Copy of the certificate of conformity issued under the Brazilian Systemof Conformity Assessment (SBAC), applicable only to medical devices with compulsorycertification, related by Anvisa in specific regulations; andIV - proof of compliance with the legal provisions determined in technicalregulations, in the form of legislation regulating specific medical devices.Single paragraph. The statement that it deals with item II shall contain thesocial reason and full address of the legal manufacturer and the requesting company,the express authorization for the requesting company to represent and market itsproducts in Brazil, and, The statement about the knowledge and compliance with therequirements of Good Manufacturing Practices of Health Products established in theResolution of the Collegiate Board - RDC No. 665, of March 30, 2022, or regulation thatwill replace - la.Section III.Registration of medical devicesArt. 14. The applicant to apply for medical device registration must proceedwith the payment of the corresponding fee and submit to Anvisa thefollowing documents:I - Form for registration of medical device, duly completed, available on theelectronic portal of Anvisa;II - Technical Dossier, as provided for in Chapter VII of this Resolution;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:273px; top:131px;,Section II.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section II.
div,['txt'],position:absolute; left:206px; top:154px;,Notification of medical devices
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Notification of medical devices
div,['txt'],position:absolute; left:144px; top:175px;,Art. 13. The applicant to request the notification of medical device must
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 13. The applicant to request the notification of medical device must
div,['txt'],position:absolute; left:84px; top:190px;,proceed with the payment of the corresponding fee and submit to Anvisa the following
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",proceed with the payment of the corresponding fee and submit to Anvisa the following
div,['txt'],position:absolute; left:84px; top:205px;,documents:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",documents:
div,['txt'],position:absolute; left:144px; top:227px;,"I - Form for notification of medical device, duly completed, available on"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - Form for notification of medical device, duly completed, available on"
div,['txt'],position:absolute; left:84px; top:242px;,the electronic portal of Anvisa;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the electronic portal of Anvisa;
div,['txt'],position:absolute; left:144px; top:263px;,II - For imported medical devices: A statement issued by the legal
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - For imported medical devices: A statement issued by the legal
div,['txt'],position:absolute; left:84px; top:278px;,"manufacturer, consulted or apostilated, written in Portuguese, English or Spanish or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","manufacturer, consulted or apostilated, written in Portuguese, English or Spanish or"
div,['txt'],position:absolute; left:84px; top:293px;,"accompanied by a sworn translation, for a maximum of two years when there is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","accompanied by a sworn translation, for a maximum of two years when there is"
div,['txt'],position:absolute; left:84px; top:308px;,"no express validity indicated in the document, authorizing the requesting company to"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","no express validity indicated in the document, authorizing the requesting company to"
div,['txt'],position:absolute; left:84px; top:322px;,represent and market its product(s) in Brazil;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",represent and market its product(s) in Brazil;
div,['txt'],position:absolute; left:144px; top:344px;,III - Copy of the certificate of conformity issued under the Brazilian System
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - Copy of the certificate of conformity issued under the Brazilian System
div,['txt'],position:absolute; left:84px; top:359px;,"of Conformity Assessment (SBAC), applicable only to medical devices with compulsory"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of Conformity Assessment (SBAC), applicable only to medical devices with compulsory"
div,['txt'],position:absolute; left:84px; top:374px;,"certification, related by Anvisa in specific regulations; and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","certification, related by Anvisa in specific regulations; and"
div,['txt'],position:absolute; left:144px; top:396px;,IV - proof of compliance with the legal provisions determined in technical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - proof of compliance with the legal provisions determined in technical
div,['txt'],position:absolute; left:84px; top:411px;,"regulations, in the form of legislation regulating specific medical devices."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","regulations, in the form of legislation regulating specific medical devices."
div,['txt'],position:absolute; left:144px; top:432px;,Single paragraph. The statement that it deals with item II shall contain the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Single paragraph. The statement that it deals with item II shall contain the
div,['txt'],position:absolute; left:84px; top:447px;,"social reason and full address of the legal manufacturer and the requesting company,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","social reason and full address of the legal manufacturer and the requesting company,"
div,['txt'],position:absolute; left:84px; top:462px;,the express authorization for the requesting company to represent and market its
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the express authorization for the requesting company to represent and market its
div,['txt'],position:absolute; left:84px; top:476px;,"products in Brazil, and, The statement about the knowledge and compliance with the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","products in Brazil, and, The statement about the knowledge and compliance with the"
div,['txt'],position:absolute; left:84px; top:491px;,requirements of Good Manufacturing Practices of Health Products established in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",requirements of Good Manufacturing Practices of Health Products established in the
div,['txt'],position:absolute; left:84px; top:505px;,"Resolution of the Collegiate Board - RDC No. 665, of March 30, 2022, or regulation that"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Resolution of the Collegiate Board - RDC No. 665, of March 30, 2022, or regulation that"
div,['txt'],position:absolute; left:84px; top:520px;,will replace - la.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",will replace - la.
div,['txt'],position:absolute; left:271px; top:543px;,Section III.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section III.
div,['txt'],position:absolute; left:214px; top:565px;,Registration of medical devices
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Registration of medical devices
div,['txt'],position:absolute; left:144px; top:587px;,Art. 14. The applicant to apply for medical device registration must proceed
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 14. The applicant to apply for medical device registration must proceed
div,['txt'],position:absolute; left:84px; top:601px;,with the payment of the corresponding fee and submit to Anvisa the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",with the payment of the corresponding fee and submit to Anvisa the
div,['txt'],position:absolute; left:84px; top:616px;,following documents:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",following documents:
div,['txt'],position:absolute; left:144px; top:638px;,"I - Form for registration of medical device, duly completed, available on the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - Form for registration of medical device, duly completed, available on the"
div,['txt'],position:absolute; left:84px; top:653px;,electronic portal of Anvisa;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",electronic portal of Anvisa;
div,['txt'],position:absolute; left:145px; top:675px;,"II - Technical Dossier, as provided for in Chapter VII of this Resolution;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","II - Technical Dossier, as provided for in Chapter VII of this Resolution;"
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAIII - For imported medical devices: A statement issued by the legalmanufacturer, consulted or apostilated, written in Portuguese, English or Spanish oraccompanied by a sworn translation, for a maximum of two years when there isno express validity indicated in the document, authorizing the requesting company torepresent and market its product(s) in Brazil;IV - for imported medical devices: proof of registration or certificate offree trade or equivalent document, granted by the competent authority of the countrywhere the medical device is manufactured and marketed or only marketed, issued fora maximum of two years when there is no express validity indicated in the document,must be consulted or apostilated, and accompanied by sworn translation when notwritten in portuguese, english or spanish;V - Certificate of Good Manufacturing Practices issued by Anvisa or proofof protocol application for Certificate of Good Manufacturing Practices;VI - Copy of the certificate of conformity issued under the Brazilian Systemof Conformity Assessment (SBAC), applicable only to medical devices with compulsorycertification, related by Anvisa in specific regulations; andVII - proof of compliance with the legal provisions determined in technicalregulations applied to specific medical devices.§ 1 The statement that it deals with item III shall contain the social reasonand full address of the legal manufacturer and the requesting company, the expressauthorization for the requesting company to represent and market its products inBrazil; And the statement about knowledge and compliance with the requirements ofGood Manufacturing Practices of Health Products established in the Resolution of theCollegiate Board - RDC No. 665, of March 30, 2022, or regulation that will replace it.§ 2º The protocol of the Application for Certification of GoodManufacturing Practices will be accepted for the purpose of petitioning, as well as thebeginning of the analysis in the petitions for granting registration.§ 3º The approval of applications for granting registration is conditional onthe publication of a certificate of good manufacturing practice issued by Anvisa andthe fulfillment of the other requirements for registration of medical devices.Section IV.Change of notification or Medical Device RegistrationArt. 15. In order to request the alteration of the notification or registrationof medical device, the requester must proceed with the payment of the correspondingfee, if applicable, and present the declaration relating the changes requested andother required documents, according to the subject requested.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAIII - For imported medical devices: A statement issued by the legalmanufacturer, consulted or apostilated, written in Portuguese, English or Spanish oraccompanied by a sworn translation, for a maximum of two years when there isno express validity indicated in the document, authorizing the requesting company torepresent and market its product(s) in Brazil;IV - for imported medical devices: proof of registration or certificate offree trade or equivalent document, granted by the competent authority of the countrywhere the medical device is manufactured and marketed or only marketed, issued fora maximum of two years when there is no express validity indicated in the document,must be consulted or apostilated, and accompanied by sworn translation when notwritten in portuguese, english or spanish;V - Certificate of Good Manufacturing Practices issued by Anvisa or proofof protocol application for Certificate of Good Manufacturing Practices;VI - Copy of the certificate of conformity issued under the Brazilian Systemof Conformity Assessment (SBAC), applicable only to medical devices with compulsorycertification, related by Anvisa in specific regulations; andVII - proof of compliance with the legal provisions determined in technicalregulations applied to specific medical devices.§ 1 The statement that it deals with item III shall contain the social reasonand full address of the legal manufacturer and the requesting company, the expressauthorization for the requesting company to represent and market its products inBrazil; And the statement about knowledge and compliance with the requirements ofGood Manufacturing Practices of Health Products established in the Resolution of theCollegiate Board - RDC No. 665, of March 30, 2022, or regulation that will replace it.§ 2º The protocol of the Application for Certification of GoodManufacturing Practices will be accepted for the purpose of petitioning, as well as thebeginning of the analysis in the petitions for granting registration.§ 3º The approval of applications for granting registration is conditional onthe publication of a certificate of good manufacturing practice issued by Anvisa andthe fulfillment of the other requirements for registration of medical devices.Section IV.Change of notification or Medical Device RegistrationArt. 15. In order to request the alteration of the notification or registrationof medical device, the requester must proceed with the payment of the correspondingfee, if applicable, and present the declaration relating the changes requested andother required documents, according to the subject requested.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,III - For imported medical devices: A statement issued by the legal
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - For imported medical devices: A statement issued by the legal
div,['txt'],position:absolute; left:84px; top:146px;,"manufacturer, consulted or apostilated, written in Portuguese, English or Spanish or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","manufacturer, consulted or apostilated, written in Portuguese, English or Spanish or"
div,['txt'],position:absolute; left:84px; top:160px;,"accompanied by a sworn translation, for a maximum of two years when there is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","accompanied by a sworn translation, for a maximum of two years when there is"
div,['txt'],position:absolute; left:84px; top:175px;,"no express validity indicated in the document, authorizing the requesting company to"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","no express validity indicated in the document, authorizing the requesting company to"
div,['txt'],position:absolute; left:84px; top:190px;,represent and market its product(s) in Brazil;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",represent and market its product(s) in Brazil;
div,['txt'],position:absolute; left:144px; top:212px;,IV - for imported medical devices: proof of registration or certificate of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - for imported medical devices: proof of registration or certificate of
div,['txt'],position:absolute; left:84px; top:226px;,"free trade or equivalent document, granted by the competent authority of the country"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","free trade or equivalent document, granted by the competent authority of the country"
div,['txt'],position:absolute; left:84px; top:241px;,"where the medical device is manufactured and marketed or only marketed, issued for"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","where the medical device is manufactured and marketed or only marketed, issued for"
div,['txt'],position:absolute; left:84px; top:256px;,"a maximum of two years when there is no express validity indicated in the document,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a maximum of two years when there is no express validity indicated in the document,"
div,['txt'],position:absolute; left:84px; top:270px;,"must be consulted or apostilated, and accompanied by sworn translation when not"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","must be consulted or apostilated, and accompanied by sworn translation when not"
div,['txt'],position:absolute; left:84px; top:285px;,"written in portuguese, english or spanish;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","written in portuguese, english or spanish;"
div,['txt'],position:absolute; left:144px; top:308px;,V - Certificate of Good Manufacturing Practices issued by Anvisa or proof
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",V - Certificate of Good Manufacturing Practices issued by Anvisa or proof
div,['txt'],position:absolute; left:84px; top:323px;,of protocol application for Certificate of Good Manufacturing Practices;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of protocol application for Certificate of Good Manufacturing Practices;
div,['txt'],position:absolute; left:144px; top:344px;,VI - Copy of the certificate of conformity issued under the Brazilian System
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",VI - Copy of the certificate of conformity issued under the Brazilian System
div,['txt'],position:absolute; left:84px; top:359px;,"of Conformity Assessment (SBAC), applicable only to medical devices with compulsory"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of Conformity Assessment (SBAC), applicable only to medical devices with compulsory"
div,['txt'],position:absolute; left:84px; top:374px;,"certification, related by Anvisa in specific regulations; and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","certification, related by Anvisa in specific regulations; and"
div,['txt'],position:absolute; left:144px; top:396px;,VII - proof of compliance with the legal provisions determined in technical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",VII - proof of compliance with the legal provisions determined in technical
div,['txt'],position:absolute; left:84px; top:411px;,regulations applied to specific medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",regulations applied to specific medical devices.
div,['txt'],position:absolute; left:144px; top:432px;,§ 1 The statement that it deals with item III shall contain the social reason
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 The statement that it deals with item III shall contain the social reason
div,['txt'],position:absolute; left:84px; top:447px;,"and full address of the legal manufacturer and the requesting company, the express"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","and full address of the legal manufacturer and the requesting company, the express"
div,['txt'],position:absolute; left:84px; top:462px;,authorization for the requesting company to represent and market its products in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",authorization for the requesting company to represent and market its products in
div,['txt'],position:absolute; left:84px; top:476px;,Brazil; And the statement about knowledge and compliance with the requirements of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Brazil; And the statement about knowledge and compliance with the requirements of
div,['txt'],position:absolute; left:84px; top:491px;,Good Manufacturing Practices of Health Products established in the Resolution of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Good Manufacturing Practices of Health Products established in the Resolution of the
div,['txt'],position:absolute; left:84px; top:506px;,"Collegiate Board - RDC No. 665, of March 30, 2022, or regulation that will replace it."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Collegiate Board - RDC No. 665, of March 30, 2022, or regulation that will replace it."
div,['txt'],position:absolute; left:144px; top:528px;,§ 2º The protocol of the Application for Certification of Good
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2º The protocol of the Application for Certification of Good
div,['txt'],position:absolute; left:84px; top:543px;,"Manufacturing Practices will be accepted for the purpose of petitioning, as well as the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Manufacturing Practices will be accepted for the purpose of petitioning, as well as the"
div,['txt'],position:absolute; left:84px; top:558px;,beginning of the analysis in the petitions for granting registration.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",beginning of the analysis in the petitions for granting registration.
div,['txt'],position:absolute; left:144px; top:579px;,§ 3º The approval of applications for granting registration is conditional on
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3º The approval of applications for granting registration is conditional on
div,['txt'],position:absolute; left:84px; top:594px;,the publication of a certificate of good manufacturing practice issued by Anvisa and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the publication of a certificate of good manufacturing practice issued by Anvisa and
div,['txt'],position:absolute; left:84px; top:609px;,the fulfillment of the other requirements for registration of medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the fulfillment of the other requirements for registration of medical devices.
div,['txt'],position:absolute; left:271px; top:631px;,Section IV.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section IV.
div,['txt'],position:absolute; left:144px; top:653px;,Change of notification or Medical Device Registration
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Change of notification or Medical Device Registration
div,['txt'],position:absolute; left:144px; top:675px;,Art. 15. In order to request the alteration of the notification or registration
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 15. In order to request the alteration of the notification or registration
div,['txt'],position:absolute; left:84px; top:690px;,"of medical device, the requester must proceed with the payment of the corresponding"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of medical device, the requester must proceed with the payment of the corresponding"
div,['txt'],position:absolute; left:84px; top:704px;,"fee, if applicable, and present the declaration relating the changes requested and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","fee, if applicable, and present the declaration relating the changes requested and"
div,['txt'],position:absolute; left:84px; top:719px;,"other required documents, according to the subject requested."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","other required documents, according to the subject requested."
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAArt. 16. Changes to information presented in the medical devicenotification or registration process are classified under:I - amendment of approval required;II - Immediate implementation change; andIII - Non-reportable change.§ 1 The petitioning of the amendments contained in paragraphs I and II ofthis article shall comply with the provisions of the Normative Instruction - IN No. 74, ofSeptember 16, 2020, published in DOU No. 180, of September 18, 2022, Section 1, p.111, which details the applicable petitioning subjects.§ 2º Any minor changes not classified as required approval or immediateimplementation are classified as non-reportable changes, and also: Changes ininformation that do not modify the medical device design; bug fixes in software; Non-technical changes such as images, formatting, layouts, symbols and text adaptations ofdocuments without additional risk; updates of company operating authorizationinformation; changes of contact (e.g. telephone numbers or postal address), technicalassistance and website.§ 3 The amendments related to §2 shall be controlled by the quality systemof the regularization holder and be incorporated into subsequent petitions.§ 4º The change petitioning for medical devices of risk classes I and II willbe performed by the immediate implementation regime, except when it is a non-reportable change.Art. 17. The subjects of petition for change of notification or registration ofmedical devices are provided by Normative Instruction - IN No. 74, of September 16,2020, which identifies the changes that are considered as required approval orimmediate implementation.Art. 18. The request to change information must be accompanied bydocumentation proving the modification to be implemented, in accordance with thecurrent health legislation.Art. 19. The immediate implementation change that is interdependentwith the required approval change should be requested in conjunction with thisamendment, incorporating its content.Art. 20. Changes resulting from field action notified to Anvisa in order toensure the safety and performance of the device in relation to the user and the patientwill have their analyzes prioritized.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAArt. 16. Changes to information presented in the medical devicenotification or registration process are classified under:I - amendment of approval required;II - Immediate implementation change; andIII - Non-reportable change.§ 1 The petitioning of the amendments contained in paragraphs I and II ofthis article shall comply with the provisions of the Normative Instruction - IN No. 74, ofSeptember 16, 2020, published in DOU No. 180, of September 18, 2022, Section 1, p.111, which details the applicable petitioning subjects.§ 2º Any minor changes not classified as required approval or immediateimplementation are classified as non-reportable changes, and also: Changes ininformation that do not modify the medical device design; bug fixes in software; Non-technical changes such as images, formatting, layouts, symbols and text adaptations ofdocuments without additional risk; updates of company operating authorizationinformation; changes of contact (e.g. telephone numbers or postal address), technicalassistance and website.§ 3 The amendments related to §2 shall be controlled by the quality systemof the regularization holder and be incorporated into subsequent petitions.§ 4º The change petitioning for medical devices of risk classes I and II willbe performed by the immediate implementation regime, except when it is a non-reportable change.Art. 17. The subjects of petition for change of notification or registration ofmedical devices are provided by Normative Instruction - IN No. 74, of September 16,2020, which identifies the changes that are considered as required approval orimmediate implementation.Art. 18. The request to change information must be accompanied bydocumentation proving the modification to be implemented, in accordance with thecurrent health legislation.Art. 19. The immediate implementation change that is interdependentwith the required approval change should be requested in conjunction with thisamendment, incorporating its content.Art. 20. Changes resulting from field action notified to Anvisa in order toensure the safety and performance of the device in relation to the user and the patientwill have their analyzes prioritized.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,Art. 16. Changes to information presented in the medical device
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 16. Changes to information presented in the medical device
div,['txt'],position:absolute; left:84px; top:146px;,notification or registration process are classified under:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",notification or registration process are classified under:
div,['txt'],position:absolute; left:145px; top:168px;,I - amendment of approval required;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - amendment of approval required;
div,['txt'],position:absolute; left:145px; top:190px;,II - Immediate implementation change; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - Immediate implementation change; and
div,['txt'],position:absolute; left:145px; top:212px;,III - Non-reportable change.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - Non-reportable change.
div,['txt'],position:absolute; left:144px; top:234px;,§ 1 The petitioning of the amendments contained in paragraphs I and II of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 The petitioning of the amendments contained in paragraphs I and II of
div,['txt'],position:absolute; left:84px; top:249px;,"this article shall comply with the provisions of the Normative Instruction - IN No. 74, of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","this article shall comply with the provisions of the Normative Instruction - IN No. 74, of"
div,['txt'],position:absolute; left:84px; top:263px;,"September 16, 2020, published in DOU No. 180, of September 18, 2022, Section 1, p."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","September 16, 2020, published in DOU No. 180, of September 18, 2022, Section 1, p."
div,['txt'],position:absolute; left:84px; top:278px;,"111, which details the applicable petitioning subjects."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","111, which details the applicable petitioning subjects."
div,['txt'],position:absolute; left:144px; top:300px;,§ 2º Any minor changes not classified as required approval or immediate
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2º Any minor changes not classified as required approval or immediate
div,['txt'],position:absolute; left:84px; top:315px;,"implementation are classified as non-reportable changes, and also: Changes in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","implementation are classified as non-reportable changes, and also: Changes in"
div,['txt'],position:absolute; left:84px; top:329px;,information that do not modify the medical device design; bug fixes in software; Non-
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",information that do not modify the medical device design; bug fixes in software; Non-
div,['txt'],position:absolute; left:84px; top:344px;,"technical changes such as images, formatting, layouts, symbols and text adaptations of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","technical changes such as images, formatting, layouts, symbols and text adaptations of"
div,['txt'],position:absolute; left:84px; top:359px;,documents without additional risk; updates of company operating authorization
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",documents without additional risk; updates of company operating authorization
div,['txt'],position:absolute; left:84px; top:374px;,"information; changes of contact (e.g. telephone numbers or postal address), technical"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","information; changes of contact (e.g. telephone numbers or postal address), technical"
div,['txt'],position:absolute; left:84px; top:389px;,assistance and website.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",assistance and website.
div,['txt'],position:absolute; left:144px; top:410px;,§ 3 The amendments related to §2 shall be controlled by the quality system
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3 The amendments related to §2 shall be controlled by the quality system
div,['txt'],position:absolute; left:84px; top:425px;,of the regularization holder and be incorporated into subsequent petitions.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of the regularization holder and be incorporated into subsequent petitions.
div,['txt'],position:absolute; left:144px; top:447px;,§ 4º The change petitioning for medical devices of risk classes I and II will
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 4º The change petitioning for medical devices of risk classes I and II will
div,['txt'],position:absolute; left:84px; top:462px;,"be performed by the immediate implementation regime, except when it is a non-"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","be performed by the immediate implementation regime, except when it is a non-"
div,['txt'],position:absolute; left:84px; top:477px;,reportable change.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",reportable change.
div,['txt'],position:absolute; left:144px; top:498px;,Art. 17. The subjects of petition for change of notification or registration of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 17. The subjects of petition for change of notification or registration of
div,['txt'],position:absolute; left:84px; top:513px;,"medical devices are provided by Normative Instruction - IN No. 74, of September 16,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","medical devices are provided by Normative Instruction - IN No. 74, of September 16,"
div,['txt'],position:absolute; left:84px; top:528px;,"2020, which identifies the changes that are considered as required approval or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","2020, which identifies the changes that are considered as required approval or"
div,['txt'],position:absolute; left:84px; top:543px;,immediate implementation.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",immediate implementation.
div,['txt'],position:absolute; left:144px; top:565px;,Art. 18. The request to change information must be accompanied by
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 18. The request to change information must be accompanied by
div,['txt'],position:absolute; left:84px; top:579px;,"documentation proving the modification to be implemented, in accordance with the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","documentation proving the modification to be implemented, in accordance with the"
div,['txt'],position:absolute; left:84px; top:594px;,current health legislation.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",current health legislation.
div,['txt'],position:absolute; left:144px; top:616px;,Art. 19. The immediate implementation change that is interdependent
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 19. The immediate implementation change that is interdependent
div,['txt'],position:absolute; left:84px; top:631px;,with the required approval change should be requested in conjunction with this
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",with the required approval change should be requested in conjunction with this
div,['txt'],position:absolute; left:84px; top:645px;,"amendment, incorporating its content."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","amendment, incorporating its content."
div,['txt'],position:absolute; left:144px; top:667px;,Art. 20. Changes resulting from field action notified to Anvisa in order to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 20. Changes resulting from field action notified to Anvisa in order to
div,['txt'],position:absolute; left:84px; top:682px;,ensure the safety and performance of the device in relation to the user and the patient
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ensure the safety and performance of the device in relation to the user and the patient
div,['txt'],position:absolute; left:84px; top:697px;,will have their analyzes prioritized.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",will have their analyzes prioritized.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASingle paragraph. To request the prioritization of the analysis cited in thecaput the company must protocol the claim, presenting evidence of sending thenotification of the field action to Anvisa.Art. 21. The required approval change will only take effect after the finaldecision is published in the Official Gazette and, where applicable, the updated data willbe published in the electronic portal of Anvisa.Art. 22. Changes in immediate implementation will be published in theOfficial Gazette and, where applicable, the updated data will be published in theelectronic portal of Anvisa, observing the period of up to thirty (30) days, counted fromthe completion of the protocol of the respective petition, regardless of documentanalysis by Anvisa.Art. 23. The request for immediate implementation may be subject todocumentary or fiscal evaluation at any time by Anvisa and, if necessary, additionalinformation or clarification may be requested.Single paragraph. Anvisa may suspend the commercialization,import and/or use of the product until its regularization, in the event that there isinconsistency in the petitioning of immediate implementation change that justifiessuch sanitary measure.Art. 24. The acceptance of requests for modification/inclusion of amanufacturing plant or change of the factory address or inclusion of products or modelsin the family/system/set of products framed in risk classes III and IV, It is conditionedto the publication of the Certificate of Good Manufacturing Practices issued by Anvisaand to the fulfillment of the other requirements corresponding to each type ofpetition.Single paragraph. The protocol of the Application for Certification of GoodManufacturing Practices will be accepted for the purpose of petitioning, as well as thebeginning of the analysis in the petitions.Art. 25. If the stock of finished products needs to be exhausted as a resultof a change, the simultaneous import and commercialization of the versions involved isallowed until the end of the shelf life or shelf life of the product.Single paragraph. Changes made to troubleshoot product security andperformance issues do not fall under the caput permission.Art. 26. It is allowed to deplete the stock of packaging, labelsand instructions for use for a period of 120 (one hundred and twenty) days from thepublication of the change.Single paragraph. Changes made to troubleshoot product security andperformance issues do not fall under the caput permission.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASingle paragraph. To request the prioritization of the analysis cited in thecaput the company must protocol the claim, presenting evidence of sending thenotification of the field action to Anvisa.Art. 21. The required approval change will only take effect after the finaldecision is published in the Official Gazette and, where applicable, the updated data willbe published in the electronic portal of Anvisa.Art. 22. Changes in immediate implementation will be published in theOfficial Gazette and, where applicable, the updated data will be published in theelectronic portal of Anvisa, observing the period of up to thirty (30) days, counted fromthe completion of the protocol of the respective petition, regardless of documentanalysis by Anvisa.Art. 23. The request for immediate implementation may be subject todocumentary or fiscal evaluation at any time by Anvisa and, if necessary, additionalinformation or clarification may be requested.Single paragraph. Anvisa may suspend the commercialization,import and/or use of the product until its regularization, in the event that there isinconsistency in the petitioning of immediate implementation change that justifiessuch sanitary measure.Art. 24. The acceptance of requests for modification/inclusion of amanufacturing plant or change of the factory address or inclusion of products or modelsin the family/system/set of products framed in risk classes III and IV, It is conditionedto the publication of the Certificate of Good Manufacturing Practices issued by Anvisaand to the fulfillment of the other requirements corresponding to each type ofpetition.Single paragraph. The protocol of the Application for Certification of GoodManufacturing Practices will be accepted for the purpose of petitioning, as well as thebeginning of the analysis in the petitions.Art. 25. If the stock of finished products needs to be exhausted as a resultof a change, the simultaneous import and commercialization of the versions involved isallowed until the end of the shelf life or shelf life of the product.Single paragraph. Changes made to troubleshoot product security andperformance issues do not fall under the caput permission.Art. 26. It is allowed to deplete the stock of packaging, labelsand instructions for use for a period of 120 (one hundred and twenty) days from thepublication of the change.Single paragraph. Changes made to troubleshoot product security andperformance issues do not fall under the caput permission.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,Single paragraph. To request the prioritization of the analysis cited in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Single paragraph. To request the prioritization of the analysis cited in the
div,['txt'],position:absolute; left:84px; top:146px;,"caput the company must protocol the claim, presenting evidence of sending the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","caput the company must protocol the claim, presenting evidence of sending the"
div,['txt'],position:absolute; left:84px; top:160px;,notification of the field action to Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",notification of the field action to Anvisa.
div,['txt'],position:absolute; left:144px; top:182px;,Art. 21. The required approval change will only take effect after the final
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 21. The required approval change will only take effect after the final
div,['txt'],position:absolute; left:84px; top:197px;,"decision is published in the Official Gazette and, where applicable, the updated data will"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","decision is published in the Official Gazette and, where applicable, the updated data will"
div,['txt'],position:absolute; left:84px; top:212px;,be published in the electronic portal of Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",be published in the electronic portal of Anvisa.
div,['txt'],position:absolute; left:144px; top:234px;,Art. 22. Changes in immediate implementation will be published in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 22. Changes in immediate implementation will be published in the
div,['txt'],position:absolute; left:84px; top:249px;,"Official Gazette and, where applicable, the updated data will be published in the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Official Gazette and, where applicable, the updated data will be published in the"
div,['txt'],position:absolute; left:84px; top:263px;,"electronic portal of Anvisa, observing the period of up to thirty (30) days, counted from"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","electronic portal of Anvisa, observing the period of up to thirty (30) days, counted from"
div,['txt'],position:absolute; left:84px; top:278px;,"the completion of the protocol of the respective petition, regardless of document"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the completion of the protocol of the respective petition, regardless of document"
div,['txt'],position:absolute; left:84px; top:293px;,analysis by Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",analysis by Anvisa.
div,['txt'],position:absolute; left:144px; top:315px;,Art. 23. The request for immediate implementation may be subject to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 23. The request for immediate implementation may be subject to
div,['txt'],position:absolute; left:84px; top:330px;,"documentary or fiscal evaluation at any time by Anvisa and, if necessary, additional"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","documentary or fiscal evaluation at any time by Anvisa and, if necessary, additional"
div,['txt'],position:absolute; left:84px; top:344px;,information or clarification may be requested.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",information or clarification may be requested.
div,['txt'],position:absolute; left:144px; top:366px;,"Single paragraph. Anvisa may suspend the commercialization,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Single paragraph. Anvisa may suspend the commercialization,"
div,['txt'],position:absolute; left:84px; top:381px;,"import and/or use of the product until its regularization, in the event that there is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","import and/or use of the product until its regularization, in the event that there is"
div,['txt'],position:absolute; left:84px; top:396px;,inconsistency in the petitioning of immediate implementation change that justifies
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",inconsistency in the petitioning of immediate implementation change that justifies
div,['txt'],position:absolute; left:84px; top:410px;,such sanitary measure.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",such sanitary measure.
div,['txt'],position:absolute; left:144px; top:432px;,Art. 24. The acceptance of requests for modification/inclusion of a
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 24. The acceptance of requests for modification/inclusion of a
div,['txt'],position:absolute; left:84px; top:447px;,manufacturing plant or change of the factory address or inclusion of products or models
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",manufacturing plant or change of the factory address or inclusion of products or models
div,['txt'],position:absolute; left:84px; top:462px;,"in the family/system/set of products framed in risk classes III and IV, It is conditioned"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","in the family/system/set of products framed in risk classes III and IV, It is conditioned"
div,['txt'],position:absolute; left:84px; top:476px;,to the publication of the Certificate of Good Manufacturing Practices issued by Anvisa
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",to the publication of the Certificate of Good Manufacturing Practices issued by Anvisa
div,['txt'],position:absolute; left:84px; top:491px;,and to the fulfillment of the other requirements corresponding to each type of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and to the fulfillment of the other requirements corresponding to each type of
div,['txt'],position:absolute; left:84px; top:506px;,petition.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",petition.
div,['txt'],position:absolute; left:144px; top:528px;,Single paragraph. The protocol of the Application for Certification of Good
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Single paragraph. The protocol of the Application for Certification of Good
div,['txt'],position:absolute; left:84px; top:542px;,"Manufacturing Practices will be accepted for the purpose of petitioning, as well as the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Manufacturing Practices will be accepted for the purpose of petitioning, as well as the"
div,['txt'],position:absolute; left:84px; top:557px;,beginning of the analysis in the petitions.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",beginning of the analysis in the petitions.
div,['txt'],position:absolute; left:144px; top:580px;,Art. 25. If the stock of finished products needs to be exhausted as a result
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 25. If the stock of finished products needs to be exhausted as a result
div,['txt'],position:absolute; left:84px; top:595px;,"of a change, the simultaneous import and commercialization of the versions involved is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of a change, the simultaneous import and commercialization of the versions involved is"
div,['txt'],position:absolute; left:84px; top:609px;,allowed until the end of the shelf life or shelf life of the product.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",allowed until the end of the shelf life or shelf life of the product.
div,['txt'],position:absolute; left:144px; top:631px;,Single paragraph. Changes made to troubleshoot product security and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Single paragraph. Changes made to troubleshoot product security and
div,['txt'],position:absolute; left:84px; top:646px;,performance issues do not fall under the caput permission.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",performance issues do not fall under the caput permission.
div,['txt'],position:absolute; left:144px; top:667px;,"Art. 26. It is allowed to deplete the stock of packaging, labels"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 26. It is allowed to deplete the stock of packaging, labels"
div,['txt'],position:absolute; left:84px; top:682px;,and instructions for use for a period of 120 (one hundred and twenty) days from the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and instructions for use for a period of 120 (one hundred and twenty) days from the
div,['txt'],position:absolute; left:84px; top:697px;,publication of the change.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",publication of the change.
div,['txt'],position:absolute; left:144px; top:719px;,Single paragraph. Changes made to troubleshoot product security and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Single paragraph. Changes made to troubleshoot product security and
div,['txt'],position:absolute; left:84px; top:734px;,performance issues do not fall under the caput permission.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",performance issues do not fall under the caput permission.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASection VMedical Device Registration RevalidationArt. 27. To request the revalidation of the medical device registration, theapplicant must proceed with the payment of the corresponding fee and present thefollowing documents:I - For imported medical devices: Declaration issued by the legalmanufacturer consulted or apostilated, written in Portuguese, English or Spanish oraccompanied by sworn translation, for a maximum of two years when there isno express validity indicated in the document, authorizing the requesting company torepresent and market its product(s) in Brazil.II - Certificate of Good Manufacturing Practice issued by valid Anvisa.§ 1 The statement that the item I deals with must contain the social reasonand full address of the legal manufacturer and the requesting company, the expressauthorization for the requesting company to represent and market its products inBrazil, and, The statement about knowledge and compliance with the requirements ofGood Manufacturing Practices of Health Products established in the Resolution of theCollegiate Board - RDC No. 665, of March 30, 2022, published in DOU No. 62, of March31, 2022, Section 1, p. 334, or regulation that will replace it.§ 2º The request for revalidation must be submitted within the time limitset by the Resolution of the Collegiate Board - RDC No. 250, of October 20, 2004.§ 3º The protocol of the Application for Certification of GoodManufacturing Practices will be accepted for the purpose of petitioning and analysis ofregistration revalidation petitions.Art. 28. The products submitted the notification regime isexempted from revalidation.Section VI.Cancellation of Notification or Registration of Medical DevicesArt. 29. The holder of notification or registration of medical device thatintends no longer to market it in the Brazilian market must request its cancellation.Section VII Complianceof InformationArt. 30. Changes made by the manufacturer in the information relating tothe medical device contained in the notification or registration shall be communicatedBy the holder to Anvisa, in accordance with the requirements set out in Section IV of thisResolution.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASection VMedical Device Registration RevalidationArt. 27. To request the revalidation of the medical device registration, theapplicant must proceed with the payment of the corresponding fee and present thefollowing documents:I - For imported medical devices: Declaration issued by the legalmanufacturer consulted or apostilated, written in Portuguese, English or Spanish oraccompanied by sworn translation, for a maximum of two years when there isno express validity indicated in the document, authorizing the requesting company torepresent and market its product(s) in Brazil.II - Certificate of Good Manufacturing Practice issued by valid Anvisa.§ 1 The statement that the item I deals with must contain the social reasonand full address of the legal manufacturer and the requesting company, the expressauthorization for the requesting company to represent and market its products inBrazil, and, The statement about knowledge and compliance with the requirements ofGood Manufacturing Practices of Health Products established in the Resolution of theCollegiate Board - RDC No. 665, of March 30, 2022, published in DOU No. 62, of March31, 2022, Section 1, p. 334, or regulation that will replace it.§ 2º The request for revalidation must be submitted within the time limitset by the Resolution of the Collegiate Board - RDC No. 250, of October 20, 2004.§ 3º The protocol of the Application for Certification of GoodManufacturing Practices will be accepted for the purpose of petitioning and analysis ofregistration revalidation petitions.Art. 28. The products submitted the notification regime isexempted from revalidation.Section VI.Cancellation of Notification or Registration of Medical DevicesArt. 29. The holder of notification or registration of medical device thatintends no longer to market it in the Brazilian market must request its cancellation.Section VII Complianceof InformationArt. 30. Changes made by the manufacturer in the information relating tothe medical device contained in the notification or registration shall be communicatedBy the holder to Anvisa, in accordance with the requirements set out in Section IV of thisResolution.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:274px; top:131px;,Section V
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section V
div,['txt'],position:absolute; left:175px; top:154px;,Medical Device Registration Revalidation
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Medical Device Registration Revalidation
div,['txt'],position:absolute; left:144px; top:175px;,"Art. 27. To request the revalidation of the medical device registration, the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 27. To request the revalidation of the medical device registration, the"
div,['txt'],position:absolute; left:84px; top:190px;,applicant must proceed with the payment of the corresponding fee and present the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",applicant must proceed with the payment of the corresponding fee and present the
div,['txt'],position:absolute; left:84px; top:205px;,following documents:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",following documents:
div,['txt'],position:absolute; left:144px; top:227px;,I - For imported medical devices: Declaration issued by the legal
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - For imported medical devices: Declaration issued by the legal
div,['txt'],position:absolute; left:84px; top:241px;,"manufacturer consulted or apostilated, written in Portuguese, English or Spanish or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","manufacturer consulted or apostilated, written in Portuguese, English or Spanish or"
div,['txt'],position:absolute; left:84px; top:256px;,"accompanied by sworn translation, for a maximum of two years when there is"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","accompanied by sworn translation, for a maximum of two years when there is"
div,['txt'],position:absolute; left:84px; top:271px;,"no express validity indicated in the document, authorizing the requesting company to"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","no express validity indicated in the document, authorizing the requesting company to"
div,['txt'],position:absolute; left:84px; top:286px;,represent and market its product(s) in Brazil.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",represent and market its product(s) in Brazil.
div,['txt'],position:absolute; left:145px; top:307px;,II - Certificate of Good Manufacturing Practice issued by valid Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - Certificate of Good Manufacturing Practice issued by valid Anvisa.
div,['txt'],position:absolute; left:144px; top:330px;,§ 1 The statement that the item I deals with must contain the social reason
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 The statement that the item I deals with must contain the social reason
div,['txt'],position:absolute; left:84px; top:345px;,"and full address of the legal manufacturer and the requesting company, the express"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","and full address of the legal manufacturer and the requesting company, the express"
div,['txt'],position:absolute; left:84px; top:359px;,authorization for the requesting company to represent and market its products in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",authorization for the requesting company to represent and market its products in
div,['txt'],position:absolute; left:84px; top:374px;,"Brazil, and, The statement about knowledge and compliance with the requirements of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Brazil, and, The statement about knowledge and compliance with the requirements of"
div,['txt'],position:absolute; left:84px; top:389px;,Good Manufacturing Practices of Health Products established in the Resolution of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Good Manufacturing Practices of Health Products established in the Resolution of the
div,['txt'],position:absolute; left:84px; top:403px;,"Collegiate Board - RDC No. 665, of March 30, 2022, published in DOU No. 62, of March"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Collegiate Board - RDC No. 665, of March 30, 2022, published in DOU No. 62, of March"
div,['txt'],position:absolute; left:84px; top:418px;,"31, 2022, Section 1, p. 334, or regulation that will replace it."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","31, 2022, Section 1, p. 334, or regulation that will replace it."
div,['txt'],position:absolute; left:144px; top:439px;,§ 2º The request for revalidation must be submitted within the time limit
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2º The request for revalidation must be submitted within the time limit
div,['txt'],position:absolute; left:84px; top:455px;,"set by the Resolution of the Collegiate Board - RDC No. 250, of October 20, 2004."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","set by the Resolution of the Collegiate Board - RDC No. 250, of October 20, 2004."
div,['txt'],position:absolute; left:144px; top:476px;,§ 3º The protocol of the Application for Certification of Good
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3º The protocol of the Application for Certification of Good
div,['txt'],position:absolute; left:84px; top:492px;,Manufacturing Practices will be accepted for the purpose of petitioning and analysis of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Manufacturing Practices will be accepted for the purpose of petitioning and analysis of
div,['txt'],position:absolute; left:84px; top:507px;,registration revalidation petitions.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",registration revalidation petitions.
div,['txt'],position:absolute; left:144px; top:528px;,Art. 28. The products submitted the notification regime is
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 28. The products submitted the notification regime is
div,['txt'],position:absolute; left:84px; top:543px;,exempted from revalidation.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",exempted from revalidation.
div,['txt'],position:absolute; left:271px; top:565px;,Section VI.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section VI.
div,['txt'],position:absolute; left:132px; top:588px;,Cancellation of Notification or Registration of Medical Devices
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Cancellation of Notification or Registration of Medical Devices
div,['txt'],position:absolute; left:144px; top:609px;,Art. 29. The holder of notification or registration of medical device that
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 29. The holder of notification or registration of medical device that
div,['txt'],position:absolute; left:84px; top:624px;,intends no longer to market it in the Brazilian market must request its cancellation.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",intends no longer to market it in the Brazilian market must request its cancellation.
div,['txt'],position:absolute; left:274px; top:646px;,Section VII Compliance
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section VII Compliance
div,['txt'],position:absolute; left:218px; top:668px;,of Information
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of Information
div,['txt'],position:absolute; left:144px; top:691px;,Art. 30. Changes made by the manufacturer in the information relating to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 30. Changes made by the manufacturer in the information relating to
div,['txt'],position:absolute; left:84px; top:705px;,the medical device contained in the notification or registration shall be communicated
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the medical device contained in the notification or registration shall be communicated
div,['txt'],position:absolute; left:84px; top:719px;,"By the holder to Anvisa, in accordance with the requirements set out in Section IV of this"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","By the holder to Anvisa, in accordance with the requirements set out in Section IV of this"
div,['txt'],position:absolute; left:84px; top:734px;,Resolution.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Resolution.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAArt. 31. Changes relating to a medical device that require prior approval byAnvisa may only be disclosed to the market after publication of the said change in theOfficial Gazette and electronic portal of Anvisa.Art. 32. All communication or advertising of medical device on the marketmust keep strict agreement with the information presented by the notification holderor registration to Anvisa.Section VIII.Document repository of medical devicesArt. 33. The loading of instructions for use in the Medical DeviceDocumentary Repository corresponds to the insertion and updating of thesedocuments linked to the processes of notification or registration of medical devices.§ 1 In the case of a medical device that does not have instructions for use(as a specific document), the labeling model must be loaded in the field of instructionsfor use, including the information provided for in Chapter VI.§ 2º The loading of instructions for use should occur through theapplicable petitioning subjects, identified as ""provision of instructions for use on theAnvisa Portal"".§ 3º The loading of instructions for use is the responsibility of the holderof the notification or the registration and shall be controlled by the holder forany audits.§ 4º The loading of instructions for use is mandatory and must be carriedout by the company responsible for the notification or registration of the product,which certifies that its content complies with the current legislation and consistencywith the regularized product.§ 5º For new products notified or registered and for changes to thoseproducts previously notified or registered, the petitioning and the respective loading ofinstructions for use shall be carried out within thirty (30) days of publication in theOfficial Gazette.§ 6 For non-reportable changes to those previously notified or registeredproducts, the petitioning and the respective loading of instructions for use should becarried out within 180 (one hundred and eighty) days after the implementation of thechange that implies a change in the instructions for use.Art. 34. The provision of instructions for use will be carried out exclusivelyon the electronic portal of Anvisa, immediately after the completion of the protocol ofthe respective petition, regardless of document analysis by the Agency.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAArt. 31. Changes relating to a medical device that require prior approval byAnvisa may only be disclosed to the market after publication of the said change in theOfficial Gazette and electronic portal of Anvisa.Art. 32. All communication or advertising of medical device on the marketmust keep strict agreement with the information presented by the notification holderor registration to Anvisa.Section VIII.Document repository of medical devicesArt. 33. The loading of instructions for use in the Medical DeviceDocumentary Repository corresponds to the insertion and updating of thesedocuments linked to the processes of notification or registration of medical devices.§ 1 In the case of a medical device that does not have instructions for use(as a specific document), the labeling model must be loaded in the field of instructionsfor use, including the information provided for in Chapter VI.§ 2º The loading of instructions for use should occur through theapplicable petitioning subjects, identified as ""provision of instructions for use on theAnvisa Portal"".§ 3º The loading of instructions for use is the responsibility of the holderof the notification or the registration and shall be controlled by the holder forany audits.§ 4º The loading of instructions for use is mandatory and must be carriedout by the company responsible for the notification or registration of the product,which certifies that its content complies with the current legislation and consistencywith the regularized product.§ 5º For new products notified or registered and for changes to thoseproducts previously notified or registered, the petitioning and the respective loading ofinstructions for use shall be carried out within thirty (30) days of publication in theOfficial Gazette.§ 6 For non-reportable changes to those previously notified or registeredproducts, the petitioning and the respective loading of instructions for use should becarried out within 180 (one hundred and eighty) days after the implementation of thechange that implies a change in the instructions for use.Art. 34. The provision of instructions for use will be carried out exclusivelyon the electronic portal of Anvisa, immediately after the completion of the protocol ofthe respective petition, regardless of document analysis by the Agency.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,Art. 31. Changes relating to a medical device that require prior approval by
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 31. Changes relating to a medical device that require prior approval by
div,['txt'],position:absolute; left:84px; top:146px;,Anvisa may only be disclosed to the market after publication of the said change in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Anvisa may only be disclosed to the market after publication of the said change in the
div,['txt'],position:absolute; left:84px; top:160px;,Official Gazette and electronic portal of Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Official Gazette and electronic portal of Anvisa.
div,['txt'],position:absolute; left:144px; top:182px;,Art. 32. All communication or advertising of medical device on the market
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 32. All communication or advertising of medical device on the market
div,['txt'],position:absolute; left:84px; top:197px;,must keep strict agreement with the information presented by the notification holder
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",must keep strict agreement with the information presented by the notification holder
div,['txt'],position:absolute; left:84px; top:212px;,or registration to Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",or registration to Anvisa.
div,['txt'],position:absolute; left:268px; top:234px;,Section VIII.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section VIII.
div,['txt'],position:absolute; left:174px; top:256px;,Document repository of medical devices
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Document repository of medical devices
div,['txt'],position:absolute; left:144px; top:278px;,Art. 33. The loading of instructions for use in the Medical Device
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 33. The loading of instructions for use in the Medical Device
div,['txt'],position:absolute; left:84px; top:293px;,Documentary Repository corresponds to the insertion and updating of these
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Documentary Repository corresponds to the insertion and updating of these
div,['txt'],position:absolute; left:84px; top:308px;,documents linked to the processes of notification or registration of medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",documents linked to the processes of notification or registration of medical devices.
div,['txt'],position:absolute; left:144px; top:330px;,§ 1 In the case of a medical device that does not have instructions for use
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 In the case of a medical device that does not have instructions for use
div,['txt'],position:absolute; left:84px; top:345px;,"(as a specific document), the labeling model must be loaded in the field of instructions"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","(as a specific document), the labeling model must be loaded in the field of instructions"
div,['txt'],position:absolute; left:84px; top:360px;,"for use, including the information provided for in Chapter VI."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","for use, including the information provided for in Chapter VI."
div,['txt'],position:absolute; left:144px; top:381px;,§ 2º The loading of instructions for use should occur through the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2º The loading of instructions for use should occur through the
div,['txt'],position:absolute; left:84px; top:396px;,"applicable petitioning subjects, identified as ""provision of instructions for use on the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","applicable petitioning subjects, identified as ""provision of instructions for use on the"
div,['txt'],position:absolute; left:84px; top:411px;,"Anvisa Portal""."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Anvisa Portal""."
div,['txt'],position:absolute; left:144px; top:433px;,§ 3º The loading of instructions for use is the responsibility of the holder
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3º The loading of instructions for use is the responsibility of the holder
div,['txt'],position:absolute; left:84px; top:448px;,of the notification or the registration and shall be controlled by the holder for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of the notification or the registration and shall be controlled by the holder for
div,['txt'],position:absolute; left:84px; top:462px;,any audits.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",any audits.
div,['txt'],position:absolute; left:144px; top:484px;,§ 4º The loading of instructions for use is mandatory and must be carried
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 4º The loading of instructions for use is mandatory and must be carried
div,['txt'],position:absolute; left:84px; top:499px;,"out by the company responsible for the notification or registration of the product,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","out by the company responsible for the notification or registration of the product,"
div,['txt'],position:absolute; left:84px; top:513px;,which certifies that its content complies with the current legislation and consistency
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which certifies that its content complies with the current legislation and consistency
div,['txt'],position:absolute; left:84px; top:528px;,with the regularized product.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",with the regularized product.
div,['txt'],position:absolute; left:144px; top:550px;,§ 5º For new products notified or registered and for changes to those
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 5º For new products notified or registered and for changes to those
div,['txt'],position:absolute; left:84px; top:565px;,"products previously notified or registered, the petitioning and the respective loading of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","products previously notified or registered, the petitioning and the respective loading of"
div,['txt'],position:absolute; left:84px; top:580px;,instructions for use shall be carried out within thirty (30) days of publication in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",instructions for use shall be carried out within thirty (30) days of publication in the
div,['txt'],position:absolute; left:84px; top:595px;,Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Official Gazette.
div,['txt'],position:absolute; left:144px; top:617px;,§ 6 For non-reportable changes to those previously notified or registered
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 6 For non-reportable changes to those previously notified or registered
div,['txt'],position:absolute; left:84px; top:631px;,"products, the petitioning and the respective loading of instructions for use should be"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","products, the petitioning and the respective loading of instructions for use should be"
div,['txt'],position:absolute; left:84px; top:646px;,carried out within 180 (one hundred and eighty) days after the implementation of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",carried out within 180 (one hundred and eighty) days after the implementation of the
div,['txt'],position:absolute; left:84px; top:661px;,change that implies a change in the instructions for use.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",change that implies a change in the instructions for use.
div,['txt'],position:absolute; left:144px; top:683px;,Art. 34. The provision of instructions for use will be carried out exclusively
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 34. The provision of instructions for use will be carried out exclusively
div,['txt'],position:absolute; left:84px; top:697px;,"on the electronic portal of Anvisa, immediately after the completion of the protocol of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","on the electronic portal of Anvisa, immediately after the completion of the protocol of"
div,['txt'],position:absolute; left:84px; top:712px;,"the respective petition, regardless of document analysis by the Agency."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the respective petition, regardless of document analysis by the Agency."
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 1 The update is performed by means of a new insertion of instructionsuse.§ 2. There is a new loading of instructions for use in the process ofnotification or registration will be kept public only those recently uploaded.§ 3 The instructions for use uploaded over time will be kept in a databasefor control and audit by Anvisa.Art. 35. The instructions for use uploaded or the absence of them underthis Resolution may be subject to documentary or fiscal evaluation at any time byAnvisa and, if necessary, the Agency may:I - to request information, further clarification or loading of theappropriate instructions for use; and/orII - withdraw instructions for use or restore a previous version, wherethere is justification for such measures.Art. 36. The companies that enter information in the DocumentaryRepository of Medical Devices that do not comply with the current legislation andconsistency with the regularized product are subject to the penalties provided for inLaw No. 6,437 of August 20, 1977.Single paragraph. In the event of non-compliance with current legislationor inconsistency that justifies a sanitary measure, Anvisa may suspend thecommercialization, import and/or use of the product until the loading of instructionsfor use appropriate to the terms of this Resolution, in accordance with the provisionsof article 15 of Law no. 6,437, of august 20, 1977.Section IX.Procedure for Reevaluation ProcedureArt. 37. Medical device notification and registration processes are subjectto procedural assessment and reassessment, audit, market monitoring and inspectionby the competent health authority.Art. 38. In cases where inconsistencies or the need to supplementinformation are evident, the holders will be urged to adapt their processes.§ 1 The adjustments to which the caput is processed must be answered bythe holder of the notification or registration within thirty (30) days from the date ofconfirmation of its receipt.§ 2º The situations that cause correction of the previously presentedinformation should be treated by means of specific petitioning.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 1 The update is performed by means of a new insertion of instructionsuse.§ 2. There is a new loading of instructions for use in the process ofnotification or registration will be kept public only those recently uploaded.§ 3 The instructions for use uploaded over time will be kept in a databasefor control and audit by Anvisa.Art. 35. The instructions for use uploaded or the absence of them underthis Resolution may be subject to documentary or fiscal evaluation at any time byAnvisa and, if necessary, the Agency may:I - to request information, further clarification or loading of theappropriate instructions for use; and/orII - withdraw instructions for use or restore a previous version, wherethere is justification for such measures.Art. 36. The companies that enter information in the DocumentaryRepository of Medical Devices that do not comply with the current legislation andconsistency with the regularized product are subject to the penalties provided for inLaw No. 6,437 of August 20, 1977.Single paragraph. In the event of non-compliance with current legislationor inconsistency that justifies a sanitary measure, Anvisa may suspend thecommercialization, import and/or use of the product until the loading of instructionsfor use appropriate to the terms of this Resolution, in accordance with the provisionsof article 15 of Law no. 6,437, of august 20, 1977.Section IX.Procedure for Reevaluation ProcedureArt. 37. Medical device notification and registration processes are subjectto procedural assessment and reassessment, audit, market monitoring and inspectionby the competent health authority.Art. 38. In cases where inconsistencies or the need to supplementinformation are evident, the holders will be urged to adapt their processes.§ 1 The adjustments to which the caput is processed must be answered bythe holder of the notification or registration within thirty (30) days from the date ofconfirmation of its receipt.§ 2º The situations that cause correction of the previously presentedinformation should be treated by means of specific petitioning.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:145px; top:131px;,§ 1 The update is performed by means of a new insertion of instructions
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 The update is performed by means of a new insertion of instructions
div,['txt'],position:absolute; left:84px; top:146px;,use.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",use.
div,['txt'],position:absolute; left:145px; top:168px;,§ 2. There is a new loading of instructions for use in the process of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2. There is a new loading of instructions for use in the process of
div,['txt'],position:absolute; left:84px; top:183px;,notification or registration will be kept public only those recently uploaded.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",notification or registration will be kept public only those recently uploaded.
div,['txt'],position:absolute; left:144px; top:205px;,§ 3 The instructions for use uploaded over time will be kept in a database
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3 The instructions for use uploaded over time will be kept in a database
div,['txt'],position:absolute; left:84px; top:220px;,for control and audit by Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",for control and audit by Anvisa.
div,['txt'],position:absolute; left:144px; top:241px;,Art. 35. The instructions for use uploaded or the absence of them under
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 35. The instructions for use uploaded or the absence of them under
div,['txt'],position:absolute; left:84px; top:256px;,this Resolution may be subject to documentary or fiscal evaluation at any time by
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",this Resolution may be subject to documentary or fiscal evaluation at any time by
div,['txt'],position:absolute; left:84px; top:271px;,"Anvisa and, if necessary, the Agency may:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Anvisa and, if necessary, the Agency may:"
div,['txt'],position:absolute; left:144px; top:293px;,"I - to request information, further clarification or loading of the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - to request information, further clarification or loading of the"
div,['txt'],position:absolute; left:84px; top:307px;,appropriate instructions for use; and/or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",appropriate instructions for use; and/or
div,['txt'],position:absolute; left:144px; top:330px;,"II - withdraw instructions for use or restore a previous version, where"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","II - withdraw instructions for use or restore a previous version, where"
div,['txt'],position:absolute; left:84px; top:345px;,there is justification for such measures.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",there is justification for such measures.
div,['txt'],position:absolute; left:144px; top:367px;,Art. 36. The companies that enter information in the Documentary
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 36. The companies that enter information in the Documentary
div,['txt'],position:absolute; left:84px; top:381px;,Repository of Medical Devices that do not comply with the current legislation and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Repository of Medical Devices that do not comply with the current legislation and
div,['txt'],position:absolute; left:84px; top:396px;,consistency with the regularized product are subject to the penalties provided for in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",consistency with the regularized product are subject to the penalties provided for in
div,['txt'],position:absolute; left:84px; top:411px;,"Law No. 6,437 of August 20, 1977."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Law No. 6,437 of August 20, 1977."
div,['txt'],position:absolute; left:144px; top:433px;,Single paragraph. In the event of non-compliance with current legislation
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Single paragraph. In the event of non-compliance with current legislation
div,['txt'],position:absolute; left:84px; top:447px;,"or inconsistency that justifies a sanitary measure, Anvisa may suspend the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","or inconsistency that justifies a sanitary measure, Anvisa may suspend the"
div,['txt'],position:absolute; left:84px; top:462px;,"commercialization, import and/or use of the product until the loading of instructions"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","commercialization, import and/or use of the product until the loading of instructions"
div,['txt'],position:absolute; left:84px; top:477px;,"for use appropriate to the terms of this Resolution, in accordance with the provisions"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","for use appropriate to the terms of this Resolution, in accordance with the provisions"
div,['txt'],position:absolute; left:84px; top:491px;,"of article 15 of Law no. 6,437, of august 20, 1977."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of article 15 of Law no. 6,437, of august 20, 1977."
div,['txt'],position:absolute; left:271px; top:514px;,Section IX.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section IX.
div,['txt'],position:absolute; left:194px; top:536px;,Procedure for Reevaluation Procedure
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Procedure for Reevaluation Procedure
div,['txt'],position:absolute; left:144px; top:558px;,Art. 37. Medical device notification and registration processes are subject
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 37. Medical device notification and registration processes are subject
div,['txt'],position:absolute; left:84px; top:572px;,"to procedural assessment and reassessment, audit, market monitoring and inspection"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","to procedural assessment and reassessment, audit, market monitoring and inspection"
div,['txt'],position:absolute; left:84px; top:588px;,by the competent health authority.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",by the competent health authority.
div,['txt'],position:absolute; left:144px; top:609px;,Art. 38. In cases where inconsistencies or the need to supplement
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 38. In cases where inconsistencies or the need to supplement
div,['txt'],position:absolute; left:84px; top:624px;,"information are evident, the holders will be urged to adapt their processes."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","information are evident, the holders will be urged to adapt their processes."
div,['txt'],position:absolute; left:144px; top:646px;,§ 1 The adjustments to which the caput is processed must be answered by
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 The adjustments to which the caput is processed must be answered by
div,['txt'],position:absolute; left:84px; top:661px;,the holder of the notification or registration within thirty (30) days from the date of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the holder of the notification or registration within thirty (30) days from the date of
div,['txt'],position:absolute; left:84px; top:675px;,confirmation of its receipt.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",confirmation of its receipt.
div,['txt'],position:absolute; left:144px; top:697px;,§ 2º The situations that cause correction of the previously presented
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2º The situations that cause correction of the previously presented
div,['txt'],position:absolute; left:84px; top:712px;,information should be treated by means of specific petitioning.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",information should be treated by means of specific petitioning.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 3º The absence of a response to the notification of adequacy referred toin the caput within thirty (30) days, counted from its issuance, will cause thecancellation of the notification, registration or alteration.CHAPTER IVADMINISTRATIVE SANCTIONSArt. 39. Anvisa may suspend the manufacture, import, marketing and useof the medical device in cases where:I - The validity of any of the documents referred to in Articles 13 and 14 ofthis Resolution is suspended for reasons of duly justified security;II - It is proven that no compliance with any requirement of Chapter III,Section VII of this Resolution is complied with; orIII - the product is under investigation by competent health authority,regarding the irregularity or defect of the product or manufacturing process, whichposes a risk to the health of the user, patient, operator or third parties involved, dulyjustified.Art. 40. The suspension of the manufacture, import, marketing and use ofmedical device will be published in the Official Gazette and will be maintained until thesolution of the problem that caused the sanction and its annulment is communicated.Art. 41. Anvisa may cancel the notification or registration of the medicaldevice in cases where:I - The falsity of information provided in any of the documents requested inthis Resolution is proven, or any of these documents are canceled by the competenthealth authority;II - in case of proof that the product or manufacturing process maypresent a risk to the health of the user, patient, operator or third parties involved;III - the absence of information or documents is identified in theprocesses of products subject to notification;IV - an error in the health environment is identified in the notificationprocedures; orV - When there is no compliance with the demands of proceduralrevaluation presented by Anvisa.Art. 42. Anvisa may determine the cancellation of changes that causeincorrectness of information or irregularity of medical device.Art. 43. Anvisa may at its discretion and at any time request information orclarifications prior to the decision to cancel irregular notification of medical device.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISA§ 3º The absence of a response to the notification of adequacy referred toin the caput within thirty (30) days, counted from its issuance, will cause thecancellation of the notification, registration or alteration.CHAPTER IVADMINISTRATIVE SANCTIONSArt. 39. Anvisa may suspend the manufacture, import, marketing and useof the medical device in cases where:I - The validity of any of the documents referred to in Articles 13 and 14 ofthis Resolution is suspended for reasons of duly justified security;II - It is proven that no compliance with any requirement of Chapter III,Section VII of this Resolution is complied with; orIII - the product is under investigation by competent health authority,regarding the irregularity or defect of the product or manufacturing process, whichposes a risk to the health of the user, patient, operator or third parties involved, dulyjustified.Art. 40. The suspension of the manufacture, import, marketing and use ofmedical device will be published in the Official Gazette and will be maintained until thesolution of the problem that caused the sanction and its annulment is communicated.Art. 41. Anvisa may cancel the notification or registration of the medicaldevice in cases where:I - The falsity of information provided in any of the documents requested inthis Resolution is proven, or any of these documents are canceled by the competenthealth authority;II - in case of proof that the product or manufacturing process maypresent a risk to the health of the user, patient, operator or third parties involved;III - the absence of information or documents is identified in theprocesses of products subject to notification;IV - an error in the health environment is identified in the notificationprocedures; orV - When there is no compliance with the demands of proceduralrevaluation presented by Anvisa.Art. 42. Anvisa may determine the cancellation of changes that causeincorrectness of information or irregularity of medical device.Art. 43. Anvisa may at its discretion and at any time request information orclarifications prior to the decision to cancel irregular notification of medical device.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,§ 3º The absence of a response to the notification of adequacy referred to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3º The absence of a response to the notification of adequacy referred to
div,['txt'],position:absolute; left:84px; top:146px;,"in the caput within thirty (30) days, counted from its issuance, will cause the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","in the caput within thirty (30) days, counted from its issuance, will cause the"
div,['txt'],position:absolute; left:84px; top:160px;,"cancellation of the notification, registration or alteration."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","cancellation of the notification, registration or alteration."
div,['txt'],position:absolute; left:265px; top:183px;,CHAPTER IV
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",CHAPTER IV
div,['txt'],position:absolute; left:224px; top:205px;,ADMINISTRATIVE SANCTIONS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ADMINISTRATIVE SANCTIONS
div,['txt'],position:absolute; left:144px; top:226px;,"Art. 39. Anvisa may suspend the manufacture, import, marketing and use"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 39. Anvisa may suspend the manufacture, import, marketing and use"
div,['txt'],position:absolute; left:84px; top:242px;,of the medical device in cases where:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of the medical device in cases where:
div,['txt'],position:absolute; left:144px; top:263px;,I - The validity of any of the documents referred to in Articles 13 and 14 of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - The validity of any of the documents referred to in Articles 13 and 14 of
div,['txt'],position:absolute; left:84px; top:278px;,this Resolution is suspended for reasons of duly justified security;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",this Resolution is suspended for reasons of duly justified security;
div,['txt'],position:absolute; left:144px; top:300px;,"II - It is proven that no compliance with any requirement of Chapter III,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","II - It is proven that no compliance with any requirement of Chapter III,"
div,['txt'],position:absolute; left:84px; top:315px;,Section VII of this Resolution is complied with; or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section VII of this Resolution is complied with; or
div,['txt'],position:absolute; left:144px; top:337px;,"III - the product is under investigation by competent health authority,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","III - the product is under investigation by competent health authority,"
div,['txt'],position:absolute; left:84px; top:352px;,"regarding the irregularity or defect of the product or manufacturing process, which"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","regarding the irregularity or defect of the product or manufacturing process, which"
div,['txt'],position:absolute; left:84px; top:367px;,"poses a risk to the health of the user, patient, operator or third parties involved, duly"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","poses a risk to the health of the user, patient, operator or third parties involved, duly"
div,['txt'],position:absolute; left:84px; top:382px;,justified.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",justified.
div,['txt'],position:absolute; left:144px; top:403px;,"Art. 40. The suspension of the manufacture, import, marketing and use of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 40. The suspension of the manufacture, import, marketing and use of"
div,['txt'],position:absolute; left:84px; top:418px;,medical device will be published in the Official Gazette and will be maintained until the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",medical device will be published in the Official Gazette and will be maintained until the
div,['txt'],position:absolute; left:84px; top:433px;,solution of the problem that caused the sanction and its annulment is communicated.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",solution of the problem that caused the sanction and its annulment is communicated.
div,['txt'],position:absolute; left:144px; top:455px;,Art. 41. Anvisa may cancel the notification or registration of the medical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 41. Anvisa may cancel the notification or registration of the medical
div,['txt'],position:absolute; left:84px; top:469px;,device in cases where:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",device in cases where:
div,['txt'],position:absolute; left:144px; top:491px;,I - The falsity of information provided in any of the documents requested in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - The falsity of information provided in any of the documents requested in
div,['txt'],position:absolute; left:84px; top:506px;,"this Resolution is proven, or any of these documents are canceled by the competent"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","this Resolution is proven, or any of these documents are canceled by the competent"
div,['txt'],position:absolute; left:84px; top:521px;,health authority;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",health authority;
div,['txt'],position:absolute; left:144px; top:543px;,II - in case of proof that the product or manufacturing process may
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - in case of proof that the product or manufacturing process may
div,['txt'],position:absolute; left:84px; top:558px;,"present a risk to the health of the user, patient, operator or third parties involved;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","present a risk to the health of the user, patient, operator or third parties involved;"
div,['txt'],position:absolute; left:144px; top:580px;,III - the absence of information or documents is identified in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - the absence of information or documents is identified in the
div,['txt'],position:absolute; left:84px; top:595px;,processes of products subject to notification;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",processes of products subject to notification;
div,['txt'],position:absolute; left:144px; top:616px;,IV - an error in the health environment is identified in the notification
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - an error in the health environment is identified in the notification
div,['txt'],position:absolute; left:84px; top:631px;,procedures; or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",procedures; or
div,['txt'],position:absolute; left:144px; top:653px;,V - When there is no compliance with the demands of procedural
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",V - When there is no compliance with the demands of procedural
div,['txt'],position:absolute; left:84px; top:668px;,revaluation presented by Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",revaluation presented by Anvisa.
div,['txt'],position:absolute; left:144px; top:690px;,Art. 42. Anvisa may determine the cancellation of changes that cause
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 42. Anvisa may determine the cancellation of changes that cause
div,['txt'],position:absolute; left:84px; top:705px;,incorrectness of information or irregularity of medical device.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",incorrectness of information or irregularity of medical device.
div,['txt'],position:absolute; left:144px; top:727px;,Art. 43. Anvisa may at its discretion and at any time request information or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 43. Anvisa may at its discretion and at any time request information or
div,['txt'],position:absolute; left:84px; top:741px;,clarifications prior to the decision to cancel irregular notification of medical device.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",clarifications prior to the decision to cancel irregular notification of medical device.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAArt. 44. The cancellation of the notification or registration of medical devicewill be published in the Official Gazette of the Union.CHAPTER VREQUESTER INFORMATION FORMS AND THEIR MEDICAL DEVICESArt. 45. The applicable forms on information of the applicant and theproduct subject to notification or registration process must be completedelectronically on the Anvisa electronic portal.Single paragraph. Where applicable, the forms must be submitted with thesignatures of legal and technical officials.CHAPTER VI.LABELS AND INSTRUCTIONS FOR USE OF MEDICAL DEVICESSection IInformation requirements on labels and instructions for useArt. 46. The label information and instructions for use of medical devicesmust meet the following general requirements:I - the information on the labels and instructions for use must be written inthe portuguese language;II - all medical devices must include instructions for use in their packaging orrefer to the way in which they are accessed;III - Exceptionally, these instructions may not be included in the packagingof medical devices falling within Classes I and II, provided that the safety of use ofthese products can be guaranteed without such instructions;IV - the information necessary for the safe use of the medical device shallbe included, where possible, on the medical device itself or on the label of itsindividual packaging, or, where this is not possible, on the label of its commercialpackaging;V - if it is not possible to individually pack each unit, this information shallbe included in the instructions for use accompanying one or more medical devices;VI - where appropriate, the information may be presented in the form ofsymbols or colors, which must comply with current regulations or technical standards;VII - if there is no regulation, the symbols and colors must be described inthe documentation accompanying the medical device; andThis text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAArt. 44. The cancellation of the notification or registration of medical devicewill be published in the Official Gazette of the Union.CHAPTER VREQUESTER INFORMATION FORMS AND THEIR MEDICAL DEVICESArt. 45. The applicable forms on information of the applicant and theproduct subject to notification or registration process must be completedelectronically on the Anvisa electronic portal.Single paragraph. Where applicable, the forms must be submitted with thesignatures of legal and technical officials.CHAPTER VI.LABELS AND INSTRUCTIONS FOR USE OF MEDICAL DEVICESSection IInformation requirements on labels and instructions for useArt. 46. The label information and instructions for use of medical devicesmust meet the following general requirements:I - the information on the labels and instructions for use must be written inthe portuguese language;II - all medical devices must include instructions for use in their packaging orrefer to the way in which they are accessed;III - Exceptionally, these instructions may not be included in the packagingof medical devices falling within Classes I and II, provided that the safety of use ofthese products can be guaranteed without such instructions;IV - the information necessary for the safe use of the medical device shallbe included, where possible, on the medical device itself or on the label of itsindividual packaging, or, where this is not possible, on the label of its commercialpackaging;V - if it is not possible to individually pack each unit, this information shallbe included in the instructions for use accompanying one or more medical devices;VI - where appropriate, the information may be presented in the form ofsymbols or colors, which must comply with current regulations or technical standards;VII - if there is no regulation, the symbols and colors must be described inthe documentation accompanying the medical device; andThis text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,Art. 44. The cancellation of the notification or registration of medical device
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 44. The cancellation of the notification or registration of medical device
div,['txt'],position:absolute; left:84px; top:146px;,will be published in the Official Gazette of the Union.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",will be published in the Official Gazette of the Union.
div,['txt'],position:absolute; left:269px; top:168px;,CHAPTER V
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",CHAPTER V
div,['txt'],position:absolute; left:134px; top:190px;,REQUESTER INFORMATION FORMS AND THEIR MEDICAL DEVICES
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",REQUESTER INFORMATION FORMS AND THEIR MEDICAL DEVICES
div,['txt'],position:absolute; left:144px; top:212px;,Art. 45. The applicable forms on information of the applicant and the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 45. The applicable forms on information of the applicant and the
div,['txt'],position:absolute; left:84px; top:227px;,product subject to notification or registration process must be completed
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",product subject to notification or registration process must be completed
div,['txt'],position:absolute; left:84px; top:242px;,electronically on the Anvisa electronic portal.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",electronically on the Anvisa electronic portal.
div,['txt'],position:absolute; left:144px; top:263px;,"Single paragraph. Where applicable, the forms must be submitted with the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Single paragraph. Where applicable, the forms must be submitted with the"
div,['txt'],position:absolute; left:84px; top:278px;,signatures of legal and technical officials.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",signatures of legal and technical officials.
div,['txt'],position:absolute; left:266px; top:301px;,CHAPTER VI.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",CHAPTER VI.
div,['txt'],position:absolute; left:150px; top:323px;,LABELS AND INSTRUCTIONS FOR USE OF MEDICAL DEVICES
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",LABELS AND INSTRUCTIONS FOR USE OF MEDICAL DEVICES
div,['txt'],position:absolute; left:276px; top:345px;,Section I
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section I
div,['txt'],position:absolute; left:151px; top:368px;,Information requirements on labels and instructions for use
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Information requirements on labels and instructions for use
div,['txt'],position:absolute; left:144px; top:390px;,Art. 46. The label information and instructions for use of medical devices
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 46. The label information and instructions for use of medical devices
div,['txt'],position:absolute; left:84px; top:404px;,must meet the following general requirements:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",must meet the following general requirements:
div,['txt'],position:absolute; left:144px; top:426px;,I - the information on the labels and instructions for use must be written in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - the information on the labels and instructions for use must be written in
div,['txt'],position:absolute; left:84px; top:441px;,the portuguese language;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the portuguese language;
div,['txt'],position:absolute; left:144px; top:463px;,II - all medical devices must include instructions for use in their packaging or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - all medical devices must include instructions for use in their packaging or
div,['txt'],position:absolute; left:84px; top:478px;,refer to the way in which they are accessed;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",refer to the way in which they are accessed;
div,['txt'],position:absolute; left:144px; top:499px;,"III - Exceptionally, these instructions may not be included in the packaging"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","III - Exceptionally, these instructions may not be included in the packaging"
div,['txt'],position:absolute; left:84px; top:514px;,"of medical devices falling within Classes I and II, provided that the safety of use of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of medical devices falling within Classes I and II, provided that the safety of use of"
div,['txt'],position:absolute; left:84px; top:529px;,these products can be guaranteed without such instructions;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",these products can be guaranteed without such instructions;
div,['txt'],position:absolute; left:144px; top:551px;,IV - the information necessary for the safe use of the medical device shall
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - the information necessary for the safe use of the medical device shall
div,['txt'],position:absolute; left:84px; top:565px;,"be included, where possible, on the medical device itself or on the label of its"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","be included, where possible, on the medical device itself or on the label of its"
div,['txt'],position:absolute; left:84px; top:580px;,"individual packaging, or, where this is not possible, on the label of its commercial"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","individual packaging, or, where this is not possible, on the label of its commercial"
div,['txt'],position:absolute; left:84px; top:595px;,packaging;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",packaging;
div,['txt'],position:absolute; left:144px; top:617px;,"V - if it is not possible to individually pack each unit, this information shall"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","V - if it is not possible to individually pack each unit, this information shall"
div,['txt'],position:absolute; left:84px; top:632px;,be included in the instructions for use accompanying one or more medical devices;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",be included in the instructions for use accompanying one or more medical devices;
div,['txt'],position:absolute; left:144px; top:654px;,"VI - where appropriate, the information may be presented in the form of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","VI - where appropriate, the information may be presented in the form of"
div,['txt'],position:absolute; left:84px; top:668px;,"symbols or colors, which must comply with current regulations or technical standards;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","symbols or colors, which must comply with current regulations or technical standards;"
div,['txt'],position:absolute; left:144px; top:691px;,"VII - if there is no regulation, the symbols and colors must be described in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","VII - if there is no regulation, the symbols and colors must be described in"
div,['txt'],position:absolute; left:84px; top:705px;,the documentation accompanying the medical device; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the documentation accompanying the medical device; and
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAVIII - if additional information is required in a specific technical regulationof a medical device due to the specific nature of the product, it shall be incorporatedinto the label or instructions for use, as applicable;Art. 47. The label template must contain the following information:I - the corporate reason and address of the legal manufacturer, precededby the term ""manufacturer"" or equivalent symbology;II - social reason and address of the holder of the notification or registration;III - the information necessary for the user to identify the medical deviceand the contents of its packaging;IV - Where applicable, the word ""Sterile"" and the method of sterilization;V - The lot code, preceded by the word ""Lot"", or the serial number, as thecase may be;VI - as applicable, date of manufacture and expiry date or date beforewhich the medical device is to be used;unique;VII - where applicable, the indication that the medical device is of useVIII - the specific conditions of storage, conservation andhandling of the product;IX - The special instructions for operation and/or use of the medicaldevice; X - all warnings and precautions to be taken;XI - name of the technical officer legally qualified for the function;XII - Number of the notification or registration of the medical device,preceded by the acronym of identification of Anvisa.Art. 48. The Model Instructions for Use must contain the followinginformation, as applicable:I - The information referred to in article 47 of this Resolution, exceptthose contained in sections ""V"", ""VI"" and ""XI"";II - the purpose of use assigned by the manufacturer as well as anypossible undesirable side effects;III - if a medical device is to be installed or connected to other medicaldevices to function according to the intended purpose, sufficient detailed informationon its characteristics must be provided to identify the medical devices that can be usedwith the product, in order to obtain a safe combination;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAVIII - if additional information is required in a specific technical regulationof a medical device due to the specific nature of the product, it shall be incorporatedinto the label or instructions for use, as applicable;Art. 47. The label template must contain the following information:I - the corporate reason and address of the legal manufacturer, precededby the term ""manufacturer"" or equivalent symbology;II - social reason and address of the holder of the notification or registration;III - the information necessary for the user to identify the medical deviceand the contents of its packaging;IV - Where applicable, the word ""Sterile"" and the method of sterilization;V - The lot code, preceded by the word ""Lot"", or the serial number, as thecase may be;VI - as applicable, date of manufacture and expiry date or date beforewhich the medical device is to be used;unique;VII - where applicable, the indication that the medical device is of useVIII - the specific conditions of storage, conservation andhandling of the product;IX - The special instructions for operation and/or use of the medicaldevice; X - all warnings and precautions to be taken;XI - name of the technical officer legally qualified for the function;XII - Number of the notification or registration of the medical device,preceded by the acronym of identification of Anvisa.Art. 48. The Model Instructions for Use must contain the followinginformation, as applicable:I - The information referred to in article 47 of this Resolution, exceptthose contained in sections ""V"", ""VI"" and ""XI"";II - the purpose of use assigned by the manufacturer as well as anypossible undesirable side effects;III - if a medical device is to be installed or connected to other medicaldevices to function according to the intended purpose, sufficient detailed informationon its characteristics must be provided to identify the medical devices that can be usedwith the product, in order to obtain a safe combination;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,VIII - if additional information is required in a specific technical regulation
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",VIII - if additional information is required in a specific technical regulation
div,['txt'],position:absolute; left:84px; top:146px;,"of a medical device due to the specific nature of the product, it shall be incorporated"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of a medical device due to the specific nature of the product, it shall be incorporated"
div,['txt'],position:absolute; left:84px; top:160px;,"into the label or instructions for use, as applicable;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","into the label or instructions for use, as applicable;"
div,['txt'],position:absolute; left:145px; top:183px;,Art. 47. The label template must contain the following information:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 47. The label template must contain the following information:
div,['txt'],position:absolute; left:144px; top:205px;,"I - the corporate reason and address of the legal manufacturer, preceded"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - the corporate reason and address of the legal manufacturer, preceded"
div,['txt'],position:absolute; left:84px; top:220px;,"by the term ""manufacturer"" or equivalent symbology;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","by the term ""manufacturer"" or equivalent symbology;"
div,['txt'],position:absolute; left:145px; top:241px;,II - social reason and address of the holder of the notification or registration;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - social reason and address of the holder of the notification or registration;
div,['txt'],position:absolute; left:144px; top:263px;,III - the information necessary for the user to identify the medical device
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - the information necessary for the user to identify the medical device
div,['txt'],position:absolute; left:84px; top:278px;,and the contents of its packaging;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and the contents of its packaging;
div,['txt'],position:absolute; left:145px; top:301px;,"IV - Where applicable, the word ""Sterile"" and the method of sterilization;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","IV - Where applicable, the word ""Sterile"" and the method of sterilization;"
div,['txt'],position:absolute; left:144px; top:323px;,"V - The lot code, preceded by the word ""Lot"", or the serial number, as the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","V - The lot code, preceded by the word ""Lot"", or the serial number, as the"
div,['txt'],position:absolute; left:84px; top:337px;,case may be;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",case may be;
div,['txt'],position:absolute; left:144px; top:359px;,"VI - as applicable, date of manufacture and expiry date or date before"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","VI - as applicable, date of manufacture and expiry date or date before"
div,['txt'],position:absolute; left:84px; top:374px;,which the medical device is to be used;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which the medical device is to be used;
div,['txt'],position:absolute; left:84px; top:396px;,"unique;VII - where applicable, the indication that the medical device is of use"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",unique;
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);","VII - where applicable, the indication that the medical device is of use"
div,['txt'],position:absolute; left:144px; top:433px;,"VIII - the specific conditions of storage, conservation and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","VIII - the specific conditions of storage, conservation and"
div,['txt'],position:absolute; left:84px; top:448px;,handling of the product;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",handling of the product;
div,['txt'],position:absolute; left:145px; top:470px;,IX - The special instructions for operation and/or use of the medical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IX - The special instructions for operation and/or use of the medical
div,['txt'],position:absolute; left:145px; top:492px;,device; X - all warnings and precautions to be taken;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",device; X - all warnings and precautions to be taken;
div,['txt'],position:absolute; left:145px; top:515px;,XI - name of the technical officer legally qualified for the function;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XI - name of the technical officer legally qualified for the function;
div,['txt'],position:absolute; left:144px; top:536px;,"XII - Number of the notification or registration of the medical device,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XII - Number of the notification or registration of the medical device,"
div,['txt'],position:absolute; left:84px; top:551px;,preceded by the acronym of identification of Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",preceded by the acronym of identification of Anvisa.
div,['txt'],position:absolute; left:144px; top:573px;,Art. 48. The Model Instructions for Use must contain the following
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 48. The Model Instructions for Use must contain the following
div,['txt'],position:absolute; left:84px; top:588px;,"information, as applicable:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","information, as applicable:"
div,['txt'],position:absolute; left:144px; top:610px;,"I - The information referred to in article 47 of this Resolution, except"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - The information referred to in article 47 of this Resolution, except"
div,['txt'],position:absolute; left:84px; top:625px;,"those contained in sections ""V"", ""VI"" and ""XI"";"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","those contained in sections ""V"", ""VI"" and ""XI"";"
div,['txt'],position:absolute; left:144px; top:647px;,II - the purpose of use assigned by the manufacturer as well as any
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - the purpose of use assigned by the manufacturer as well as any
div,['txt'],position:absolute; left:84px; top:661px;,possible undesirable side effects;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",possible undesirable side effects;
div,['txt'],position:absolute; left:144px; top:683px;,III - if a medical device is to be installed or connected to other medical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - if a medical device is to be installed or connected to other medical
div,['txt'],position:absolute; left:84px; top:698px;,"devices to function according to the intended purpose, sufficient detailed information"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","devices to function according to the intended purpose, sufficient detailed information"
div,['txt'],position:absolute; left:84px; top:713px;,on its characteristics must be provided to identify the medical devices that can be used
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",on its characteristics must be provided to identify the medical devices that can be used
div,['txt'],position:absolute; left:84px; top:728px;,"with the product, in order to obtain a safe combination;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","with the product, in order to obtain a safe combination;"
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAIV - all information that can prove whether a medical device is wellinstalled and can function properly and safely, as well as information regarding thenature and frequency of the maintenance and calibration operations to be carried outin order to ensure the permanent functioning and safety of the medical device;V - information useful to avoid certain risks arising from the implantationof the medical device;VI - information on the risks of reciprocal interference arising from thepresence of the medical device in specific investigations or treatments;VII - the necessary instructions in the event of damage to the protectivesterility packaging and, where applicable, the indication of the appropriate methods ofre-sterilization;VIII - where the medical device is reusable, information on appropriateprocedures for re-use, including cleaning, disinfection, packaging and, as appropriate,the sterilization method, if the product is to be re-sterilized, and any restrictions on thepossible number of re-uses;IX - Where the medical device is to be sterilized before use, theinstructions for cleaning and sterilization shall be formulated in such a way that, ifproperly performed, the product meets the requirements laid down by themanufacturer as to the essential requirements of Safety and Performance (orEffectiveness);X - information on additional treatment or procedure to be performedbefore using the medical device;XI - where a medical device emits radiations for medical purposes,information concerning the nature, type, intensity and distribution of such radiationsshall be described;XII - instructions for use shall include information enabling the healthprofessional to inform the patient of contraindications and precautions to be taken;XIII - the precautions to be taken in the event of a change in thefunctioning of the medical device;XIV - precautions to be taken concerning exposure, under reasonablyforeseeable environmental conditions, to magnetic fields, external electricalinfluences, electrostatic discharge, pressure or pressure variations, acceleration andthermal ignition sources, among others;XV - appropriate information on the medicinal product(s) which themedical device is intended to administer, including any restrictions on the choice ofsuch substances;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAIV - all information that can prove whether a medical device is wellinstalled and can function properly and safely, as well as information regarding thenature and frequency of the maintenance and calibration operations to be carried outin order to ensure the permanent functioning and safety of the medical device;V - information useful to avoid certain risks arising from the implantationof the medical device;VI - information on the risks of reciprocal interference arising from thepresence of the medical device in specific investigations or treatments;VII - the necessary instructions in the event of damage to the protectivesterility packaging and, where applicable, the indication of the appropriate methods ofre-sterilization;VIII - where the medical device is reusable, information on appropriateprocedures for re-use, including cleaning, disinfection, packaging and, as appropriate,the sterilization method, if the product is to be re-sterilized, and any restrictions on thepossible number of re-uses;IX - Where the medical device is to be sterilized before use, theinstructions for cleaning and sterilization shall be formulated in such a way that, ifproperly performed, the product meets the requirements laid down by themanufacturer as to the essential requirements of Safety and Performance (orEffectiveness);X - information on additional treatment or procedure to be performedbefore using the medical device;XI - where a medical device emits radiations for medical purposes,information concerning the nature, type, intensity and distribution of such radiationsshall be described;XII - instructions for use shall include information enabling the healthprofessional to inform the patient of contraindications and precautions to be taken;XIII - the precautions to be taken in the event of a change in thefunctioning of the medical device;XIV - precautions to be taken concerning exposure, under reasonablyforeseeable environmental conditions, to magnetic fields, external electricalinfluences, electrostatic discharge, pressure or pressure variations, acceleration andthermal ignition sources, among others;XV - appropriate information on the medicinal product(s) which themedical device is intended to administer, including any restrictions on the choice ofsuch substances;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,IV - all information that can prove whether a medical device is well
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - all information that can prove whether a medical device is well
div,['txt'],position:absolute; left:84px; top:146px;,"installed and can function properly and safely, as well as information regarding the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","installed and can function properly and safely, as well as information regarding the"
div,['txt'],position:absolute; left:84px; top:160px;,nature and frequency of the maintenance and calibration operations to be carried out
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",nature and frequency of the maintenance and calibration operations to be carried out
div,['txt'],position:absolute; left:84px; top:175px;,in order to ensure the permanent functioning and safety of the medical device;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",in order to ensure the permanent functioning and safety of the medical device;
div,['txt'],position:absolute; left:144px; top:197px;,V - information useful to avoid certain risks arising from the implantation
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",V - information useful to avoid certain risks arising from the implantation
div,['txt'],position:absolute; left:84px; top:212px;,of the medical device;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of the medical device;
div,['txt'],position:absolute; left:144px; top:234px;,VI - information on the risks of reciprocal interference arising from the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",VI - information on the risks of reciprocal interference arising from the
div,['txt'],position:absolute; left:84px; top:249px;,presence of the medical device in specific investigations or treatments;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",presence of the medical device in specific investigations or treatments;
div,['txt'],position:absolute; left:144px; top:270px;,VII - the necessary instructions in the event of damage to the protective
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",VII - the necessary instructions in the event of damage to the protective
div,['txt'],position:absolute; left:84px; top:285px;,"sterility packaging and, where applicable, the indication of the appropriate methods of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","sterility packaging and, where applicable, the indication of the appropriate methods of"
div,['txt'],position:absolute; left:84px; top:300px;,re-sterilization;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",re-sterilization;
div,['txt'],position:absolute; left:144px; top:323px;,"VIII - where the medical device is reusable, information on appropriate"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","VIII - where the medical device is reusable, information on appropriate"
div,['txt'],position:absolute; left:84px; top:337px;,"procedures for re-use, including cleaning, disinfection, packaging and, as appropriate,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","procedures for re-use, including cleaning, disinfection, packaging and, as appropriate,"
div,['txt'],position:absolute; left:84px; top:352px;,"the sterilization method, if the product is to be re-sterilized, and any restrictions on the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the sterilization method, if the product is to be re-sterilized, and any restrictions on the"
div,['txt'],position:absolute; left:84px; top:367px;,possible number of re-uses;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",possible number of re-uses;
div,['txt'],position:absolute; left:144px; top:388px;,"IX - Where the medical device is to be sterilized before use, the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","IX - Where the medical device is to be sterilized before use, the"
div,['txt'],position:absolute; left:84px; top:403px;,"instructions for cleaning and sterilization shall be formulated in such a way that, if"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","instructions for cleaning and sterilization shall be formulated in such a way that, if"
div,['txt'],position:absolute; left:84px; top:418px;,"properly performed, the product meets the requirements laid down by the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","properly performed, the product meets the requirements laid down by the"
div,['txt'],position:absolute; left:84px; top:433px;,manufacturer as to the essential requirements of Safety and Performance (or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",manufacturer as to the essential requirements of Safety and Performance (or
div,['txt'],position:absolute; left:84px; top:447px;,Effectiveness);
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Effectiveness);
div,['txt'],position:absolute; left:144px; top:469px;,X - information on additional treatment or procedure to be performed
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X - information on additional treatment or procedure to be performed
div,['txt'],position:absolute; left:84px; top:484px;,before using the medical device;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",before using the medical device;
div,['txt'],position:absolute; left:144px; top:506px;,"XI - where a medical device emits radiations for medical purposes,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XI - where a medical device emits radiations for medical purposes,"
div,['txt'],position:absolute; left:84px; top:521px;,"information concerning the nature, type, intensity and distribution of such radiations"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","information concerning the nature, type, intensity and distribution of such radiations"
div,['txt'],position:absolute; left:84px; top:536px;,shall be described;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",shall be described;
div,['txt'],position:absolute; left:144px; top:558px;,XII - instructions for use shall include information enabling the health
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XII - instructions for use shall include information enabling the health
div,['txt'],position:absolute; left:84px; top:573px;,professional to inform the patient of contraindications and precautions to be taken;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",professional to inform the patient of contraindications and precautions to be taken;
div,['txt'],position:absolute; left:144px; top:594px;,XIII - the precautions to be taken in the event of a change in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XIII - the precautions to be taken in the event of a change in the
div,['txt'],position:absolute; left:84px; top:609px;,functioning of the medical device;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",functioning of the medical device;
div,['txt'],position:absolute; left:144px; top:631px;,"XIV - precautions to be taken concerning exposure, under reasonably"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","XIV - precautions to be taken concerning exposure, under reasonably"
div,['txt'],position:absolute; left:84px; top:646px;,"foreseeable environmental conditions, to magnetic fields, external electrical"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","foreseeable environmental conditions, to magnetic fields, external electrical"
div,['txt'],position:absolute; left:84px; top:661px;,"influences, electrostatic discharge, pressure or pressure variations, acceleration and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","influences, electrostatic discharge, pressure or pressure variations, acceleration and"
div,['txt'],position:absolute; left:84px; top:675px;,"thermal ignition sources, among others;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","thermal ignition sources, among others;"
div,['txt'],position:absolute; left:144px; top:697px;,XV - appropriate information on the medicinal product(s) which the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XV - appropriate information on the medicinal product(s) which the
div,['txt'],position:absolute; left:84px; top:712px;,"medical device is intended to administer, including any restrictions on the choice of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","medical device is intended to administer, including any restrictions on the choice of"
div,['txt'],position:absolute; left:84px; top:726px;,such substances;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",such substances;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXVI - the precautions to be taken if the medical device presents a specificunpredictable risk associated with its elimination;XVII - mention of medicinal products incorporated into the medical deviceas an integral part of the medical device; andXVIII - the level of accuracy assigned to medical measuring devices.Art. 49. The notified or registered health surveillance equipment must haveaffixed an indelible label indicating:I - trade name of the product, with indication of the model, whereapplicable; II - name of the legal manufacturer or brand;III - Notification number or registration with Anvisa; andIV - serial number or other identifier allowing traceability of theequipment.§ 1 For small size and/or implantable equipment, where such a label cannotbe fixed, identification of the manufacturer or brand and traceability elements shall berequired.§ 2 In the case of systems, all its components must be identified asmembers of the system to which they are associated.§ 3 Excludes non-implantable single-use equipment from the caput.Section II.Instructions for use in unprinted formatArt. 50. Instructions for use in non-printed form may be provided onphysical media or made available on the Internet or in another format that meets allthe requirements of this Resolution.Art. 51. These are requirements for the provision of instructions for use innon-printed format:I - to inform on the external label how to obtain the correlation betweenthe product provided and the version of the corresponding instruction of use;II - Indicate on the label a Consumer Care Service where the printedformat of the instructions for use can be requested at no additional cost (includingshipping);III - ensure the availability of the instructions for use throughout theperiod in which the product supplied is on the market; andThis text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAXVI - the precautions to be taken if the medical device presents a specificunpredictable risk associated with its elimination;XVII - mention of medicinal products incorporated into the medical deviceas an integral part of the medical device; andXVIII - the level of accuracy assigned to medical measuring devices.Art. 49. The notified or registered health surveillance equipment must haveaffixed an indelible label indicating:I - trade name of the product, with indication of the model, whereapplicable; II - name of the legal manufacturer or brand;III - Notification number or registration with Anvisa; andIV - serial number or other identifier allowing traceability of theequipment.§ 1 For small size and/or implantable equipment, where such a label cannotbe fixed, identification of the manufacturer or brand and traceability elements shall berequired.§ 2 In the case of systems, all its components must be identified asmembers of the system to which they are associated.§ 3 Excludes non-implantable single-use equipment from the caput.Section II.Instructions for use in unprinted formatArt. 50. Instructions for use in non-printed form may be provided onphysical media or made available on the Internet or in another format that meets allthe requirements of this Resolution.Art. 51. These are requirements for the provision of instructions for use innon-printed format:I - to inform on the external label how to obtain the correlation betweenthe product provided and the version of the corresponding instruction of use;II - Indicate on the label a Consumer Care Service where the printedformat of the instructions for use can be requested at no additional cost (includingshipping);III - ensure the availability of the instructions for use throughout theperiod in which the product supplied is on the market; andThis text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,XVI - the precautions to be taken if the medical device presents a specific
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XVI - the precautions to be taken if the medical device presents a specific
div,['txt'],position:absolute; left:84px; top:146px;,unpredictable risk associated with its elimination;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",unpredictable risk associated with its elimination;
div,['txt'],position:absolute; left:144px; top:168px;,XVII - mention of medicinal products incorporated into the medical device
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XVII - mention of medicinal products incorporated into the medical device
div,['txt'],position:absolute; left:84px; top:183px;,as an integral part of the medical device; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",as an integral part of the medical device; and
div,['txt'],position:absolute; left:144px; top:205px;,XVIII - the level of accuracy assigned to medical measuring devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",XVIII - the level of accuracy assigned to medical measuring devices.
div,['txt'],position:absolute; left:144px; top:226px;,Art. 49. The notified or registered health surveillance equipment must have
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 49. The notified or registered health surveillance equipment must have
div,['txt'],position:absolute; left:84px; top:242px;,affixed an indelible label indicating:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",affixed an indelible label indicating:
div,['txt'],position:absolute; left:145px; top:264px;,"I - trade name of the product, with indication of the model, where"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - trade name of the product, with indication of the model, where"
div,['txt'],position:absolute; left:145px; top:286px;,applicable; II - name of the legal manufacturer or brand;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",applicable; II - name of the legal manufacturer or brand;
div,['txt'],position:absolute; left:145px; top:308px;,III - Notification number or registration with Anvisa; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - Notification number or registration with Anvisa; and
div,['txt'],position:absolute; left:144px; top:330px;,IV - serial number or other identifier allowing traceability of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - serial number or other identifier allowing traceability of the
div,['txt'],position:absolute; left:84px; top:345px;,equipment.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",equipment.
div,['txt'],position:absolute; left:144px; top:367px;,"§ 1 For small size and/or implantable equipment, where such a label cannot"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 1 For small size and/or implantable equipment, where such a label cannot"
div,['txt'],position:absolute; left:84px; top:382px;,"be fixed, identification of the manufacturer or brand and traceability elements shall be"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","be fixed, identification of the manufacturer or brand and traceability elements shall be"
div,['txt'],position:absolute; left:84px; top:397px;,required.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",required.
div,['txt'],position:absolute; left:144px; top:419px;,"§ 2 In the case of systems, all its components must be identified as"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 2 In the case of systems, all its components must be identified as"
div,['txt'],position:absolute; left:84px; top:434px;,members of the system to which they are associated.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",members of the system to which they are associated.
div,['txt'],position:absolute; left:144px; top:456px;,§ 3 Excludes non-implantable single-use equipment from the caput.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3 Excludes non-implantable single-use equipment from the caput.
div,['txt'],position:absolute; left:273px; top:477px;,Section II.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Section II.
div,['txt'],position:absolute; left:185px; top:500px;,Instructions for use in unprinted format
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Instructions for use in unprinted format
div,['txt'],position:absolute; left:144px; top:522px;,Art. 50. Instructions for use in non-printed form may be provided on
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 50. Instructions for use in non-printed form may be provided on
div,['txt'],position:absolute; left:84px; top:536px;,physical media or made available on the Internet or in another format that meets all
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",physical media or made available on the Internet or in another format that meets all
div,['txt'],position:absolute; left:84px; top:551px;,the requirements of this Resolution.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the requirements of this Resolution.
div,['txt'],position:absolute; left:144px; top:573px;,Art. 51. These are requirements for the provision of instructions for use in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 51. These are requirements for the provision of instructions for use in
div,['txt'],position:absolute; left:84px; top:588px;,non-printed format:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",non-printed format:
div,['txt'],position:absolute; left:144px; top:610px;,I - to inform on the external label how to obtain the correlation between
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - to inform on the external label how to obtain the correlation between
div,['txt'],position:absolute; left:84px; top:625px;,the product provided and the version of the corresponding instruction of use;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the product provided and the version of the corresponding instruction of use;
div,['txt'],position:absolute; left:144px; top:647px;,II - Indicate on the label a Consumer Care Service where the printed
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - Indicate on the label a Consumer Care Service where the printed
div,['txt'],position:absolute; left:84px; top:661px;,format of the instructions for use can be requested at no additional cost (including
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",format of the instructions for use can be requested at no additional cost (including
div,['txt'],position:absolute; left:84px; top:676px;,shipping);
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",shipping);
div,['txt'],position:absolute; left:144px; top:698px;,III - ensure the availability of the instructions for use throughout the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - ensure the availability of the instructions for use throughout the
div,['txt'],position:absolute; left:84px; top:713px;,period in which the product supplied is on the market; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",period in which the product supplied is on the market; and
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAIV - specify the necessary resources for reading user instructions for use.§ 1 Where the dimensions of external labeling do not permit, theinformation required in this Article may be included in a document attached to theproduct.§ 2 The manufacturer or holder of the notification or registration ofequipment shall consider the period indicated in item III as the specified service life forthe product, counted from the last unit marketed of the product.Art. 52. Instructions for use provided in non-printed format shouldcontain:I - All information required in this Chapter and, where applicable, inregulations dedicated to specific medical devices;II - identification of the version of the instructions for use correspondingto the respective product;III - an alert to the user to observe the correlation of the version of theinstructions for use indicated with the product purchased, as made available by themanufacturer; andIV - the indication of how to obtain, at no additional cost (includingshipping), the instructions for use of the product in the printed format.Art. 53. In order to provide the instructions for use over the internet, inaddition to the provisions set out in articles 51 and 52, the following requirementsmust also be met:I - provide with the product clear guidance on how to find thecorresponding and up-to-date instructions for use at the e-mail address available on theinternet;II - ensure the basic security requirements of the e-mail address;III - make available the file of the instructions for use in the electronicaddress in non-editable reading format;IV - provide in the electronic address free access to the necessary tool forreading the instructions for use; andV - ensure that the file made available and printed by this means isidentical to that provided by the manufacturer or holder of the notification orregistration, when requested, in the printed format.Art. 54. It is forbidden to provide the instructions for use in non-printedformat for the following products:I - Equipment for health use that have indication of:This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAIV - specify the necessary resources for reading user instructions for use.§ 1 Where the dimensions of external labeling do not permit, theinformation required in this Article may be included in a document attached to theproduct.§ 2 The manufacturer or holder of the notification or registration ofequipment shall consider the period indicated in item III as the specified service life forthe product, counted from the last unit marketed of the product.Art. 52. Instructions for use provided in non-printed format shouldcontain:I - All information required in this Chapter and, where applicable, inregulations dedicated to specific medical devices;II - identification of the version of the instructions for use correspondingto the respective product;III - an alert to the user to observe the correlation of the version of theinstructions for use indicated with the product purchased, as made available by themanufacturer; andIV - the indication of how to obtain, at no additional cost (includingshipping), the instructions for use of the product in the printed format.Art. 53. In order to provide the instructions for use over the internet, inaddition to the provisions set out in articles 51 and 52, the following requirementsmust also be met:I - provide with the product clear guidance on how to find thecorresponding and up-to-date instructions for use at the e-mail address available on theinternet;II - ensure the basic security requirements of the e-mail address;III - make available the file of the instructions for use in the electronicaddress in non-editable reading format;IV - provide in the electronic address free access to the necessary tool forreading the instructions for use; andV - ensure that the file made available and printed by this means isidentical to that provided by the manufacturer or holder of the notification orregistration, when requested, in the printed format.Art. 54. It is forbidden to provide the instructions for use in non-printedformat for the following products:I - Equipment for health use that have indication of:This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,IV - specify the necessary resources for reading user instructions for use.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - specify the necessary resources for reading user instructions for use.
div,['txt'],position:absolute; left:144px; top:153px;,"§ 1 Where the dimensions of external labeling do not permit, the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 1 Where the dimensions of external labeling do not permit, the"
div,['txt'],position:absolute; left:84px; top:167px;,information required in this Article may be included in a document attached to the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",information required in this Article may be included in a document attached to the
div,['txt'],position:absolute; left:84px; top:182px;,product.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",product.
div,['txt'],position:absolute; left:144px; top:204px;,§ 2 The manufacturer or holder of the notification or registration of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2 The manufacturer or holder of the notification or registration of
div,['txt'],position:absolute; left:84px; top:219px;,equipment shall consider the period indicated in item III as the specified service life for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",equipment shall consider the period indicated in item III as the specified service life for
div,['txt'],position:absolute; left:84px; top:233px;,"the product, counted from the last unit marketed of the product."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the product, counted from the last unit marketed of the product."
div,['txt'],position:absolute; left:145px; top:255px;,Art. 52. Instructions for use provided in non-printed format should
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 52. Instructions for use provided in non-printed format should
div,['txt'],position:absolute; left:84px; top:270px;,contain
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",contain
div,['txt'],position:absolute; left:84px; top:285px;,":I - All information required in this Chapter and, where applicable, in"
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - All information required in this Chapter and, where applicable, in"
div,['txt'],position:absolute; left:84px; top:308px;,regulations dedicated to specific medical devices;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",regulations dedicated to specific medical devices;
div,['txt'],position:absolute; left:144px; top:329px;,II - identification of the version of the instructions for use corresponding
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - identification of the version of the instructions for use corresponding
div,['txt'],position:absolute; left:84px; top:345px;,to the respective product;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",to the respective product;
div,['txt'],position:absolute; left:144px; top:366px;,III - an alert to the user to observe the correlation of the version of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - an alert to the user to observe the correlation of the version of the
div,['txt'],position:absolute; left:84px; top:381px;,"instructions for use indicated with the product purchased, as made available by the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","instructions for use indicated with the product purchased, as made available by the"
div,['txt'],position:absolute; left:84px; top:396px;,manufacturer; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",manufacturer; and
div,['txt'],position:absolute; left:144px; top:417px;,"IV - the indication of how to obtain, at no additional cost (including"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","IV - the indication of how to obtain, at no additional cost (including"
div,['txt'],position:absolute; left:84px; top:432px;,"shipping), the instructions for use of the product in the printed format."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","shipping), the instructions for use of the product in the printed format."
div,['txt'],position:absolute; left:144px; top:454px;,"Art. 53. In order to provide the instructions for use over the internet, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 53. In order to provide the instructions for use over the internet, in"
div,['txt'],position:absolute; left:84px; top:469px;,"addition to the provisions set out in articles 51 and 52, the following requirements"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","addition to the provisions set out in articles 51 and 52, the following requirements"
div,['txt'],position:absolute; left:84px; top:484px;,must also be met:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",must also be met:
div,['txt'],position:absolute; left:144px; top:506px;,I - provide with the product clear guidance on how to find the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - provide with the product clear guidance on how to find the
div,['txt'],position:absolute; left:84px; top:521px;,corresponding and up-to-date instructions for use at the e-mail address available on the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",corresponding and up-to-date instructions for use at the e-mail address available on the
div,['txt'],position:absolute; left:84px; top:536px;,internet;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",internet;
div,['txt'],position:absolute; left:145px; top:558px;,II - ensure the basic security requirements of the e-mail address;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II - ensure the basic security requirements of the e-mail address;
div,['txt'],position:absolute; left:144px; top:580px;,III - make available the file of the instructions for use in the electronic
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III - make available the file of the instructions for use in the electronic
div,['txt'],position:absolute; left:84px; top:595px;,address in non-editable reading format;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",address in non-editable reading format;
div,['txt'],position:absolute; left:144px; top:617px;,IV - provide in the electronic address free access to the necessary tool for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - provide in the electronic address free access to the necessary tool for
div,['txt'],position:absolute; left:84px; top:632px;,reading the instructions for use; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",reading the instructions for use; and
div,['txt'],position:absolute; left:144px; top:654px;,V - ensure that the file made available and printed by this means is
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",V - ensure that the file made available and printed by this means is
div,['txt'],position:absolute; left:84px; top:668px;,identical to that provided by the manufacturer or holder of the notification or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",identical to that provided by the manufacturer or holder of the notification or
div,['txt'],position:absolute; left:84px; top:683px;,"registration, when requested, in the printed format."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","registration, when requested, in the printed format."
div,['txt'],position:absolute; left:144px; top:705px;,Art. 54. It is forbidden to provide the instructions for use in non-printed
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 54. It is forbidden to provide the instructions for use in non-printed
div,['txt'],position:absolute; left:84px; top:720px;,format for the following products:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",format for the following products:
div,['txt'],position:absolute; left:145px; top:742px;,I - Equipment for health use that have indication of:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",I - Equipment for health use that have indication of:
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASAD; Ea) Household use in general, including those used in home care service -b) operation by laypersons , regardless of the place of use. II -Health use materials used by lay public.CHAPTER VII.TECHNICAL DOSSIERArt. 55. The legal and technical officers of the requesting company areresponsible for the information and documents presented.Art. 56. It is the responsibility of the holder of the medical devicenotification to keep the technical dossier up to date, containing all the documents andinformation indicated in this Resolution, for the purpose of surveillance by the NationalHealth Surveillance System.§ 1 This Technical Dossier must not be filed with Anvisa as part of theproduct notification request, and must remain in the possession of the company thatowns the notification.§ 2º The Technical Dossier does not need to correspond to a physical orelectronic file containing all the information described below, and may be composed ofreferences to documents and information that make up other files or records of thecompany's quality system, Which should be available for supervision of the NationalHealth Surveillance System.§ 3 In specific cases, when investigations and investigations are necessary,the Technical Dossier may be requested to send to Anvisa.Art. 57. The Technical Dossier must include the following information,which must be structured as described in Annex II to this Resolution:I - a detailed description of the medical device, including the grounds for itsoperation and its action, its content or composition, where applicable, and the list ofaccessories intended to integrate the product;II - indication, purpose or use for which the medical device is intended, asindicated by the manufacturer;III - precautions, restrictions, warnings, special care and clarifications onthe use of the medical device, as well as its storage and transportation;IV - forms of presentation of the medical device;V - label templates and instructions for use, according to art. 46 to 49 ofResolution this;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASAD; Ea) Household use in general, including those used in home care service -b) operation by laypersons , regardless of the place of use. II -Health use materials used by lay public.CHAPTER VII.TECHNICAL DOSSIERArt. 55. The legal and technical officers of the requesting company areresponsible for the information and documents presented.Art. 56. It is the responsibility of the holder of the medical devicenotification to keep the technical dossier up to date, containing all the documents andinformation indicated in this Resolution, for the purpose of surveillance by the NationalHealth Surveillance System.§ 1 This Technical Dossier must not be filed with Anvisa as part of theproduct notification request, and must remain in the possession of the company thatowns the notification.§ 2º The Technical Dossier does not need to correspond to a physical orelectronic file containing all the information described below, and may be composed ofreferences to documents and information that make up other files or records of thecompany's quality system, Which should be available for supervision of the NationalHealth Surveillance System.§ 3 In specific cases, when investigations and investigations are necessary,the Technical Dossier may be requested to send to Anvisa.Art. 57. The Technical Dossier must include the following information,which must be structured as described in Annex II to this Resolution:I - a detailed description of the medical device, including the grounds for itsoperation and its action, its content or composition, where applicable, and the list ofaccessories intended to integrate the product;II - indication, purpose or use for which the medical device is intended, asindicated by the manufacturer;III - precautions, restrictions, warnings, special care and clarifications onthe use of the medical device, as well as its storage and transportation;IV - forms of presentation of the medical device;V - label templates and instructions for use, according to art. 46 to 49 ofResolution this;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:84px; top:131px;,"SAD; Ea) Household use in general, including those used in home care service -"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",SAD; E
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);","a) Household use in general, including those used in home care service -"
div,['txt'],position:absolute; left:145px; top:168px;,"b) operation by laypersons , regardless of the place of use. II -"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","b) operation by laypersons , regardless of the place of use. II -"
div,['txt'],position:absolute; left:145px; top:190px;,Health use materials used by lay public.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Health use materials used by lay public.
div,['txt'],position:absolute; left:265px; top:212px;,CHAPTER VII.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",CHAPTER VII.
div,['txt'],position:absolute; left:246px; top:235px;,TECHNICAL DOSSIER
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",TECHNICAL DOSSIER
div,['txt'],position:absolute; left:144px; top:256px;,Art. 55. The legal and technical officers of the requesting company are
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 55. The legal and technical officers of the requesting company are
div,['txt'],position:absolute; left:84px; top:271px;,responsible for the information and documents presented.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",responsible for the information and documents presented.
div,['txt'],position:absolute; left:144px; top:293px;,Art. 56. It is the responsibility of the holder of the medical device
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 56. It is the responsibility of the holder of the medical device
div,['txt'],position:absolute; left:84px; top:308px;,"notification to keep the technical dossier up to date, containing all the documents and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","notification to keep the technical dossier up to date, containing all the documents and"
div,['txt'],position:absolute; left:84px; top:323px;,"information indicated in this Resolution, for the purpose of surveillance by the National"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","information indicated in this Resolution, for the purpose of surveillance by the National"
div,['txt'],position:absolute; left:84px; top:337px;,Health Surveillance System.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Health Surveillance System.
div,['txt'],position:absolute; left:144px; top:359px;,§ 1 This Technical Dossier must not be filed with Anvisa as part of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 This Technical Dossier must not be filed with Anvisa as part of the
div,['txt'],position:absolute; left:84px; top:374px;,"product notification request, and must remain in the possession of the company that"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","product notification request, and must remain in the possession of the company that"
div,['txt'],position:absolute; left:84px; top:389px;,owns the notification.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",owns the notification.
div,['txt'],position:absolute; left:144px; top:411px;,§ 2º The Technical Dossier does not need to correspond to a physical or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2º The Technical Dossier does not need to correspond to a physical or
div,['txt'],position:absolute; left:84px; top:426px;,"electronic file containing all the information described below, and may be composed of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","electronic file containing all the information described below, and may be composed of"
div,['txt'],position:absolute; left:84px; top:440px;,references to documents and information that make up other files or records of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",references to documents and information that make up other files or records of the
div,['txt'],position:absolute; left:84px; top:455px;,"company's quality system, Which should be available for supervision of the National"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","company's quality system, Which should be available for supervision of the National"
div,['txt'],position:absolute; left:84px; top:469px;,Health Surveillance System.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Health Surveillance System.
div,['txt'],position:absolute; left:144px; top:491px;,"§ 3 In specific cases, when investigations and investigations are necessary,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 3 In specific cases, when investigations and investigations are necessary,"
div,['txt'],position:absolute; left:84px; top:506px;,the Technical Dossier may be requested to send to Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the Technical Dossier may be requested to send to Anvisa.
div,['txt'],position:absolute; left:144px; top:528px;,"Art. 57. The Technical Dossier must include the following information,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 57. The Technical Dossier must include the following information,"
div,['txt'],position:absolute; left:84px; top:543px;,which must be structured as described in Annex II to this Resolution:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which must be structured as described in Annex II to this Resolution:
div,['txt'],position:absolute; left:144px; top:565px;,"I - a detailed description of the medical device, including the grounds for its"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - a detailed description of the medical device, including the grounds for its"
div,['txt'],position:absolute; left:84px; top:580px;,"operation and its action, its content or composition, where applicable, and the list of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","operation and its action, its content or composition, where applicable, and the list of"
div,['txt'],position:absolute; left:84px; top:595px;,accessories intended to integrate the product;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",accessories intended to integrate the product;
div,['txt'],position:absolute; left:144px; top:616px;,"II - indication, purpose or use for which the medical device is intended, as"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","II - indication, purpose or use for which the medical device is intended, as"
div,['txt'],position:absolute; left:84px; top:631px;,indicated by the manufacturer;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",indicated by the manufacturer;
div,['txt'],position:absolute; left:144px; top:653px;,"III - precautions, restrictions, warnings, special care and clarifications on"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","III - precautions, restrictions, warnings, special care and clarifications on"
div,['txt'],position:absolute; left:84px; top:668px;,"the use of the medical device, as well as its storage and transportation;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the use of the medical device, as well as its storage and transportation;"
div,['txt'],position:absolute; left:144px; top:690px;,IV - forms of presentation of the medical device;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - forms of presentation of the medical device;
div,['txt'],position:absolute; left:144px; top:712px;,"V - label templates and instructions for use, according to art. 46 to 49 of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","V - label templates and instructions for use, according to art. 46 to 49 of"
div,['txt'],position:absolute; left:84px; top:726px;,Resolution this
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Resolution this
div,['txt'],position:absolute; left:84px; top:741px;,;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAVI - flow diagram containing the steps of the manufacturing process of themedical device with a description of each step of the process, until the finishedproduct is obtained, with the indication of the manufacturing units and theirrespective stages;VII - description of the safety and performance of the medical device, inaccordance with the current regulation providing for the essential safety andperformance requirements of medical devices.§ 1 The proof of the safety and performance of the medical device mustmeet the requirements set out in applicable technical standards.§ 2 If necessary, the health authority may request additional information orclarifications, as well as presentation of additional documentation, including a clinicalstudy report specifically designed and conducted for investigation of the medical devicesubject to interest.Art. 58. The information of the Technical Dossier shall be organizedaccording to the health risk class of the product, as set out in Annex II to this Resolution.CHAPTER VIII FINALPROVISIONS AND TRANSITÓRIASArt. 59. The notification regime applies the same types of health violationsand the associated actions in force for the registration regimeof medical devices.Art. 60. The notifications and records of medical devices, their changes andother acts will be published in the Official Gazette and will remain available forconsultation on the electronic portal of Anvisa.§ 1 Products subject to notification and registration may only beindustrialized, imported, exposed for sale or delivered to consumption after thepublication of the said notification or registration number.§ 2 Products manufactured in national territory exclusively for exportpurposes do not require notification or registration with Anvisa.Art. 61. Protocols of medical device registration petitions will be acceptedwith the structuring of a technical report provided for in the Resolution of theCollegiate Board of Directors - RDC No. 185, of October 22, 2001, protocolized untilFebruary 28, 2023.Single paragraph. For records granted during the term of RDC No. 185, ofOctober 22, 2001, the maintenance of the structuring of technical report will beallowed until possible request for change of approval registration required, whichshould include the new structure of Technical Dossier.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAVI - flow diagram containing the steps of the manufacturing process of themedical device with a description of each step of the process, until the finishedproduct is obtained, with the indication of the manufacturing units and theirrespective stages;VII - description of the safety and performance of the medical device, inaccordance with the current regulation providing for the essential safety andperformance requirements of medical devices.§ 1 The proof of the safety and performance of the medical device mustmeet the requirements set out in applicable technical standards.§ 2 If necessary, the health authority may request additional information orclarifications, as well as presentation of additional documentation, including a clinicalstudy report specifically designed and conducted for investigation of the medical devicesubject to interest.Art. 58. The information of the Technical Dossier shall be organizedaccording to the health risk class of the product, as set out in Annex II to this Resolution.CHAPTER VIII FINALPROVISIONS AND TRANSITÓRIASArt. 59. The notification regime applies the same types of health violationsand the associated actions in force for the registration regimeof medical devices.Art. 60. The notifications and records of medical devices, their changes andother acts will be published in the Official Gazette and will remain available forconsultation on the electronic portal of Anvisa.§ 1 Products subject to notification and registration may only beindustrialized, imported, exposed for sale or delivered to consumption after thepublication of the said notification or registration number.§ 2 Products manufactured in national territory exclusively for exportpurposes do not require notification or registration with Anvisa.Art. 61. Protocols of medical device registration petitions will be acceptedwith the structuring of a technical report provided for in the Resolution of theCollegiate Board of Directors - RDC No. 185, of October 22, 2001, protocolized untilFebruary 28, 2023.Single paragraph. For records granted during the term of RDC No. 185, ofOctober 22, 2001, the maintenance of the structuring of technical report will beallowed until possible request for change of approval registration required, whichshould include the new structure of Technical Dossier.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,VI - flow diagram containing the steps of the manufacturing process of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",VI - flow diagram containing the steps of the manufacturing process of the
div,['txt'],position:absolute; left:84px; top:146px;,"medical device with a description of each step of the process, until the finished"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","medical device with a description of each step of the process, until the finished"
div,['txt'],position:absolute; left:84px; top:160px;,"product is obtained, with the indication of the manufacturing units and their"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","product is obtained, with the indication of the manufacturing units and their"
div,['txt'],position:absolute; left:84px; top:175px;,respective stages;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",respective stages;
div,['txt'],position:absolute; left:144px; top:197px;,"VII - description of the safety and performance of the medical device, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","VII - description of the safety and performance of the medical device, in"
div,['txt'],position:absolute; left:84px; top:212px;,accordance with the current regulation providing for the essential safety and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",accordance with the current regulation providing for the essential safety and
div,['txt'],position:absolute; left:84px; top:227px;,performance requirements of medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",performance requirements of medical devices.
div,['txt'],position:absolute; left:144px; top:249px;,§ 1 The proof of the safety and performance of the medical device must
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 The proof of the safety and performance of the medical device must
div,['txt'],position:absolute; left:84px; top:263px;,meet the requirements set out in applicable technical standards.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",meet the requirements set out in applicable technical standards.
div,['txt'],position:absolute; left:144px; top:285px;,"§ 2 If necessary, the health authority may request additional information or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","§ 2 If necessary, the health authority may request additional information or"
div,['txt'],position:absolute; left:84px; top:300px;,"clarifications, as well as presentation of additional documentation, including a clinical"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","clarifications, as well as presentation of additional documentation, including a clinical"
div,['txt'],position:absolute; left:84px; top:315px;,study report specifically designed and conducted for investigation of the medical device
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",study report specifically designed and conducted for investigation of the medical device
div,['txt'],position:absolute; left:84px; top:330px;,subject to interest.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",subject to interest.
div,['txt'],position:absolute; left:144px; top:351px;,Art. 58. The information of the Technical Dossier shall be organized
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 58. The information of the Technical Dossier shall be organized
div,['txt'],position:absolute; left:84px; top:366px;,"according to the health risk class of the product, as set out in Annex II to this Resolution."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","according to the health risk class of the product, as set out in Annex II to this Resolution."
div,['txt'],position:absolute; left:262px; top:388px;,CHAPTER VIII FINAL
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",CHAPTER VIII FINAL
div,['txt'],position:absolute; left:203px; top:411px;,PROVISIONS AND TRANSITÓRIAS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",PROVISIONS AND TRANSITÓRIAS
div,['txt'],position:absolute; left:144px; top:432px;,Art. 59. The notification regime applies the same types of health violations
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 59. The notification regime applies the same types of health violations
div,['txt'],position:absolute; left:84px; top:447px;,and the associated actions in force for the registration regime
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",and the associated actions in force for the registration regime
div,['txt'],position:absolute; left:84px; top:462px;,of medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of medical devices.
div,['txt'],position:absolute; left:144px; top:483px;,"Art. 60. The notifications and records of medical devices, their changes and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 60. The notifications and records of medical devices, their changes and"
div,['txt'],position:absolute; left:84px; top:498px;,other acts will be published in the Official Gazette and will remain available for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",other acts will be published in the Official Gazette and will remain available for
div,['txt'],position:absolute; left:84px; top:513px;,consultation on the electronic portal of Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",consultation on the electronic portal of Anvisa.
div,['txt'],position:absolute; left:144px; top:535px;,§ 1 Products subject to notification and registration may only be
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 Products subject to notification and registration may only be
div,['txt'],position:absolute; left:84px; top:550px;,"industrialized, imported, exposed for sale or delivered to consumption after the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","industrialized, imported, exposed for sale or delivered to consumption after the"
div,['txt'],position:absolute; left:84px; top:564px;,publication of the said notification or registration number.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",publication of the said notification or registration number.
div,['txt'],position:absolute; left:144px; top:587px;,§ 2 Products manufactured in national territory exclusively for export
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2 Products manufactured in national territory exclusively for export
div,['txt'],position:absolute; left:84px; top:602px;,purposes do not require notification or registration with Anvisa.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",purposes do not require notification or registration with Anvisa.
div,['txt'],position:absolute; left:144px; top:624px;,Art. 61. Protocols of medical device registration petitions will be accepted
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 61. Protocols of medical device registration petitions will be accepted
div,['txt'],position:absolute; left:84px; top:638px;,with the structuring of a technical report provided for in the Resolution of the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",with the structuring of a technical report provided for in the Resolution of the
div,['txt'],position:absolute; left:84px; top:653px;,"Collegiate Board of Directors - RDC No. 185, of October 22, 2001, protocolized until"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Collegiate Board of Directors - RDC No. 185, of October 22, 2001, protocolized until"
div,['txt'],position:absolute; left:84px; top:668px;,"February 28, 2023."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","February 28, 2023."
div,['txt'],position:absolute; left:144px; top:690px;,"Single paragraph. For records granted during the term of RDC No. 185, of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Single paragraph. For records granted during the term of RDC No. 185, of"
div,['txt'],position:absolute; left:84px; top:704px;,"October 22, 2001, the maintenance of the structuring of technical report will be"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","October 22, 2001, the maintenance of the structuring of technical report will be"
div,['txt'],position:absolute; left:84px; top:719px;,"allowed until possible request for change of approval registration required, which"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","allowed until possible request for change of approval registration required, which"
div,['txt'],position:absolute; left:84px; top:734px;,should include the new structure of Technical Dossier.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",should include the new structure of Technical Dossier.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAArt. 62. The period of 365 (three hundred sixty-five) days, counted from theentry into force of this Resolution, is hereby established. in order for the holders ofmedical device notifications to protocol sanitary reframing petitions of products thathad their regime modified from notification to registration according to the updating ofclassification rules.§ 1 The petition must be instructed with the same documentationrequired for new product registration.§ 2º The protocol of the Application for Certification of GoodManufacturing Practices will be accepted for the purpose of petitioning, as well as thebeginning of the analysis in the petitions for sanitary reframing.§ 3º The approval of requests for sanitary reframing is conditional on thepublication of a certificate of good manufacturing practice issued by Anvisa and oncompliance with the other requirements for registration of medical devices.§ 4º The failure to comply with the provisions of the caput will result in thecancellation of the product notification.Art. 63. The registration processes whose products have had theirregularization regime modified from registration to notification due to the updating ofthe classification rules will be treated by means of Anvisa rectification office.Art. 64. The Collegiate Board Resolution - RDC No. 270, of February 28,2019, published in DOU No. 43, of March 1°, 2019, Section 1, p. 68, becomes effectivewith the following amendment:""Article 5 Notification of medical devices, their changes and other acts willbe published in the Official Gazette and will remain available for consultation on theelectronic portal of Anvisa.""Art. 65. The Resolution of the Collegiate Board of Directors - RDC No. 340,of March 6, 2020, published in DOU No. 48, of March 11, 2020, Section 1, p. 56,becomes effective with the following amendment:""Article 9 The immediate implementation changes will be published in theOfficial Gazette and, where applicable, the updated data will be published in theelectronic portal of Anvisa, observing the period of up to thirty (30) days, counted fromthe completion of the protocol of the respective petition, Regardless of documentanalysis by Anvisa.""Art. 66. They shall be repealed from the date of entry into force of the latterResolution: 2001;I - Resolution of the Collegiate Board of Directors - RDC No. 185, of October22This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAArt. 62. The period of 365 (three hundred sixty-five) days, counted from theentry into force of this Resolution, is hereby established. in order for the holders ofmedical device notifications to protocol sanitary reframing petitions of products thathad their regime modified from notification to registration according to the updating ofclassification rules.§ 1 The petition must be instructed with the same documentationrequired for new product registration.§ 2º The protocol of the Application for Certification of GoodManufacturing Practices will be accepted for the purpose of petitioning, as well as thebeginning of the analysis in the petitions for sanitary reframing.§ 3º The approval of requests for sanitary reframing is conditional on thepublication of a certificate of good manufacturing practice issued by Anvisa and oncompliance with the other requirements for registration of medical devices.§ 4º The failure to comply with the provisions of the caput will result in thecancellation of the product notification.Art. 63. The registration processes whose products have had theirregularization regime modified from registration to notification due to the updating ofthe classification rules will be treated by means of Anvisa rectification office.Art. 64. The Collegiate Board Resolution - RDC No. 270, of February 28,2019, published in DOU No. 43, of March 1°, 2019, Section 1, p. 68, becomes effectivewith the following amendment:""Article 5 Notification of medical devices, their changes and other acts willbe published in the Official Gazette and will remain available for consultation on theelectronic portal of Anvisa.""Art. 65. The Resolution of the Collegiate Board of Directors - RDC No. 340,of March 6, 2020, published in DOU No. 48, of March 11, 2020, Section 1, p. 56,becomes effective with the following amendment:""Article 9 The immediate implementation changes will be published in theOfficial Gazette and, where applicable, the updated data will be published in theelectronic portal of Anvisa, observing the period of up to thirty (30) days, counted fromthe completion of the protocol of the respective petition, Regardless of documentanalysis by Anvisa.""Art. 66. They shall be repealed from the date of entry into force of the latterResolution: 2001;I - Resolution of the Collegiate Board of Directors - RDC No. 185, of October22This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,"Art. 62. The period of 365 (three hundred sixty-five) days, counted from the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 62. The period of 365 (three hundred sixty-five) days, counted from the"
div,['txt'],position:absolute; left:84px; top:146px;,"entry into force of this Resolution, is hereby established. in order for the holders of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","entry into force of this Resolution, is hereby established. in order for the holders of"
div,['txt'],position:absolute; left:84px; top:160px;,medical device notifications to protocol sanitary reframing petitions of products that
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",medical device notifications to protocol sanitary reframing petitions of products that
div,['txt'],position:absolute; left:84px; top:175px;,had their regime modified from notification to registration according to the updating of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",had their regime modified from notification to registration according to the updating of
div,['txt'],position:absolute; left:84px; top:190px;,classification rules.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classification rules.
div,['txt'],position:absolute; left:144px; top:212px;,§ 1 The petition must be instructed with the same documentation
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 1 The petition must be instructed with the same documentation
div,['txt'],position:absolute; left:84px; top:226px;,required for new product registration.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",required for new product registration.
div,['txt'],position:absolute; left:144px; top:248px;,§ 2º The protocol of the Application for Certification of Good
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 2º The protocol of the Application for Certification of Good
div,['txt'],position:absolute; left:84px; top:263px;,"Manufacturing Practices will be accepted for the purpose of petitioning, as well as the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Manufacturing Practices will be accepted for the purpose of petitioning, as well as the"
div,['txt'],position:absolute; left:84px; top:278px;,beginning of the analysis in the petitions for sanitary reframing.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",beginning of the analysis in the petitions for sanitary reframing.
div,['txt'],position:absolute; left:144px; top:300px;,§ 3º The approval of requests for sanitary reframing is conditional on the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 3º The approval of requests for sanitary reframing is conditional on the
div,['txt'],position:absolute; left:84px; top:315px;,publication of a certificate of good manufacturing practice issued by Anvisa and on
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",publication of a certificate of good manufacturing practice issued by Anvisa and on
div,['txt'],position:absolute; left:84px; top:329px;,compliance with the other requirements for registration of medical devices.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",compliance with the other requirements for registration of medical devices.
div,['txt'],position:absolute; left:144px; top:351px;,§ 4º The failure to comply with the provisions of the caput will result in the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",§ 4º The failure to comply with the provisions of the caput will result in the
div,['txt'],position:absolute; left:84px; top:366px;,cancellation of the product notification.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",cancellation of the product notification.
div,['txt'],position:absolute; left:144px; top:388px;,Art. 63. The registration processes whose products have had their
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 63. The registration processes whose products have had their
div,['txt'],position:absolute; left:84px; top:403px;,regularization regime modified from registration to notification due to the updating of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",regularization regime modified from registration to notification due to the updating of
div,['txt'],position:absolute; left:84px; top:418px;,the classification rules will be treated by means of Anvisa rectification office.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the classification rules will be treated by means of Anvisa rectification office.
div,['txt'],position:absolute; left:144px; top:440px;,"Art. 64. The Collegiate Board Resolution - RDC No. 270, of February 28,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 64. The Collegiate Board Resolution - RDC No. 270, of February 28,"
div,['txt'],position:absolute; left:84px; top:454px;,"2019, published in DOU No. 43, of March 1°, 2019, Section 1, p. 68, becomes effective"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","2019, published in DOU No. 43, of March 1°, 2019, Section 1, p. 68, becomes effective"
div,['txt'],position:absolute; left:84px; top:469px;,with the following amendment:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",with the following amendment:
div,['txt'],position:absolute; left:144px; top:491px;,"""Article 5 Notification of medical devices, their changes and other acts will"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","""Article 5 Notification of medical devices, their changes and other acts will"
div,['txt'],position:absolute; left:84px; top:506px;,be published in the Official Gazette and will remain available for consultation on the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",be published in the Official Gazette and will remain available for consultation on the
div,['txt'],position:absolute; left:84px; top:521px;,"electronic portal of Anvisa."""
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","electronic portal of Anvisa."""
div,['txt'],position:absolute; left:144px; top:542px;,"Art. 65. The Resolution of the Collegiate Board of Directors - RDC No. 340,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Art. 65. The Resolution of the Collegiate Board of Directors - RDC No. 340,"
div,['txt'],position:absolute; left:84px; top:558px;,"of March 6, 2020, published in DOU No. 48, of March 11, 2020, Section 1, p. 56,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of March 6, 2020, published in DOU No. 48, of March 11, 2020, Section 1, p. 56,"
div,['txt'],position:absolute; left:84px; top:573px;,becomes effective with the following amendment:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",becomes effective with the following amendment:
div,['txt'],position:absolute; left:144px; top:594px;,"""Article 9 The immediate implementation changes will be published in the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","""Article 9 The immediate implementation changes will be published in the"
div,['txt'],position:absolute; left:84px; top:609px;,"Official Gazette and, where applicable, the updated data will be published in the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Official Gazette and, where applicable, the updated data will be published in the"
div,['txt'],position:absolute; left:84px; top:624px;,"electronic portal of Anvisa, observing the period of up to thirty (30) days, counted from"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","electronic portal of Anvisa, observing the period of up to thirty (30) days, counted from"
div,['txt'],position:absolute; left:84px; top:638px;,"the completion of the protocol of the respective petition, Regardless of document"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the completion of the protocol of the respective petition, Regardless of document"
div,['txt'],position:absolute; left:84px; top:653px;,"analysis by Anvisa."""
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","analysis by Anvisa."""
div,['txt'],position:absolute; left:145px; top:674px;,Art. 66. They shall be repealed from the date of entry into force of the latter
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Art. 66. They shall be repealed from the date of entry into force of the latter
div,['txt'],position:absolute; left:84px; top:690px;,Resolution
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Resolution
div,['txt'],position:absolute; left:84px; top:727px;,: 2001;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",: 2001;
div,['txt'],position:absolute; left:144px; top:711px;,"I - Resolution of the Collegiate Board of Directors - RDC No. 185, of October"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","I - Resolution of the Collegiate Board of Directors - RDC No. 185, of October"
div,['txt'],position:absolute; left:151px; top:726px;,22
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",22
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"2006;Ministry of Health - MSNational Health Surveillance Agency–ANVISAII - Resolution - RE No. 1554, of August 19, 2002;III - Resolution of the Collegiate Board of Directors - RDC No. 207, ofNovember 7IV - Article 2(I) and (ii) and Article 5(ii) of the InstructionNormative - IN No. 4, of June 15, 2012;V - Resolution of the Collegiate Board of Directors - RDC No. 15, of March28, 2014; VI - Resolution of the Collegiate Board of Directors - RDC No. 40,of August 26, 2015. Art. 67. This Resolution comes into force on March 1,2023.ANTONIO BAR TOWERSDirector-PresidentThis text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"2006;Ministry of Health - MSNational Health Surveillance Agency–ANVISAII - Resolution - RE No. 1554, of August 19, 2002;III - Resolution of the Collegiate Board of Directors - RDC No. 207, ofNovember 7IV - Article 2(I) and (ii) and Article 5(ii) of the InstructionNormative - IN No. 4, of June 15, 2012;V - Resolution of the Collegiate Board of Directors - RDC No. 15, of March28, 2014; VI - Resolution of the Collegiate Board of Directors - RDC No. 40,of August 26, 2015. Art. 67. This Resolution comes into force on March 1,2023.ANTONIO BAR TOWERSDirector-PresidentThis text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:84px; top:168px;,2006;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",2006;
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:145px; top:131px;,"II - Resolution - RE No. 1554, of August 19, 2002;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","II - Resolution - RE No. 1554, of August 19, 2002;"
div,['txt'],position:absolute; left:145px; top:153px;,"III - Resolution of the Collegiate Board of Directors - RDC No. 207, of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","III - Resolution of the Collegiate Board of Directors - RDC No. 207, of"
div,['txt'],position:absolute; left:157px; top:168px;,November 7
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",November 7
div,['txt'],position:absolute; left:145px; top:204px;,IV - Article 2(I) and (ii) and Article 5(ii) of the Instruction
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",IV - Article 2(I) and (ii) and Article 5(ii) of the Instruction
div,['txt'],position:absolute; left:84px; top:220px;,"Normative - IN No. 4, of June 15, 2012;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Normative - IN No. 4, of June 15, 2012;"
div,['txt'],position:absolute; left:145px; top:242px;,"V - Resolution of the Collegiate Board of Directors - RDC No. 15, of March"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","V - Resolution of the Collegiate Board of Directors - RDC No. 15, of March"
div,['txt'],position:absolute; left:145px; top:264px;,"28, 2014; VI - Resolution of the Collegiate Board of Directors - RDC No. 40,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","28, 2014; VI - Resolution of the Collegiate Board of Directors - RDC No. 40,"
div,['txt'],position:absolute; left:145px; top:286px;,"of August 26, 2015. Art. 67. This Resolution comes into force on March 1,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of August 26, 2015. Art. 67. This Resolution comes into force on March 1,"
div,['txt'],position:absolute; left:145px; top:308px;,2023.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",2023.
div,['txt'],position:absolute; left:238px; top:338px;,ANTONIO BAR TOWERS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANTONIO BAR TOWERS
div,['txt'],position:absolute; left:251px; top:352px;,Director-President
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Director-President
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAANNEX IRules of Risk Classification of Medical Devices Non-invasive devicesRule 1All non-invasive devices are classified in Class I unless one of the followingrules applies.Rule 2All non-invasive devices intended for the conduction or storage of blood,fluids, body cells or tissues, liquids or gases with a view to possible perfusion,administration or introduction into the body are classified in Class II:a) If they can be connected to an active class II, III or IV device;orb) if they are intended to be used for driving or storageBlood or other body fluids or for the storage of organs, parts of organs or cells andbody tissues, with the exception of blood bags and hemocomponents, which areclassified in Class III.In all other cases, these devices are classified in class I.Rule 3All non-invasive devices intended to alter the compositionBiological or chemical of tissues or cells of human origin, blood, other bodily fluids, orother liquids for implantation or administration in the body are classified in Class III,unless the treatment in which the device is used consists of filtration, centrifugation orexchange of gases or heat, Case in which they are classified in class II.All non-invasive devices consisting of a substance or mixture of substancesintended for use in vitro in direct contact with human cells, tissues or organs takenfrom the human body or used in vitro with human embryos prior to their implantationor administration in the body, They are classified in class IV.Rule 4All non-invasive devices that come into contact with injured skin or mucousmembrane are classified:a) In Class I, where they are intended to be used as a mechanical barrier,for compression or for absorption of exudates;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAANNEX IRules of Risk Classification of Medical Devices Non-invasive devicesRule 1All non-invasive devices are classified in Class I unless one of the followingrules applies.Rule 2All non-invasive devices intended for the conduction or storage of blood,fluids, body cells or tissues, liquids or gases with a view to possible perfusion,administration or introduction into the body are classified in Class II:a) If they can be connected to an active class II, III or IV device;orb) if they are intended to be used for driving or storageBlood or other body fluids or for the storage of organs, parts of organs or cells andbody tissues, with the exception of blood bags and hemocomponents, which areclassified in Class III.In all other cases, these devices are classified in class I.Rule 3All non-invasive devices intended to alter the compositionBiological or chemical of tissues or cells of human origin, blood, other bodily fluids, orother liquids for implantation or administration in the body are classified in Class III,unless the treatment in which the device is used consists of filtration, centrifugation orexchange of gases or heat, Case in which they are classified in class II.All non-invasive devices consisting of a substance or mixture of substancesintended for use in vitro in direct contact with human cells, tissues or organs takenfrom the human body or used in vitro with human embryos prior to their implantationor administration in the body, They are classified in class IV.Rule 4All non-invasive devices that come into contact with injured skin or mucousmembrane are classified:a) In Class I, where they are intended to be used as a mechanical barrier,for compression or for absorption of exudates;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:276px; top:130px;,ANNEX I
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANNEX I
div,['txt'],position:absolute; left:156px; top:160px;,Rules of Risk Classification of Medical Devices Non-invasive devices
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rules of Risk Classification of Medical Devices Non-invasive devices
div,['txt'],position:absolute; left:84px; top:182px;,Rule 1
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 1
div,['txt'],position:absolute; left:144px; top:203px;,All non-invasive devices are classified in Class I unless one of the following
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All non-invasive devices are classified in Class I unless one of the following
div,['txt'],position:absolute; left:84px; top:218px;,rules applies.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",rules applies.
div,['txt'],position:absolute; left:84px; top:241px;,Rule 2
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 2
div,['txt'],position:absolute; left:144px; top:262px;,"All non-invasive devices intended for the conduction or storage of blood,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","All non-invasive devices intended for the conduction or storage of blood,"
div,['txt'],position:absolute; left:84px; top:277px;,"fluids, body cells or tissues, liquids or gases with a view to possible perfusion,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","fluids, body cells or tissues, liquids or gases with a view to possible perfusion,"
div,['txt'],position:absolute; left:84px; top:292px;,administration or introduction into the body are classified in Class II:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",administration or introduction into the body are classified in Class II:
div,['txt'],position:absolute; left:144px; top:314px;,"a) If they can be connected to an active class II, III or IV device;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) If they can be connected to an active class II, III or IV device;"
div,['txt'],position:absolute; left:84px; top:329px;,or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",or
div,['txt'],position:absolute; left:145px; top:351px;,b) if they are intended to be used for driving or storage
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) if they are intended to be used for driving or storage
div,['txt'],position:absolute; left:84px; top:366px;,"Blood or other body fluids or for the storage of organs, parts of organs or cells and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Blood or other body fluids or for the storage of organs, parts of organs or cells and"
div,['txt'],position:absolute; left:84px; top:380px;,"body tissues, with the exception of blood bags and hemocomponents, which are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","body tissues, with the exception of blood bags and hemocomponents, which are"
div,['txt'],position:absolute; left:84px; top:395px;,classified in Class III.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classified in Class III.
div,['txt'],position:absolute; left:145px; top:417px;,"In all other cases, these devices are classified in class I."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","In all other cases, these devices are classified in class I."
div,['txt'],position:absolute; left:84px; top:439px;,Rule 3
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 3
div,['txt'],position:absolute; left:145px; top:461px;,All non-invasive devices intended to alter the composition
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All non-invasive devices intended to alter the composition
div,['txt'],position:absolute; left:84px; top:476px;,"Biological or chemical of tissues or cells of human origin, blood, other bodily fluids, or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Biological or chemical of tissues or cells of human origin, blood, other bodily fluids, or"
div,['txt'],position:absolute; left:84px; top:491px;,"other liquids for implantation or administration in the body are classified in Class III,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","other liquids for implantation or administration in the body are classified in Class III,"
div,['txt'],position:absolute; left:84px; top:505px;,"unless the treatment in which the device is used consists of filtration, centrifugation or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","unless the treatment in which the device is used consists of filtration, centrifugation or"
div,['txt'],position:absolute; left:84px; top:520px;,"exchange of gases or heat, Case in which they are classified in class II."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","exchange of gases or heat, Case in which they are classified in class II."
div,['txt'],position:absolute; left:144px; top:542px;,All non-invasive devices consisting of a substance or mixture of substances
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All non-invasive devices consisting of a substance or mixture of substances
div,['txt'],position:absolute; left:84px; top:557px;,"intended for use in vitro in direct contact with human cells, tissues or organs taken"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","intended for use in vitro in direct contact with human cells, tissues or organs taken"
div,['txt'],position:absolute; left:84px; top:571px;,from the human body or used in vitro with human embryos prior to their implantation
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",from the human body or used in vitro with human embryos prior to their implantation
div,['txt'],position:absolute; left:84px; top:586px;,"or administration in the body, They are classified in class IV."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","or administration in the body, They are classified in class IV."
div,['txt'],position:absolute; left:84px; top:608px;,Rule 4
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 4
div,['txt'],position:absolute; left:144px; top:630px;,All non-invasive devices that come into contact with injured skin or mucous
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All non-invasive devices that come into contact with injured skin or mucous
div,['txt'],position:absolute; left:84px; top:645px;,membrane are classified:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",membrane are classified:
div,['txt'],position:absolute; left:144px; top:667px;,"a) In Class I, where they are intended to be used as a mechanical barrier,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) In Class I, where they are intended to be used as a mechanical barrier,"
div,['txt'],position:absolute; left:84px; top:682px;,for compression or for absorption of exudates;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",for compression or for absorption of exudates;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAb) In Class III, if they are intended to be used mainly in skin lesions thathave produced rupture of the dermis or mucous membranes and which can only healby second intention;c) In class II, the case is mainly intended to control the microenvironment ofthe injured skin or mucous membrane; andd) In class II in all other cases.This rule also applies to invasive devices that come into contact with adamaged mucous membrane.Invasive Devices Rule5All invasive medical devices applicable to body holes,Except surgically invasive devices, which are not intended to be connected to an activedevice or are intended to be connected to an active class I device, are classified:a) In Class I, where they are intended for transitional use;b) In class II, if they are intended for short-term use, except if used in theoral cavity to the pharynx, in the ear canal to the tympanum or in the nasal cavity, inwhich case they are classified in class I; andc) In class III, if they are intended for long-term use, except if used in theoral cavity to the pharynx, in the ear canal to the tympanum or in the nasal cavity, and ifthey are not susceptible to absorption by the mucosa, in which case they are classified inclass II.All invasive medical devices applicable to body holes, except surgicallyinvasive devices, which are intended to be connected to an active Class II, III or IVmedical device, are classified in Class II.Rule 6All surgically invasive devices intended for transitory use are classified inClass II, unless:a) Are specifically intended to control, diagnose, monitor or correctcardiac or central circulatory system dysfunctions through direct contact with theseparts of the body, in which case they are classified in Class IV;b) are reusable surgical instruments, in which case they are classifiedIn class I;c) they are specifically intended to be used in direct contact withHeart, the central circulatory system or the central nervous system, in which case theyare classified in class IV;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAb) In Class III, if they are intended to be used mainly in skin lesions thathave produced rupture of the dermis or mucous membranes and which can only healby second intention;c) In class II, the case is mainly intended to control the microenvironment ofthe injured skin or mucous membrane; andd) In class II in all other cases.This rule also applies to invasive devices that come into contact with adamaged mucous membrane.Invasive Devices Rule5All invasive medical devices applicable to body holes,Except surgically invasive devices, which are not intended to be connected to an activedevice or are intended to be connected to an active class I device, are classified:a) In Class I, where they are intended for transitional use;b) In class II, if they are intended for short-term use, except if used in theoral cavity to the pharynx, in the ear canal to the tympanum or in the nasal cavity, inwhich case they are classified in class I; andc) In class III, if they are intended for long-term use, except if used in theoral cavity to the pharynx, in the ear canal to the tympanum or in the nasal cavity, and ifthey are not susceptible to absorption by the mucosa, in which case they are classified inclass II.All invasive medical devices applicable to body holes, except surgicallyinvasive devices, which are intended to be connected to an active Class II, III or IVmedical device, are classified in Class II.Rule 6All surgically invasive devices intended for transitory use are classified inClass II, unless:a) Are specifically intended to control, diagnose, monitor or correctcardiac or central circulatory system dysfunctions through direct contact with theseparts of the body, in which case they are classified in Class IV;b) are reusable surgical instruments, in which case they are classifiedIn class I;c) they are specifically intended to be used in direct contact withHeart, the central circulatory system or the central nervous system, in which case theyare classified in class IV;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,"b) In Class III, if they are intended to be used mainly in skin lesions that"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","b) In Class III, if they are intended to be used mainly in skin lesions that"
div,['txt'],position:absolute; left:84px; top:146px;,have produced rupture of the dermis or mucous membranes and which can only heal
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",have produced rupture of the dermis or mucous membranes and which can only heal
div,['txt'],position:absolute; left:84px; top:160px;,by second intention;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",by second intention;
div,['txt'],position:absolute; left:144px; top:182px;,"c) In class II, the case is mainly intended to control the microenvironment of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","c) In class II, the case is mainly intended to control the microenvironment of"
div,['txt'],position:absolute; left:84px; top:197px;,the injured skin or mucous membrane; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the injured skin or mucous membrane; and
div,['txt'],position:absolute; left:145px; top:220px;,d) In class II in all other cases.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",d) In class II in all other cases.
div,['txt'],position:absolute; left:144px; top:242px;,This rule also applies to invasive devices that come into contact with a
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",This rule also applies to invasive devices that come into contact with a
div,['txt'],position:absolute; left:84px; top:256px;,damaged mucous membrane.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",damaged mucous membrane.
div,['txt'],position:absolute; left:84px; top:278px;,Invasive Devices Rule
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Invasive Devices Rule
div,['txt'],position:absolute; left:84px; top:301px;,5
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",5
div,['txt'],position:absolute; left:145px; top:323px;,"All invasive medical devices applicable to body holes,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","All invasive medical devices applicable to body holes,"
div,['txt'],position:absolute; left:84px; top:337px;,"Except surgically invasive devices, which are not intended to be connected to an active"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Except surgically invasive devices, which are not intended to be connected to an active"
div,['txt'],position:absolute; left:84px; top:352px;,"device or are intended to be connected to an active class I device, are classified:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","device or are intended to be connected to an active class I device, are classified:"
div,['txt'],position:absolute; left:144px; top:375px;,"a) In Class I, where they are intended for transitional use;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) In Class I, where they are intended for transitional use;"
div,['txt'],position:absolute; left:144px; top:396px;,"b) In class II, if they are intended for short-term use, except if used in the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","b) In class II, if they are intended for short-term use, except if used in the"
div,['txt'],position:absolute; left:84px; top:411px;,"oral cavity to the pharynx, in the ear canal to the tympanum or in the nasal cavity, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","oral cavity to the pharynx, in the ear canal to the tympanum or in the nasal cavity, in"
div,['txt'],position:absolute; left:84px; top:426px;,which case they are classified in class I; and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which case they are classified in class I; and
div,['txt'],position:absolute; left:144px; top:448px;,"c) In class III, if they are intended for long-term use, except if used in the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","c) In class III, if they are intended for long-term use, except if used in the"
div,['txt'],position:absolute; left:84px; top:462px;,"oral cavity to the pharynx, in the ear canal to the tympanum or in the nasal cavity, and if"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","oral cavity to the pharynx, in the ear canal to the tympanum or in the nasal cavity, and if"
div,['txt'],position:absolute; left:84px; top:477px;,"they are not susceptible to absorption by the mucosa, in which case they are classified in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","they are not susceptible to absorption by the mucosa, in which case they are classified in"
div,['txt'],position:absolute; left:84px; top:492px;,class II.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",class II.
div,['txt'],position:absolute; left:144px; top:514px;,"All invasive medical devices applicable to body holes, except surgically"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","All invasive medical devices applicable to body holes, except surgically"
div,['txt'],position:absolute; left:84px; top:529px;,"invasive devices, which are intended to be connected to an active Class II, III or IV"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","invasive devices, which are intended to be connected to an active Class II, III or IV"
div,['txt'],position:absolute; left:84px; top:544px;,"medical device, are classified in Class II."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","medical device, are classified in Class II."
div,['txt'],position:absolute; left:84px; top:565px;,Rule 6
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 6
div,['txt'],position:absolute; left:144px; top:588px;,All surgically invasive devices intended for transitory use are classified in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All surgically invasive devices intended for transitory use are classified in
div,['txt'],position:absolute; left:84px; top:603px;,"Class II, unless:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Class II, unless:"
div,['txt'],position:absolute; left:144px; top:624px;,"a) Are specifically intended to control, diagnose, monitor or correct"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) Are specifically intended to control, diagnose, monitor or correct"
div,['txt'],position:absolute; left:84px; top:639px;,cardiac or central circulatory system dysfunctions through direct contact with these
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",cardiac or central circulatory system dysfunctions through direct contact with these
div,['txt'],position:absolute; left:84px; top:654px;,"parts of the body, in which case they are classified in Class IV;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","parts of the body, in which case they are classified in Class IV;"
div,['txt'],position:absolute; left:144px; top:675px;,"b) are reusable surgical instruments, in which case they are classified"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","b) are reusable surgical instruments, in which case they are classified"
div,['txt'],position:absolute; left:84px; top:691px;,In class I;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",In class I;
div,['txt'],position:absolute; left:144px; top:712px;,c) they are specifically intended to be used in direct contact with
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",c) they are specifically intended to be used in direct contact with
div,['txt'],position:absolute; left:84px; top:727px;,"Heart, the central circulatory system or the central nervous system, in which case they"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Heart, the central circulatory system or the central nervous system, in which case they"
div,['txt'],position:absolute; left:84px; top:742px;,are classified in class IV;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",are classified in class IV;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAd) Are intended to provide energy in the form of ionizing radiation, inwhich case they are classified in Class III;e) Have a biological effect or are absorbed, in whole or in large part, inwhich case they are classified in Class III; orf) They are intended for the administration of medicines by means of adelivery system, when carried out in a potentially dangerous manner, considering themode of application, in which case they are classified in Class III.Rule 7All surgically invasive devices intended for short-term use are classified inClass II, unless:a) Are specifically intended to control, diagnose, monitor or correctcardiac or central circulatory system dysfunctions through direct contact with theseparts of the body, in which case they are classified in Class IV;b) They are specifically intended to be used in direct contact with theheart, the central circulatory system or the central nervous system, in which case theyare classified in class IV;c) Are intended to provide energy in the form of ionizing radiation, inwhich case they are classified in Class III;d) Have a biological effect or are absorbed, in whole or in large part, inwhich case they are classified in Class IV;e) They are intended to undergo a chemical transformation in the body, inwhich case they belong to Class III, unless they are placed on the teeth; orf) they are intended to administer medicines, in which case they areclassifiedIn class III.Rule 8All implantable devices and devices surgicallyInvasive drugs intended for long-term use are classified in Class III, unless:Class II;a) they are intended to be placed on the teeth, in which case they areclassified inb) they are intended to be used in direct contact with the heart, the systemCentral circulatory system or central nervous system, in which case they are classified inclass IV;c) Have a biological effect or are absorbed, in whole or in large part, inwhich case they are classified in Class IV;This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAd) Are intended to provide energy in the form of ionizing radiation, inwhich case they are classified in Class III;e) Have a biological effect or are absorbed, in whole or in large part, inwhich case they are classified in Class III; orf) They are intended for the administration of medicines by means of adelivery system, when carried out in a potentially dangerous manner, considering themode of application, in which case they are classified in Class III.Rule 7All surgically invasive devices intended for short-term use are classified inClass II, unless:a) Are specifically intended to control, diagnose, monitor or correctcardiac or central circulatory system dysfunctions through direct contact with theseparts of the body, in which case they are classified in Class IV;b) They are specifically intended to be used in direct contact with theheart, the central circulatory system or the central nervous system, in which case theyare classified in class IV;c) Are intended to provide energy in the form of ionizing radiation, inwhich case they are classified in Class III;d) Have a biological effect or are absorbed, in whole or in large part, inwhich case they are classified in Class IV;e) They are intended to undergo a chemical transformation in the body, inwhich case they belong to Class III, unless they are placed on the teeth; orf) they are intended to administer medicines, in which case they areclassifiedIn class III.Rule 8All implantable devices and devices surgicallyInvasive drugs intended for long-term use are classified in Class III, unless:Class II;a) they are intended to be placed on the teeth, in which case they areclassified inb) they are intended to be used in direct contact with the heart, the systemCentral circulatory system or central nervous system, in which case they are classified inclass IV;c) Have a biological effect or are absorbed, in whole or in large part, inwhich case they are classified in Class IV;This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,"d) Are intended to provide energy in the form of ionizing radiation, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","d) Are intended to provide energy in the form of ionizing radiation, in"
div,['txt'],position:absolute; left:84px; top:146px;,which case they are classified in Class III;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which case they are classified in Class III;
div,['txt'],position:absolute; left:144px; top:168px;,"e) Have a biological effect or are absorbed, in whole or in large part, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","e) Have a biological effect or are absorbed, in whole or in large part, in"
div,['txt'],position:absolute; left:84px; top:183px;,which case they are classified in Class III; or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which case they are classified in Class III; or
div,['txt'],position:absolute; left:144px; top:205px;,f) They are intended for the administration of medicines by means of a
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",f) They are intended for the administration of medicines by means of a
div,['txt'],position:absolute; left:84px; top:219px;,"delivery system, when carried out in a potentially dangerous manner, considering the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","delivery system, when carried out in a potentially dangerous manner, considering the"
div,['txt'],position:absolute; left:84px; top:234px;,"mode of application, in which case they are classified in Class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","mode of application, in which case they are classified in Class III."
div,['txt'],position:absolute; left:84px; top:256px;,Rule 7
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 7
div,['txt'],position:absolute; left:144px; top:278px;,All surgically invasive devices intended for short-term use are classified in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All surgically invasive devices intended for short-term use are classified in
div,['txt'],position:absolute; left:84px; top:293px;,"Class II, unless:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Class II, unless:"
div,['txt'],position:absolute; left:144px; top:315px;,"a) Are specifically intended to control, diagnose, monitor or correct"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) Are specifically intended to control, diagnose, monitor or correct"
div,['txt'],position:absolute; left:84px; top:330px;,cardiac or central circulatory system dysfunctions through direct contact with these
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",cardiac or central circulatory system dysfunctions through direct contact with these
div,['txt'],position:absolute; left:84px; top:345px;,"parts of the body, in which case they are classified in Class IV;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","parts of the body, in which case they are classified in Class IV;"
div,['txt'],position:absolute; left:144px; top:367px;,b) They are specifically intended to be used in direct contact with the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) They are specifically intended to be used in direct contact with the
div,['txt'],position:absolute; left:84px; top:381px;,"heart, the central circulatory system or the central nervous system, in which case they"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","heart, the central circulatory system or the central nervous system, in which case they"
div,['txt'],position:absolute; left:84px; top:396px;,are classified in class IV;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",are classified in class IV;
div,['txt'],position:absolute; left:144px; top:418px;,"c) Are intended to provide energy in the form of ionizing radiation, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","c) Are intended to provide energy in the form of ionizing radiation, in"
div,['txt'],position:absolute; left:84px; top:433px;,which case they are classified in Class III;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which case they are classified in Class III;
div,['txt'],position:absolute; left:144px; top:455px;,"d) Have a biological effect or are absorbed, in whole or in large part, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","d) Have a biological effect or are absorbed, in whole or in large part, in"
div,['txt'],position:absolute; left:84px; top:470px;,which case they are classified in Class IV;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which case they are classified in Class IV;
div,['txt'],position:absolute; left:144px; top:492px;,"e) They are intended to undergo a chemical transformation in the body, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","e) They are intended to undergo a chemical transformation in the body, in"
div,['txt'],position:absolute; left:84px; top:506px;,"which case they belong to Class III, unless they are placed on the teeth; or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","which case they belong to Class III, unless they are placed on the teeth; or"
div,['txt'],position:absolute; left:144px; top:528px;,"f) they are intended to administer medicines, in which case they are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","f) they are intended to administer medicines, in which case they are"
div,['txt'],position:absolute; left:155px; top:543px;,classified
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classified
div,['txt'],position:absolute; left:84px; top:558px;,In class III.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",In class III.
div,['txt'],position:absolute; left:84px; top:580px;,Rule 8
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 8
div,['txt'],position:absolute; left:145px; top:602px;,All implantable devices and devices surgically
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All implantable devices and devices surgically
div,['txt'],position:absolute; left:84px; top:617px;,"Invasive drugs intended for long-term use are classified in Class III, unless:"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Invasive drugs intended for long-term use are classified in Class III, unless:"
div,['txt'],position:absolute; left:84px; top:668px;,Class II;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Class II;
div,['txt'],position:absolute; left:144px; top:639px;,"a) they are intended to be placed on the teeth, in which case they are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) they are intended to be placed on the teeth, in which case they are"
div,['txt'],position:absolute; left:157px; top:654px;,classified in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classified in
div,['txt'],position:absolute; left:145px; top:690px;,"b) they are intended to be used in direct contact with the heart, the system"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","b) they are intended to be used in direct contact with the heart, the system"
div,['txt'],position:absolute; left:84px; top:705px;,"Central circulatory system or central nervous system, in which case they are classified in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Central circulatory system or central nervous system, in which case they are classified in"
div,['txt'],position:absolute; left:84px; top:720px;,class IV;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",class IV;
div,['txt'],position:absolute; left:144px; top:742px;,"c) Have a biological effect or are absorbed, in whole or in large part, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","c) Have a biological effect or are absorbed, in whole or in large part, in"
div,['txt'],position:absolute; left:84px; top:757px;,which case they are classified in Class IV;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which case they are classified in Class IV;
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAd) Are intended to undergo a chemical transformation in the body, in whichcase they are classified in Class IV, except if they are placed on the teeth;e) they are intended to administer medicines, in which case they areclassifiedIn class IV;f) be active implantable devices or their accessories, in which caseAre classified in class IV;class IV;g) Breast implants or surgical screens, in which case they are classified inh) Are total or partial joint prostheses, in which case they are classified inclass IV, with the exception of auxiliary components such as screws, wedges, plates andinstruments; ori) They are intervertebral disc replacement implants or implantabledevices that come into contact with the spine, in which case they are classified in ClassIV, with the exception of components such as screws, wedges, plates, and instruments.Active DevicesRule 9All active therapeutic devices intended to supply or exchange energy areclassified in Class II, unless by their characteristics they canProvide energy to the human body or exchange energy with it in a potentiallydangerous way, taking into account the nature, density and place of application ofenergy, in which case they are classified in Class III.All active medical devices intended to control or monitor the performanceof active Class III therapeutic devices, or to directly influence the performance of thesedevices, are classified in Class III.All active medical devices intended to emit ionizing radiation fortherapeutic purposes, including medical devices that control or monitor such devicesor that directly influence their performance, are classified in Class III.All active medical devices intended to directly control, monitor, orinfluence the performance of active implantable devices are classified in Class IV.Rule 10where:Active devices for diagnosis and monitoring are classified in Class II in casesThis text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAd) Are intended to undergo a chemical transformation in the body, in whichcase they are classified in Class IV, except if they are placed on the teeth;e) they are intended to administer medicines, in which case they areclassifiedIn class IV;f) be active implantable devices or their accessories, in which caseAre classified in class IV;class IV;g) Breast implants or surgical screens, in which case they are classified inh) Are total or partial joint prostheses, in which case they are classified inclass IV, with the exception of auxiliary components such as screws, wedges, plates andinstruments; ori) They are intervertebral disc replacement implants or implantabledevices that come into contact with the spine, in which case they are classified in ClassIV, with the exception of components such as screws, wedges, plates, and instruments.Active DevicesRule 9All active therapeutic devices intended to supply or exchange energy areclassified in Class II, unless by their characteristics they canProvide energy to the human body or exchange energy with it in a potentiallydangerous way, taking into account the nature, density and place of application ofenergy, in which case they are classified in Class III.All active medical devices intended to control or monitor the performanceof active Class III therapeutic devices, or to directly influence the performance of thesedevices, are classified in Class III.All active medical devices intended to emit ionizing radiation fortherapeutic purposes, including medical devices that control or monitor such devicesor that directly influence their performance, are classified in Class III.All active medical devices intended to directly control, monitor, orinfluence the performance of active implantable devices are classified in Class IV.Rule 10where:Active devices for diagnosis and monitoring are classified in Class II in casesThis text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,"d) Are intended to undergo a chemical transformation in the body, in which"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","d) Are intended to undergo a chemical transformation in the body, in which"
div,['txt'],position:absolute; left:84px; top:146px;,"case they are classified in Class IV, except if they are placed on the teeth;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","case they are classified in Class IV, except if they are placed on the teeth;"
div,['txt'],position:absolute; left:144px; top:168px;,"e) they are intended to administer medicines, in which case they are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","e) they are intended to administer medicines, in which case they are"
div,['txt'],position:absolute; left:157px; top:183px;,classified
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classified
div,['txt'],position:absolute; left:84px; top:197px;,In class IV;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",In class IV;
div,['txt'],position:absolute; left:144px; top:219px;,"f) be active implantable devices or their accessories, in which case"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","f) be active implantable devices or their accessories, in which case"
div,['txt'],position:absolute; left:84px; top:234px;,Are classified in class IV;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Are classified in class IV;
div,['txt'],position:absolute; left:84px; top:256px;,"class IV;g) Breast implants or surgical screens, in which case they are classified in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",class IV;
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);","g) Breast implants or surgical screens, in which case they are classified in"
div,['txt'],position:absolute; left:144px; top:293px;,"h) Are total or partial joint prostheses, in which case they are classified in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","h) Are total or partial joint prostheses, in which case they are classified in"
div,['txt'],position:absolute; left:84px; top:308px;,"class IV, with the exception of auxiliary components such as screws, wedges, plates and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","class IV, with the exception of auxiliary components such as screws, wedges, plates and"
div,['txt'],position:absolute; left:84px; top:322px;,instruments; or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",instruments; or
div,['txt'],position:absolute; left:144px; top:345px;,i) They are intervertebral disc replacement implants or implantable
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",i) They are intervertebral disc replacement implants or implantable
div,['txt'],position:absolute; left:84px; top:360px;,"devices that come into contact with the spine, in which case they are classified in Class"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","devices that come into contact with the spine, in which case they are classified in Class"
div,['txt'],position:absolute; left:84px; top:374px;,"IV, with the exception of components such as screws, wedges, plates, and instruments."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","IV, with the exception of components such as screws, wedges, plates, and instruments."
div,['txt'],position:absolute; left:84px; top:396px;,Active Devices
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Active Devices
div,['txt'],position:absolute; left:84px; top:419px;,Rule 9
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 9
div,['txt'],position:absolute; left:144px; top:440px;,All active therapeutic devices intended to supply or exchange energy are
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All active therapeutic devices intended to supply or exchange energy are
div,['txt'],position:absolute; left:84px; top:455px;,"classified in Class II, unless by their characteristics they can"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","classified in Class II, unless by their characteristics they can"
div,['txt'],position:absolute; left:84px; top:469px;,Provide energy to the human body or exchange energy with it in a potentially
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Provide energy to the human body or exchange energy with it in a potentially
div,['txt'],position:absolute; left:84px; top:484px;,"dangerous way, taking into account the nature, density and place of application of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","dangerous way, taking into account the nature, density and place of application of"
div,['txt'],position:absolute; left:84px; top:499px;,"energy, in which case they are classified in Class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","energy, in which case they are classified in Class III."
div,['txt'],position:absolute; left:144px; top:521px;,All active medical devices intended to control or monitor the performance
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All active medical devices intended to control or monitor the performance
div,['txt'],position:absolute; left:84px; top:535px;,"of active Class III therapeutic devices, or to directly influence the performance of these"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","of active Class III therapeutic devices, or to directly influence the performance of these"
div,['txt'],position:absolute; left:84px; top:551px;,"devices, are classified in Class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","devices, are classified in Class III."
div,['txt'],position:absolute; left:144px; top:572px;,All active medical devices intended to emit ionizing radiation for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All active medical devices intended to emit ionizing radiation for
div,['txt'],position:absolute; left:84px; top:587px;,"therapeutic purposes, including medical devices that control or monitor such devices"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","therapeutic purposes, including medical devices that control or monitor such devices"
div,['txt'],position:absolute; left:84px; top:602px;,"or that directly influence their performance, are classified in Class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","or that directly influence their performance, are classified in Class III."
div,['txt'],position:absolute; left:144px; top:624px;,"All active medical devices intended to directly control, monitor, or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","All active medical devices intended to directly control, monitor, or"
div,['txt'],position:absolute; left:84px; top:638px;,influence the performance of active implantable devices are classified in Class IV.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",influence the performance of active implantable devices are classified in Class IV.
div,['txt'],position:absolute; left:84px; top:660px;,Rule 10
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 10
div,['txt'],position:absolute; left:84px; top:682px;,where:Active devices for diagnosis and monitoring are classified in Class II in cases
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",where:
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",Active devices for diagnosis and monitoring are classified in Class II in cases
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAa) Are intended to provide energy that will be absorbed by the humanbody, except for devices intended to illuminate the patient's body in the visiblespectrum, in which case they are classified in Class I;b) they are intended to visualize in vivo the dissemination ofradiopharmaceutical products; orc) Are intended to allow direct diagnosis or monitoring of vitalphysiological processes, unless specifically intended for monitoring or observing vitalphysiological parameters and that the nature of the variations in these parametersmay result in immediate danger to the patient, as is the case of dasVariations in the heart rate, breathing and activity of the central nervoussystem, or are intended for diagnosis in clinical situations where the patient is inimmediate danger, cases in which they are classified in class III.Active devices intended to emit ionizing radiation for diagnostic ortherapeutic radiology, including interventional radiology devices and those that controlor monitor such devices, or that directly influence their performance, are classified inClass III.Rule 11Software intended to provide information used for decision-making fortherapeutic or diagnostic purposes is classified in Class II, unless such decisions have animpact that may cause:a) The death or irreversible deterioration of a person's state of health, inwhich case it is classified in Class IV; orb) A serious deterioration in the health status of a person or a surgicalintervention, in which case it is classified in Class III.The software intended to monitor physiological processes is classified inclass II, except when it is intended to monitor vital physiological parameters, when thenature of the variations of these parameters may result in immediate danger to thepatient, in which case it is classified in class III.Class I.Any other Software as a Medical Device (SaMD) is classified inRule 12All active medical devices intended to administer in the bodyHuman or to remove from it medicinal products, body fluids or other substances areclassified in Class II, unless this is done in a potentially dangerous manner, taking intoaccount the nature of the substances or part of the body involved and the mode ofapplication, Case in which they are classified in class III.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAa) Are intended to provide energy that will be absorbed by the humanbody, except for devices intended to illuminate the patient's body in the visiblespectrum, in which case they are classified in Class I;b) they are intended to visualize in vivo the dissemination ofradiopharmaceutical products; orc) Are intended to allow direct diagnosis or monitoring of vitalphysiological processes, unless specifically intended for monitoring or observing vitalphysiological parameters and that the nature of the variations in these parametersmay result in immediate danger to the patient, as is the case of dasVariations in the heart rate, breathing and activity of the central nervoussystem, or are intended for diagnosis in clinical situations where the patient is inimmediate danger, cases in which they are classified in class III.Active devices intended to emit ionizing radiation for diagnostic ortherapeutic radiology, including interventional radiology devices and those that controlor monitor such devices, or that directly influence their performance, are classified inClass III.Rule 11Software intended to provide information used for decision-making fortherapeutic or diagnostic purposes is classified in Class II, unless such decisions have animpact that may cause:a) The death or irreversible deterioration of a person's state of health, inwhich case it is classified in Class IV; orb) A serious deterioration in the health status of a person or a surgicalintervention, in which case it is classified in Class III.The software intended to monitor physiological processes is classified inclass II, except when it is intended to monitor vital physiological parameters, when thenature of the variations of these parameters may result in immediate danger to thepatient, in which case it is classified in class III.Class I.Any other Software as a Medical Device (SaMD) is classified inRule 12All active medical devices intended to administer in the bodyHuman or to remove from it medicinal products, body fluids or other substances areclassified in Class II, unless this is done in a potentially dangerous manner, taking intoaccount the nature of the substances or part of the body involved and the mode ofapplication, Case in which they are classified in class III.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,a) Are intended to provide energy that will be absorbed by the human
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",a) Are intended to provide energy that will be absorbed by the human
div,['txt'],position:absolute; left:84px; top:146px;,"body, except for devices intended to illuminate the patient's body in the visible"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","body, except for devices intended to illuminate the patient's body in the visible"
div,['txt'],position:absolute; left:84px; top:160px;,"spectrum, in which case they are classified in Class I;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","spectrum, in which case they are classified in Class I;"
div,['txt'],position:absolute; left:144px; top:182px;,b) they are intended to visualize in vivo the dissemination of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) they are intended to visualize in vivo the dissemination of
div,['txt'],position:absolute; left:84px; top:197px;,radiopharmaceutical products; or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",radiopharmaceutical products; or
div,['txt'],position:absolute; left:144px; top:219px;,c) Are intended to allow direct diagnosis or monitoring of vital
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",c) Are intended to allow direct diagnosis or monitoring of vital
div,['txt'],position:absolute; left:84px; top:234px;,"physiological processes, unless specifically intended for monitoring or observing vital"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","physiological processes, unless specifically intended for monitoring or observing vital"
div,['txt'],position:absolute; left:84px; top:248px;,physiological parameters and that the nature of the variations in these parameters
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",physiological parameters and that the nature of the variations in these parameters
div,['txt'],position:absolute; left:84px; top:263px;,"may result in immediate danger to the patient, as is the case of das"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","may result in immediate danger to the patient, as is the case of das"
div,['txt'],position:absolute; left:144px; top:285px;,"Variations in the heart rate, breathing and activity of the central nervous"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Variations in the heart rate, breathing and activity of the central nervous"
div,['txt'],position:absolute; left:84px; top:300px;,"system, or are intended for diagnosis in clinical situations where the patient is in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","system, or are intended for diagnosis in clinical situations where the patient is in"
div,['txt'],position:absolute; left:84px; top:315px;,"immediate danger, cases in which they are classified in class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","immediate danger, cases in which they are classified in class III."
div,['txt'],position:absolute; left:144px; top:337px;,Active devices intended to emit ionizing radiation for diagnostic or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Active devices intended to emit ionizing radiation for diagnostic or
div,['txt'],position:absolute; left:84px; top:352px;,"therapeutic radiology, including interventional radiology devices and those that control"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","therapeutic radiology, including interventional radiology devices and those that control"
div,['txt'],position:absolute; left:84px; top:366px;,"or monitor such devices, or that directly influence their performance, are classified in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","or monitor such devices, or that directly influence their performance, are classified in"
div,['txt'],position:absolute; left:84px; top:381px;,Class III.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Class III.
div,['txt'],position:absolute; left:84px; top:403px;,Rule 11
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 11
div,['txt'],position:absolute; left:144px; top:425px;,Software intended to provide information used for decision-making for
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Software intended to provide information used for decision-making for
div,['txt'],position:absolute; left:84px; top:439px;,"therapeutic or diagnostic purposes is classified in Class II, unless such decisions have an"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","therapeutic or diagnostic purposes is classified in Class II, unless such decisions have an"
div,['txt'],position:absolute; left:84px; top:454px;,impact that may cause:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",impact that may cause:
div,['txt'],position:absolute; left:144px; top:476px;,"a) The death or irreversible deterioration of a person's state of health, in"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) The death or irreversible deterioration of a person's state of health, in"
div,['txt'],position:absolute; left:84px; top:491px;,which case it is classified in Class IV; or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",which case it is classified in Class IV; or
div,['txt'],position:absolute; left:144px; top:513px;,b) A serious deterioration in the health status of a person or a surgical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) A serious deterioration in the health status of a person or a surgical
div,['txt'],position:absolute; left:84px; top:528px;,"intervention, in which case it is classified in Class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","intervention, in which case it is classified in Class III."
div,['txt'],position:absolute; left:144px; top:550px;,The software intended to monitor physiological processes is classified in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",The software intended to monitor physiological processes is classified in
div,['txt'],position:absolute; left:84px; top:565px;,"class II, except when it is intended to monitor vital physiological parameters, when the"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","class II, except when it is intended to monitor vital physiological parameters, when the"
div,['txt'],position:absolute; left:84px; top:579px;,nature of the variations of these parameters may result in immediate danger to the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",nature of the variations of these parameters may result in immediate danger to the
div,['txt'],position:absolute; left:84px; top:594px;,"patient, in which case it is classified in class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","patient, in which case it is classified in class III."
div,['txt'],position:absolute; left:84px; top:616px;,Class I.Any other Software as a Medical Device (SaMD) is classified in
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Class I.
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",Any other Software as a Medical Device (SaMD) is classified in
div,['txt'],position:absolute; left:84px; top:653px;,Rule 12
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 12
div,['txt'],position:absolute; left:145px; top:675px;,All active medical devices intended to administer in the body
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All active medical devices intended to administer in the body
div,['txt'],position:absolute; left:84px; top:690px;,"Human or to remove from it medicinal products, body fluids or other substances are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Human or to remove from it medicinal products, body fluids or other substances are"
div,['txt'],position:absolute; left:84px; top:704px;,"classified in Class II, unless this is done in a potentially dangerous manner, taking into"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","classified in Class II, unless this is done in a potentially dangerous manner, taking into"
div,['txt'],position:absolute; left:84px; top:719px;,account the nature of the substances or part of the body involved and the mode of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",account the nature of the substances or part of the body involved and the mode of
div,['txt'],position:absolute; left:84px; top:734px;,"application, Case in which they are classified in class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","application, Case in which they are classified in class III."
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISARule 13All other active medical devices, not framed in the rulesPrevious ones are classified in class I.Special RulesRule 14All devices containing, as an integral part, a substance which, if usedseparately, can be considered a medicinal product, including a medicinal productderived from human blood or plasma, and which has a complementary action to that ofthe devices, are classified in Class IV.Rule 15All devices used in contraception or in the prevention of transmission ofsexually transmitted diseases are classified in Class III, except in the case ofimplantable or invasive devices intended for long-term use, in which case they areclassified in Class IV.Rule 16All medical devices specifically intended to be used to disinfect, clean,wash or, if applicable, moisturize contact lenses are classified in Class III.All devices specifically intended to be used to disinfect or sterilize medicaldevices are classified in Class II, except in the case of washing and disinfectingmachines specifically intended to be used to disinfect invasive devices as the finalstage of processing, Case in which they are classified in class III.This rule does not apply to devices intended for the cleaning, solely byphysical action, of devices other than contact lenses.Artificial tears and ophthalmic lubricants, when framed as medicaldevices, are classified in Class III.Rule 17The devicesspecifically intendedgenerated diagnostic images are classified in class II.Recording X-rayRule 18All devices manufactured by the use of cells, tissues, or their non-viablederivatives (without metabolism or multiplication capacity) or made non-viable, areclassified in Class IV, unless they are devices intended to come into contact solely withintact skin.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISARule 13All other active medical devices, not framed in the rulesPrevious ones are classified in class I.Special RulesRule 14All devices containing, as an integral part, a substance which, if usedseparately, can be considered a medicinal product, including a medicinal productderived from human blood or plasma, and which has a complementary action to that ofthe devices, are classified in Class IV.Rule 15All devices used in contraception or in the prevention of transmission ofsexually transmitted diseases are classified in Class III, except in the case ofimplantable or invasive devices intended for long-term use, in which case they areclassified in Class IV.Rule 16All medical devices specifically intended to be used to disinfect, clean,wash or, if applicable, moisturize contact lenses are classified in Class III.All devices specifically intended to be used to disinfect or sterilize medicaldevices are classified in Class II, except in the case of washing and disinfectingmachines specifically intended to be used to disinfect invasive devices as the finalstage of processing, Case in which they are classified in class III.This rule does not apply to devices intended for the cleaning, solely byphysical action, of devices other than contact lenses.Artificial tears and ophthalmic lubricants, when framed as medicaldevices, are classified in Class III.Rule 17The devicesspecifically intendedgenerated diagnostic images are classified in class II.Recording X-rayRule 18All devices manufactured by the use of cells, tissues, or their non-viablederivatives (without metabolism or multiplication capacity) or made non-viable, areclassified in Class IV, unless they are devices intended to come into contact solely withintact skin.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:84px; top:131px;,Rule 13
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 13
div,['txt'],position:absolute; left:145px; top:153px;,"All other active medical devices, not framed in the rules"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","All other active medical devices, not framed in the rules"
div,['txt'],position:absolute; left:84px; top:168px;,Previous ones are classified in class I.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Previous ones are classified in class I.
div,['txt'],position:absolute; left:84px; top:190px;,Special Rules
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Special Rules
div,['txt'],position:absolute; left:84px; top:212px;,Rule 14
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 14
div,['txt'],position:absolute; left:144px; top:234px;,"All devices containing, as an integral part, a substance which, if used"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","All devices containing, as an integral part, a substance which, if used"
div,['txt'],position:absolute; left:84px; top:249px;,"separately, can be considered a medicinal product, including a medicinal product"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","separately, can be considered a medicinal product, including a medicinal product"
div,['txt'],position:absolute; left:84px; top:264px;,"derived from human blood or plasma, and which has a complementary action to that of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","derived from human blood or plasma, and which has a complementary action to that of"
div,['txt'],position:absolute; left:84px; top:278px;,"the devices, are classified in Class IV."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","the devices, are classified in Class IV."
div,['txt'],position:absolute; left:84px; top:301px;,Rule 15
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 15
div,['txt'],position:absolute; left:144px; top:323px;,All devices used in contraception or in the prevention of transmission of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All devices used in contraception or in the prevention of transmission of
div,['txt'],position:absolute; left:84px; top:337px;,"sexually transmitted diseases are classified in Class III, except in the case of"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","sexually transmitted diseases are classified in Class III, except in the case of"
div,['txt'],position:absolute; left:84px; top:352px;,"implantable or invasive devices intended for long-term use, in which case they are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","implantable or invasive devices intended for long-term use, in which case they are"
div,['txt'],position:absolute; left:84px; top:367px;,classified in Class IV.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classified in Class IV.
div,['txt'],position:absolute; left:84px; top:389px;,Rule 16
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 16
div,['txt'],position:absolute; left:144px; top:411px;,"All medical devices specifically intended to be used to disinfect, clean,"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","All medical devices specifically intended to be used to disinfect, clean,"
div,['txt'],position:absolute; left:84px; top:426px;,"wash or, if applicable, moisturize contact lenses are classified in Class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","wash or, if applicable, moisturize contact lenses are classified in Class III."
div,['txt'],position:absolute; left:144px; top:447px;,All devices specifically intended to be used to disinfect or sterilize medical
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All devices specifically intended to be used to disinfect or sterilize medical
div,['txt'],position:absolute; left:84px; top:462px;,"devices are classified in Class II, except in the case of washing and disinfecting"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","devices are classified in Class II, except in the case of washing and disinfecting"
div,['txt'],position:absolute; left:84px; top:477px;,machines specifically intended to be used to disinfect invasive devices as the final
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",machines specifically intended to be used to disinfect invasive devices as the final
div,['txt'],position:absolute; left:84px; top:492px;,"stage of processing, Case in which they are classified in class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","stage of processing, Case in which they are classified in class III."
div,['txt'],position:absolute; left:144px; top:514px;,"This rule does not apply to devices intended for the cleaning, solely by"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","This rule does not apply to devices intended for the cleaning, solely by"
div,['txt'],position:absolute; left:84px; top:529px;,"physical action, of devices other than contact lenses."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","physical action, of devices other than contact lenses."
div,['txt'],position:absolute; left:144px; top:550px;,"Artificial tears and ophthalmic lubricants, when framed as medical"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Artificial tears and ophthalmic lubricants, when framed as medical"
div,['txt'],position:absolute; left:84px; top:565px;,"devices, are classified in Class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","devices, are classified in Class III."
div,['txt'],position:absolute; left:84px; top:588px;,Rule 17
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 17
div,['txt'],position:absolute; left:144px; top:610px;,The devices
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",The devices
div,['txt'],position:absolute; left:232px; top:610px;,specifically intended
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",specifically intended
div,['txt'],position:absolute; left:84px; top:625px;,generated diagnostic images are classified in class II.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",generated diagnostic images are classified in class II.
div,['txt'],position:absolute; left:383px; top:610px;,Recording X-ray
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Recording X-ray
div,['txt'],position:absolute; left:84px; top:646px;,Rule 18
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 18
div,['txt'],position:absolute; left:144px; top:668px;,"All devices manufactured by the use of cells, tissues, or their non-viable"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","All devices manufactured by the use of cells, tissues, or their non-viable"
div,['txt'],position:absolute; left:84px; top:683px;,"derivatives (without metabolism or multiplication capacity) or made non-viable, are"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","derivatives (without metabolism or multiplication capacity) or made non-viable, are"
div,['txt'],position:absolute; left:84px; top:698px;,"classified in Class IV, unless they are devices intended to come into contact solely with"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","classified in Class IV, unless they are devices intended to come into contact solely with"
div,['txt'],position:absolute; left:84px; top:712px;,intact skin.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",intact skin.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAThis rule does not apply to advanced therapy products, which are treatedby a specific regulation.Rule 19All devices incorporating nanomaterials or consisting of nanomaterials areclassified:a) In class IV, if they have a high or medium internal exposure potential;b) In class III, if they have a low potential for internal exposure; andinternal.c) In class II, if they present an insignificant potential for exposureRule 20All invasive devices applicable to body holes exceptSurgically invasive devices intended for the administration of inhalation medicationsare classified in Class II unless their mode of action has a significant impact on theefficacy and safety of the medicinal product administered or is intended to treat life-threatening conditions, Case in which they are classified in class III.Rule 21Medical devices consisting of substances or combinations of substancesintended to be introduced into the human body by means of a body hole or applied tothe skin and which are absorbed or disseminated by the human body or locallydispersed therein shall be classified:a) In Class IV if devices or their metabolism products are absorbed ordisseminated systematically by the human body to achieve the intended purpose;b) Class IV if they achieve the intended purpose in the stomach or lowergastrointestinal tract and if the devices or their metabolism products are absorbed ordisseminated systemically by the human body;c) In Class II if applied to the skin or if applied to the nasal or oral cavitiesto the pharynx, and if the intended purpose in those cavities is achieved; andd) In class III in all other cases.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAThis rule does not apply to advanced therapy products, which are treatedby a specific regulation.Rule 19All devices incorporating nanomaterials or consisting of nanomaterials areclassified:a) In class IV, if they have a high or medium internal exposure potential;b) In class III, if they have a low potential for internal exposure; andinternal.c) In class II, if they present an insignificant potential for exposureRule 20All invasive devices applicable to body holes exceptSurgically invasive devices intended for the administration of inhalation medicationsare classified in Class II unless their mode of action has a significant impact on theefficacy and safety of the medicinal product administered or is intended to treat life-threatening conditions, Case in which they are classified in class III.Rule 21Medical devices consisting of substances or combinations of substancesintended to be introduced into the human body by means of a body hole or applied tothe skin and which are absorbed or disseminated by the human body or locallydispersed therein shall be classified:a) In Class IV if devices or their metabolism products are absorbed ordisseminated systematically by the human body to achieve the intended purpose;b) Class IV if they achieve the intended purpose in the stomach or lowergastrointestinal tract and if the devices or their metabolism products are absorbed ordisseminated systemically by the human body;c) In Class II if applied to the skin or if applied to the nasal or oral cavitiesto the pharynx, and if the intended purpose in those cavities is achieved; andd) In class III in all other cases.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:144px; top:131px;,"This rule does not apply to advanced therapy products, which are treated"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","This rule does not apply to advanced therapy products, which are treated"
div,['txt'],position:absolute; left:84px; top:146px;,by a specific regulation.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",by a specific regulation.
div,['txt'],position:absolute; left:84px; top:168px;,Rule 19
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 19
div,['txt'],position:absolute; left:144px; top:190px;,All devices incorporating nanomaterials or consisting of nanomaterials are
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All devices incorporating nanomaterials or consisting of nanomaterials are
div,['txt'],position:absolute; left:84px; top:205px;,classified:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",classified:
div,['txt'],position:absolute; left:144px; top:226px;,"a) In class IV, if they have a high or medium internal exposure potential;"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","a) In class IV, if they have a high or medium internal exposure potential;"
div,['txt'],position:absolute; left:145px; top:249px;,"b) In class III, if they have a low potential for internal exposure; and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","b) In class III, if they have a low potential for internal exposure; and"
div,['txt'],position:absolute; left:84px; top:271px;,"internal.c) In class II, if they present an insignificant potential for exposure"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",internal.
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);","c) In class II, if they present an insignificant potential for exposure"
div,['txt'],position:absolute; left:84px; top:307px;,Rule 20
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 20
div,['txt'],position:absolute; left:145px; top:330px;,All invasive devices applicable to body holes except
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",All invasive devices applicable to body holes except
div,['txt'],position:absolute; left:84px; top:345px;,Surgically invasive devices intended for the administration of inhalation medications
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Surgically invasive devices intended for the administration of inhalation medications
div,['txt'],position:absolute; left:84px; top:360px;,are classified in Class II unless their mode of action has a significant impact on the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",are classified in Class II unless their mode of action has a significant impact on the
div,['txt'],position:absolute; left:84px; top:374px;,efficacy and safety of the medicinal product administered or is intended to treat life-
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",efficacy and safety of the medicinal product administered or is intended to treat life-
div,['txt'],position:absolute; left:84px; top:389px;,"threatening conditions, Case in which they are classified in class III."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","threatening conditions, Case in which they are classified in class III."
div,['txt'],position:absolute; left:84px; top:410px;,Rule 21
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 21
div,['txt'],position:absolute; left:144px; top:432px;,Medical devices consisting of substances or combinations of substances
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Medical devices consisting of substances or combinations of substances
div,['txt'],position:absolute; left:84px; top:447px;,intended to be introduced into the human body by means of a body hole or applied to
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",intended to be introduced into the human body by means of a body hole or applied to
div,['txt'],position:absolute; left:84px; top:462px;,the skin and which are absorbed or disseminated by the human body or locally
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",the skin and which are absorbed or disseminated by the human body or locally
div,['txt'],position:absolute; left:84px; top:477px;,dispersed therein shall be classified:
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",dispersed therein shall be classified:
div,['txt'],position:absolute; left:144px; top:498px;,a) In Class IV if devices or their metabolism products are absorbed or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",a) In Class IV if devices or their metabolism products are absorbed or
div,['txt'],position:absolute; left:84px; top:513px;,disseminated systematically by the human body to achieve the intended purpose;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",disseminated systematically by the human body to achieve the intended purpose;
div,['txt'],position:absolute; left:144px; top:535px;,b) Class IV if they achieve the intended purpose in the stomach or lower
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",b) Class IV if they achieve the intended purpose in the stomach or lower
div,['txt'],position:absolute; left:84px; top:550px;,gastrointestinal tract and if the devices or their metabolism products are absorbed or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",gastrointestinal tract and if the devices or their metabolism products are absorbed or
div,['txt'],position:absolute; left:84px; top:565px;,disseminated systemically by the human body;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",disseminated systemically by the human body;
div,['txt'],position:absolute; left:144px; top:587px;,c) In Class II if applied to the skin or if applied to the nasal or oral cavities
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",c) In Class II if applied to the skin or if applied to the nasal or oral cavities
div,['txt'],position:absolute; left:84px; top:601px;,"to the pharynx, and if the intended purpose in those cavities is achieved; and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","to the pharynx, and if the intended purpose in those cavities is achieved; and"
div,['txt'],position:absolute; left:145px; top:624px;,d) In class III in all other cases.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",d) In class III in all other cases.
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISARule 22Active therapeutic devices with integrated diagnostic function orBuilt-in that significantly direct patient management, such as closed-loop systems orexternal automatic defibrillators, are classified in Class IV.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISARule 22Active therapeutic devices with integrated diagnostic function orBuilt-in that significantly direct patient management, such as closed-loop systems orexternal automatic defibrillators, are classified in Class IV.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:84px; top:131px;,Rule 22
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Rule 22
div,['txt'],position:absolute; left:145px; top:153px;,Active therapeutic devices with integrated diagnostic function or
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Active therapeutic devices with integrated diagnostic function or
div,['txt'],position:absolute; left:84px; top:168px;,"Built-in that significantly direct patient management, such as closed-loop systems or"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Built-in that significantly direct patient management, such as closed-loop systems or"
div,['txt'],position:absolute; left:84px; top:183px;,"external automatic defibrillators, are classified in Class IV."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","external automatic defibrillators, are classified in Class IV."
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAANNEX II.Technical Dossier Structure of Medical Devices subject to notification andregistration with AnvisaTechnical Device dossier Médico¹Chapter 1Administrative and technical information (formsavailable on the Anvisa Portal)List of devices (Models / Components / Variants)NotificationClass I ClassII.RegistrationClass ClassIII. IV.XXXXXXXXChapter 2Detailed Description of Medical Device andFundamentals of Operation and ActionXXXXDescription of the Packaging and presentation waysof the deviceX X X XIntended purpose (purpose of use); Purpose of use;Intended user; Indication of useX X X XEnvironment / context of intended useXXXXContraindications of useXXXXGlobal Marketing History-XXXChapter 3Risk managementXXXXList of essential Safety and Performance requirements- X X XList of technical standardsXXXXPhysical and Mechanical CharacterizationXXXXCharacterization of Material/ChemistryXXXXElectrical Systems: Safety, Mechanical andXXXXEnvironmental Protection, and ElectromagneticCompatibilityDescription of Software / FirmwareXXXXBiocompatibility assessmentXXXXReview of PirogenicityXXXXThis text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISAANNEX II.Technical Dossier Structure of Medical Devices subject to notification andregistration with AnvisaTechnical Device dossier Médico¹Chapter 1Administrative and technical information (formsavailable on the Anvisa Portal)List of devices (Models / Components / Variants)NotificationClass I ClassII.RegistrationClass ClassIII. IV.XXXXXXXXChapter 2Detailed Description of Medical Device andFundamentals of Operation and ActionXXXXDescription of the Packaging and presentation waysof the deviceX X X XIntended purpose (purpose of use); Purpose of use;Intended user; Indication of useX X X XEnvironment / context of intended useXXXXContraindications of useXXXXGlobal Marketing History-XXXChapter 3Risk managementXXXXList of essential Safety and Performance requirements- X X XList of technical standardsXXXXPhysical and Mechanical CharacterizationXXXXCharacterization of Material/ChemistryXXXXElectrical Systems: Safety, Mechanical andXXXXEnvironmental Protection, and ElectromagneticCompatibilityDescription of Software / FirmwareXXXXBiocompatibility assessmentXXXXReview of PirogenicityXXXXThis text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:273px; top:130px;,ANNEX II.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANNEX II.
div,['txt'],position:absolute; left:114px; top:160px;,Technical Dossier Structure of Medical Devices subject to notification and
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Technical Dossier Structure of Medical Devices subject to notification and
div,['txt'],position:absolute; left:237px; top:175px;,registration with Anvisa
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",registration with Anvisa
div,['txt'],position:absolute; left:87px; top:201px;,Technical Device dossier Médico¹
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Technical Device dossier Médico¹
div,['txt'],position:absolute; left:87px; top:256px;,Chapter 1
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Chapter 1
div,['txt'],position:absolute; left:87px; top:275px;,Administrative and technical information (forms
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Administrative and technical information (forms
div,['txt'],position:absolute; left:87px; top:290px;,available on the Anvisa Portal)
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",available on the Anvisa Portal)
div,['txt'],position:absolute; left:87px; top:310px;,List of devices (Models / Components / Variants)
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",List of devices (Models / Components / Variants)
div,['txt'],position:absolute; left:354px; top:201px;,Notification
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Notification
div,['txt'],position:absolute; left:354px; top:220px;,Class I Class
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Class I Class
div,['txt'],position:absolute; left:392px; top:236px;,II.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",II.
div,['txt'],position:absolute; left:432px; top:201px;,Registration
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Registration
div,['txt'],position:absolute; left:432px; top:220px;,Class Class
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Class Class
div,['txt'],position:absolute; left:432px; top:236px;,III. IV.
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",III. IV.
div,['txt'],position:absolute; left:354px; top:283px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:283px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:283px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:283px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:354px; top:317px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:317px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:317px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:317px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:344px;,Chapter 2
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Chapter 2
div,['txt'],position:absolute; left:90px; top:364px;,Detailed Description of Medical Device and
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Detailed Description of Medical Device and
div,['txt'],position:absolute; left:87px; top:378px;,Fundamentals of Operation and Action
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Fundamentals of Operation and Action
div,['txt'],position:absolute; left:354px; top:372px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:372px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:372px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:372px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:399px;,Description of the Packaging and presentation waysof the deviceX X X X
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",Description of the Packaging and presentation ways
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",of the device
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",X X X X
div,['txt'],position:absolute; left:87px; top:433px;,Intended purpose (purpose of use); Purpose of use;Intended user; Indication of useX X X X
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",Intended purpose (purpose of use); Purpose of use;
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Intended user; Indication of use
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",X X X X
div,['txt'],position:absolute; left:87px; top:468px;,Environment / context of intended use
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Environment / context of intended use
div,['txt'],position:absolute; left:354px; top:468px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:468px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:468px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:468px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:488px;,Contraindications of use
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Contraindications of use
div,['txt'],position:absolute; left:354px; top:488px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:488px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:488px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:488px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:508px;,Global Marketing History
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Global Marketing History
div,['txt'],position:absolute; left:354px; top:508px;,-
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",-
div,['txt'],position:absolute; left:392px; top:508px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:508px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:508px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:528px;,Chapter 3
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Chapter 3
div,['txt'],position:absolute; left:87px; top:548px;,Risk management
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Risk management
div,['txt'],position:absolute; left:354px; top:548px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:548px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:548px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:548px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:568px;,List of essential Safety and Performance requirements- X X X
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",List of essential Safety and Performance requirements
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",- X X X
div,['txt'],position:absolute; left:87px; top:602px;,List of technical standards
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",List of technical standards
div,['txt'],position:absolute; left:354px; top:602px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:602px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:602px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:602px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:622px;,Physical and Mechanical Characterization
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Physical and Mechanical Characterization
div,['txt'],position:absolute; left:354px; top:622px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:622px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:622px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:622px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:642px;,Characterization of Material/Chemistry
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Characterization of Material/Chemistry
div,['txt'],position:absolute; left:354px; top:642px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:642px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:642px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:642px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:662px;,"Electrical Systems: Safety, Mechanical and"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Electrical Systems: Safety, Mechanical and"
div,['txt'],position:absolute; left:354px; top:669px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:669px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:669px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:669px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:677px;,"Environmental Protection, and Electromagnetic"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Environmental Protection, and Electromagnetic"
div,['txt'],position:absolute; left:87px; top:692px;,Compatibility
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Compatibility
div,['txt'],position:absolute; left:87px; top:710px;,Description of Software / Firmware
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Description of Software / Firmware
div,['txt'],position:absolute; left:354px; top:710px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:710px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:710px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:710px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:730px;,Biocompatibility assessment
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Biocompatibility assessment
div,['txt'],position:absolute; left:354px; top:730px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:730px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:730px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:730px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:749px;,Review of Pirogenicity
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Review of Pirogenicity
div,['txt'],position:absolute; left:354px; top:749px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:749px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:749px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:749px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
html,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASafety of Biological MaterialsXXXXValidation of sterilizationXXXXResidual toxicityXXXXCleaning and Disinfection of Reusable ProductsXXXXUsability / Human FactorsXXXXProduct shelf life and Packaging Validation / StabilityX X X XStudyChapter 4General Summary of Clinical Evidence ²XXXXRelevant Clinical Literature-XXXChapter 5Product Labeling / PackagingXXXXInstructions for use / User ManualXXXXChapter 6General Manufacturing Information (factoryaddresses)XXXXManufacturing Process (Flowchart)XXXXProject and Development InformationXXXXNotes:1) The Medical Device Technical Dossier structure is aligned with thedocument issued by the International Medical Device Regulators Forum - IMDRF/RPSWG/N9 (Edition 3) FINAL:2019 - Non-In Vitro Diagnostic Device Market AuthorizationTable of Contents (nlVD MA TOC), and can be updated considering future editions.2) Applicable only when clinical evidence is required as a result ofdemonstration of safety and performance, technological innovations and newindications of use. In accordance with the current health legislation for clinical trialsconducted in Brazil, the Specific Special Notice should be presented.This text does not replace the published in the Official Gazette."
head,[],,
meta,[],,
style,[],,".txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url(""0.ttf""); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url(""1.ttf""); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url(""2.ttf""); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }
.f5 { font-family:monospace; font-weight:normal; font-style:normal; }"
body,[],,"Ministry of Health - MSNational Health Surveillance Agency–ANVISASafety of Biological MaterialsXXXXValidation of sterilizationXXXXResidual toxicityXXXXCleaning and Disinfection of Reusable ProductsXXXXUsability / Human FactorsXXXXProduct shelf life and Packaging Validation / StabilityX X X XStudyChapter 4General Summary of Clinical Evidence ²XXXXRelevant Clinical Literature-XXXChapter 5Product Labeling / PackagingXXXXInstructions for use / User ManualXXXXChapter 6General Manufacturing Information (factoryaddresses)XXXXManufacturing Process (Flowchart)XXXXProject and Development InformationXXXXNotes:1) The Medical Device Technical Dossier structure is aligned with thedocument issued by the International Medical Device Regulators Forum - IMDRF/RPSWG/N9 (Edition 3) FINAL:2019 - Non-In Vitro Diagnostic Device Market AuthorizationTable of Contents (nlVD MA TOC), and can be updated considering future editions.2) Applicable only when clinical evidence is required as a result ofdemonstration of safety and performance, technological innovations and newindications of use. In accordance with the current health legislation for clinical trialsconducted in Brazil, the Specific Special Notice should be presented.This text does not replace the published in the Official Gazette."
img,[],position:absolute; left:0px; top:0px;,
div,['txt'],position:absolute; left:253px; top:89px;,Ministry of Health - MS
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Ministry of Health - MS
div,['txt'],position:absolute; left:196px; top:103px;,National Health Surveillance Agency–ANVISA
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",National Health Surveillance Agency
span,['f2'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",–
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",ANVISA
div,['txt'],position:absolute; left:87px; top:134px;,Safety of Biological Materials
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Safety of Biological Materials
div,['txt'],position:absolute; left:354px; top:134px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:134px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:134px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:134px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:154px;,Validation of sterilization
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Validation of sterilization
div,['txt'],position:absolute; left:354px; top:154px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:154px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:154px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:154px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:174px;,Residual toxicity
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Residual toxicity
div,['txt'],position:absolute; left:354px; top:174px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:174px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:174px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:174px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:193px;,Cleaning and Disinfection of Reusable Products
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Cleaning and Disinfection of Reusable Products
div,['txt'],position:absolute; left:354px; top:193px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:193px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:193px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:193px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:214px;,Usability / Human Factors
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Usability / Human Factors
div,['txt'],position:absolute; left:354px; top:214px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:214px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:214px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:214px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:233px;,Product shelf life and Packaging Validation / StabilityX X X X
span,['f3'],"font-size:12px;vertical-align:super;color:rgba(0,0,0,1);",Product shelf life and Packaging Validation / Stability
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X X X X
div,['txt'],position:absolute; left:87px; top:248px;,Study
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Study
div,['txt'],position:absolute; left:87px; top:268px;,Chapter 4
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Chapter 4
div,['txt'],position:absolute; left:87px; top:288px;,General Summary of Clinical Evidence ²
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",General Summary of Clinical Evidence ²
div,['txt'],position:absolute; left:354px; top:288px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:288px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:288px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:288px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:307px;,Relevant Clinical Literature
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Relevant Clinical Literature
div,['txt'],position:absolute; left:354px; top:307px;,-
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",-
div,['txt'],position:absolute; left:392px; top:307px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:307px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:307px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:328px;,Chapter 5
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Chapter 5
div,['txt'],position:absolute; left:87px; top:348px;,Product Labeling / Packaging
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Product Labeling / Packaging
div,['txt'],position:absolute; left:354px; top:348px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:348px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:348px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:348px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:367px;,Instructions for use / User Manual
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Instructions for use / User Manual
div,['txt'],position:absolute; left:354px; top:367px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:367px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:367px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:367px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:388px;,Chapter 6
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Chapter 6
div,['txt'],position:absolute; left:87px; top:407px;,General Manufacturing Information (factory
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",General Manufacturing Information (factory
div,['txt'],position:absolute; left:87px; top:422px;,addresses)
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",addresses)
div,['txt'],position:absolute; left:354px; top:415px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:415px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:415px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:415px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:442px;,Manufacturing Process (Flowchart)
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Manufacturing Process (Flowchart)
div,['txt'],position:absolute; left:354px; top:442px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:442px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:442px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:442px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:87px; top:462px;,Project and Development Information
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Project and Development Information
div,['txt'],position:absolute; left:354px; top:462px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:392px; top:462px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:432px; top:462px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:472px; top:462px;,X
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",X
div,['txt'],position:absolute; left:145px; top:502px;,Notes:
span,['f1'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",Notes:
div,['txt'],position:absolute; left:144px; top:524px;,1) The Medical Device Technical Dossier structure is aligned with the
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",1) The Medical Device Technical Dossier structure is aligned with the
div,['txt'],position:absolute; left:84px; top:539px;,document issued by the International Medical Device Regulators Forum - IMDRF/RPS
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",document issued by the International Medical Device Regulators Forum - IMDRF/RPS
div,['txt'],position:absolute; left:84px; top:553px;,WG/N9 (Edition 3) FINAL:2019 - Non-In Vitro Diagnostic Device Market Authorization
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",WG/N9 (Edition 3) FINAL:2019 - Non-In Vitro Diagnostic Device Market Authorization
div,['txt'],position:absolute; left:84px; top:568px;,"Table of Contents (nlVD MA TOC), and can be updated considering future editions."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","Table of Contents (nlVD MA TOC), and can be updated considering future editions."
div,['txt'],position:absolute; left:144px; top:590px;,2) Applicable only when clinical evidence is required as a result of
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",2) Applicable only when clinical evidence is required as a result of
div,['txt'],position:absolute; left:84px; top:605px;,"demonstration of safety and performance, technological innovations and new"
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","demonstration of safety and performance, technological innovations and new"
div,['txt'],position:absolute; left:84px; top:620px;,indications of use. In accordance with the current health legislation for clinical trials
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);",indications of use. In accordance with the current health legislation for clinical trials
div,['txt'],position:absolute; left:84px; top:634px;,"conducted in Brazil, the Specific Special Notice should be presented."
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);","conducted in Brazil, the Specific Special Notice should be presented."
div,['txt'],position:absolute; left:145px; top:782px;,This text does not replace the published in the Official Gazette.
span,['f3'],"font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);",This text does not replace the published in the Official Gazette.
